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ABSTRACT 
Only 5-10 % of Mycobacterium tuberculosis (Mtb) infected individuals develop active 
pulmonary TB (PTB), and around < 1 % develop disseminated TB meningitis (TBM). 
Macrophages are one of the first defense barriers, but it is unclear how their 
antimicrobial activities influence TB presentations and clinical outcomes. Many studies 
have shown host and bacterial genetics are important factors in TB susceptibility and 
progression. I hypothesized that an impairment of macrophage phagocytic function, 
under the influence of genetic factors, may help explain the pathogenesis of the 
transition from latent to active or disseminated TB, and that the virulence of clinical 
Mtb isolates are associated with Mtb lineages and distinct host immune responses. 
I developed assays using ligand coated beads and Mtb reporter strain to measure the 
macrophage antimicrobial activities. Our assays were able to detect the variation in 
macrophage activities among different individuals. 
I investigated the macrophage antimicrobial functions and its association with different 
TB phenotypes. I measured the macrophage activities in 43 latent TB (LTB) and active 
TB (ATB) cases combining 54 PTB and 60 TBM patients. Our results showed that 
macrophages treated with ligands displayed higher antimicrobial activities in LTB than 
ATB, but no difference between PTB and TBM. Whereas, in Mtb-infected macrophages 
from both LTB and ATB, proteolysis was reduced due to the modulation of Mtb and 
there was no difference in their ability to control Mtb. Our data also indicated that the 
antimicrobial activities of macrophages were ligand-specific or pathway-dependent. 
The influence of host genetics on TB susceptibility was examined by the association of 
variants on phagocytic genes using a case-control study with 450 TBM, 450 PTB and 
450 controls. Heterozygotes of Macrophage receptor with collagenous structure 
(MARCO) single nucleotide polymorphisms (SNPs) were associated with increased TB 
susceptibility, abnormal chest X-ray, infection by Beijing strains and also with impaired 
macrophage phagocytosis of ligand coated beads.   
The virulence of Mtb strains was examined by observing cell lysis of macrophages 
infected with 159 Mtb strains. Virulence phenotype was grouped as low, moderate and 
high. High virulence was associated with Beijing lineage, reduced TNF-α and IL-6 and 
increased IL-1β concentration. 
Overall, this thesis provides new insights into the influence of host and bacterial factors 
on TB susceptibility. It also provides a foundation for further studies on factors 
influencing TB susceptibility. 
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Chapter 1 
INTRODUCTION 
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1.1 Tuberculosis (TB) 
1.1.1 History of tuberculosis 
Tuberculosis is a very old disease that was assumed to have accompanied human 
migrants out-of-Africa between 35,000-89,000 years ago, spreading to other parts of the 
world by land or coastal water travel
1
. However, a genomic study in 2014 has suggested 
that TB  is younger than 6,000 years old and seals could be the mode of transmission of 
the disease from Africa to South America
2
. The disease is very common and associated 
with death, thus it has been known with other names such as phthisis, Robber of youth, 
the Captain among these men of death, or the King of evil
3
. During the 19
th
 century, TB 
had become epidemic with high mortality rate among young and middle-aged adults
1
.  
The history of tuberculosis was changed dramatically on 24
th
 March, 1882, when Koch 
discovered Mycobacterium tuberculosis (Mtb) as the causative agent
1
 and explained the 
etiology of tuberculosis. The discovery was the greatest of the era and 24
th
 March is 
recognized as the World TB day. Koch’s discovery opened the way toward diagnosing 
and preventing tuberculosis. The other big achievements, still important today, were the 
development of the Pirquet and Mantoux tuberculin skin tests and Bacille Calmette-
Guerin (BCG) vaccine
1
. The discovery of streptomycin, isoniazid and rifampin also 
began a new era of TB treatment with the hope of eliminating the disease
1
. However, 
despite these tools, TB remains a major public health problem, compounded by HIV-TB 
co-infection and multi-drug resistant strains. 
1.1.2 Epidemiology of TB   
Although TB incidence has been falling globally at an average rate of 1.5 % per year 
since 2000, TB still remains a challenge for healthcare systems worldwide with an 
estimated 9.6 million new TB cases in 2014. Among these, there are 56.25 % men, 
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33.33 % women and 10.42 % children
4
. As a disease of poverty, TB cases are pre-
dominant in low-income countries. Six countries including China, India, Indonesia 
Nigeria, Pakistan and South Africa collectively accounted for 60% of new cases 
worldwide
5
. South Africa region has the highest incidence with 281 cases per 100,000 
population, which is twice the global average of 133
4
. High-income countries, including 
most countries in Western Europe, Canada, the United States of America, Australia and 
New Zealand, have very low burden with less than 10 cases per 100,000 population per 
year
6
.  
In addition, the synergistic interaction with HIV drives TB to be particularly difficult to 
control. The risk of developing TB in HIV-infected individuals are 26-31 times higher 
than those who are HIV-uninfected
7
. 13% of new incidence TB cases were estimated to 
be associated with HIV infection in 2014. TB has been considered as one of the leading 
causes of death among HIV-infected patients. The prevalence of TB and HIV co-
infection was highest in Africa region. In some African countries, up to 80% active TB 
patients were associated with HIV infection while this number was lower in the Asian 
region. In 2015, about 25% of all TB deaths had HIV co-infection and about 35% of 
HIV deaths were due to TB
8
.  
Drug resistant TB presents a threat for public health globally. The number of cases with 
multidrug resistant (MDR-TB), defined as resistance to both isoniazid and rifampicin, 
slightly increase in recent years with an estimated 3.9 % of new cases and 21% of re-
treatment cases
5
. According to the WHO report in 2015, there were an estimated 
480,000 new cases of MDR-TB, and half of them were in China, India, South Africa 
and European Regions
5
. Cases with extensively drug-resistant tuberculosis (XDR-TB), 
defined as resistance to isoniazid, rifampin plus resistance to at least one 
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fluoroquinoline and a second-line injectable agent have been reported in total 105 
countries
4
. About 9.7% of patients with MDR-TB have XDR-TB on average
5
.  
From 2015 Vietnam has been reported to have reached the global target of 50 % 
reduction compared to 1990 in TB prevalence and mortality. However, Vietnam is still 
one of 22 high TB-burden countries in the world with an estimated 140 new cases per 
100,000 population. Almost 18,000 people die from TB every year. The TB incidence is 
geographically distributed with significantly higher rates in the Southern provinces of 
Vietnam, especially in Ho Chi Minh City and the greater Mekong River Delta
9,10
. 
Vietnam ranks 14
th
 among 27 highest MDR-TB countries with an estimated 4% MDR-
TB among new cases and 23% among the previously treated patients
4
. The proportion 
of HIV-positive patients with TB also slightly declined from 8.0 % in 2011 to 5.2 % in 
2014
11
. 
1.1.3 Pathogenesis of TB  
When a TB patient coughs, sneezes, or spits, 1-5 µm aerosols containing Mtb that 
causes the disease are produced; another person who inhale this air-drop may get 
infection. The droplet size negatively correlates to the infectiousness. The smaller sizes 
are likely responsible for transmission of the disease since they facilitate entry of Mtb to 
the lower lung, a place where bacteria can avoid continuous waves of microbicidal 
macrophages recruited by resident microflora or inhaled environmental microbes
12
. In 
the lower lung, the first encounter of Mtb with alveolar macrophages initiates a cascade 
of phagocytosis events, which may result in different scenarios. The macrophage 
response can kill the bacteria effectively and prevent progression to active disease. 
Otherwise, if the immune response is insufficient to control the bacterial replication, it 
will lead to the development of the clinical disease known as primary progressive TB in 
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approximately 5 % of those who get infection
13
. The disease could be remained in the 
lungs (first site of TB infection) or else some bacilli may move through the blood, 
spreading to different parts of the body to cause extra-pulmonary forms of primary TB, 
particularly in the meninges, bones, joints and kidneys
14
. In most infected individuals, 
the infected macrophages are surrounded by other immune cells including uninfected 
macrophages, neutrophils, T cells and B cells to form a structure known as a granuloma. 
Mtb may be kept in this structure in a dormant stage and they are unable to cause 
disease
15
. A person with this scenario is classified as having latent infection as 
evidenced by T-cell reactivity to mycobacterial antigens but they are asymptomatic and 
not contagious. Using an advanced image technology comprising positron emission 
tomography combined with computed tomography (PET-CT) provides evidence for the 
biological heterogeneity in the lung lesions of people with LTB
16
. Those harbouring 
severe abnormalities suggestive of a subclinical phase of disease, such as infiltrates, 
scars, or active nodules, have an increased risk to progress to symptomatic active TB. 
By contrast, those showing no evidence of subclinical pathology are less likely to suffer 
from the reactivation. Generally, about 10 % among these may develop the post-primary 
active disease during their lifetime. The question of whether endogenous re-activation 
or exogenous re-infection is the cause of the second episode of TB has been 
controversial. Current opinion favors reinfection being a  source of adult TB in high 
incidence areas
17
 with the proportion of cases attributed to reinfection varying from 12 
% to 75 %
18
. Upon reinfection, latent TB is protective against the progressive TB while 
the prior active TB is associated with the post-primary disease c
13,18,19
. 
The determinants for containment of infection or progression to disease are not well 
understood and are multifactorial. Host and environment are thought to be important 
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variables that determine outcomes of TB disease. However, there is increasing evidence 
that pathogen determinants and their interaction with the host and environment are also 
important in understanding of TB pathogenesis
20
. 
1.1.4 Clinical features of TB 
TB case definition for public health surveillance from WHO 2013 includes both 
laboratory and clinical criteria
21
. According to this definition, a TB case is confirmed 
when Mtb is detected in the clinical specimen using one of these methods: smear 
microscopy, culture or WHO-approved rapid diagnosis such as Xpert MTB/RIF
21
. In the 
absence of laboratory confirmation, a case can be diagnosed by clinical criteria 
including positive tuberculin skin test, chest X-ray, signs and symptoms compatible 
with TB, and response to treatment with two or more anti-TB medications. 
TB cases could be classified according to the anatomical site of the disease. Pulmonary 
tuberculosis (PTB) refers to any cases of TB in the lung parenchyma or the 
tracheobronchial tree. The classic clinical features of PTB include chronic cough, fever, 
night sweats, loss of weight and appetite, and hemoptysis. Chest pain and difficulty in 
breathing as a result of parenchymal lung involvement can be present in extensive 
disease. Physical findings in pulmonary TB are often not helpful in defining TB. Chest 
X-ray examination can be used to diagnose and monitor the lesions in the lung
22
. Extra-
pulmonary or disseminated TB refers to any case of TB in organs other than the lungs, 
for example, meninges, lymph nodes, abdomen, skin, and bones. Disseminated TB 
occurs in 10 % to 42 % of patients, depending on ethnicity, age, co-infection, Mtb 
strain, and immune status
20,23
. Meningeal TB is common in young children and in HIV-
infected people. This is the most severe form of extra-pulmonary TB, which kills or 
leaves neural sequelae in half of people affected
24
.  
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1.1.5 Treatment and prevention of TB  
An early and accurate diagnosis, a screening for drug resistance, administration of 
appropriate antibiotics, and an adherence of patients during the treatment course are 
essential factors for the successful treatment for TB. The current standard treatment 
regimens using four first-lines dugs (isoniazid, rifampin, pyrazinamide, and ethambutol) 
have achieved around 90 % - 95 % cure rates in PTB treatment under provision of 
tuberculosis-control programs
25
. This regimen requires at least 6 months for two phases, 
including the intensive phase lasting 2 months of all four drugs and the continuation 
phase lasting 4 months of isoniazid and rifampin. In case of TB and HIV co-infection, 
since the early initiation of antiretroviral therapy results in a reduction in mortality 
especially in those with more advanced degree of immunosuppression
26
, it is 
recommended that the antiretroviral therapy should be initiated within first 2 or 8 weeks 
of starting TB treatment depending on the CD4
+
 T-cell count
27
. Patients with MDR-TB 
are considered incurable with conventional regimens. WHO treatment guidelines 
recommend that the intensive phase of regimen should last for at least 8 months, and a 
fluoroquinolone and a second-line injectable agent should routinely be included
28
. 
XDR-TB, which kills more than 70 % of patients, is extremely difficult to treat. New 
drugs are being investigated in trials, with several studies being conducted to access 
shortened regimens for drug-sensitive disease and more effective therapy for drug-
resistant disease. The Nix-TB trial of three antibiotics (bedaquiline, pretomanid, and 
linezolid), that have not been combined before to treat TB, is investigating whether they 
may offer simpler, safer regimens for XDR-TB and MDR-TB treatment
29
.    
BCG is an anti-TB vaccine containing attenuated live bovine tuberculosis bacilli (M. 
bovis) that lost their virulence by being serially sub-cultured on bile potato medium for 
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years
30
. Studies of protective efficacy of BCG vaccination range from no protection to ≥ 
80 % protection; this variation appears to be attributable to differences in populations, 
age at vaccination, nutrition status, vaccine strains, virulence of Mtb strains
31
. A meta-
analysis study of 1,264 publications found that BCG vaccination significantly reduces 
the risk of TB by 50 % on average
32
. Interestingly, the vaccine successfully protects 
children against the most severe forms of TB such as miliary and TB meningitis, with 
the protective effectiveness being more than 80 %
31
. BCG is still used for infants at 
birth in most countries with a high TB burden. New vaccines to replace BCG, or boost 
BCG are being studied, offering hope for future TB control
23
.   
1.2 Mycobacterium tuberculosis - the pathogen 
Mtb is one of the most successful human pathogens. The bacteria can utilize the host 
immune response for its survival and replication (discussed in later sections), resulting 
in complex clinical manifestations. The diagnosis and the treatment of the disease have 
been posing challenges for TB healthcare systems for more than 100 years. Therefore, 
understanding the bacterial genetics and its associated phenotypes could be essential for 
TB treatment and elimination. 
1.2.1 Characteristics of Mtb  
Mtb is an obligate pathogenic bacterial species in the Mycobacterium genus and the 
main causative agent of TB disease in humans. Koch first discovered Mtb in 1882 by 
culturing the crushed granulomas. Mtb is a member of Mtb complex which in addition 
includes other species that all cause disease in human and maybe in other hosts. These 
species include M. africanum causing TB in human only in certain regions of Africa; M. 
bovis, M. caprae and M. pinnipedii causing TB in wild and domesticated mammals; M. 
microti causing TB in voles
33
. Mtb has a rod-like and slightly curved shape, 0.5 μm in 
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diameter and 1-4 μm in length. The bacteria do not have flagellum, capsules, or spores, 
although some studies suggest spore formation in aged mycobacterial culture
34,35
. The 
cell wall of Mtb mainly consists of a thick layer of hydrophobic mycolic acids at its 
external portion. Mtb is not classified as a Gram positive or negative bacterium as the 
cell is poorly permeable to Gram staining. The unique characteristic of lipid-rich cell 
wall made the bacillus resistant to decolourization by acids during staining procedures. 
As such, Mtb is called an acid-fast bacillus and can be detected by red color on a stained 
smear, which has been taken advantage of in TB diagnosis. The characteristic of cell 
wall is also thought to impair the entry of nutrients, which causes slow growth of 
mycobacteria with the doubling time of Mtb being about 24 hours
36
.  
1.2.2 Genetic diversity of Mtb strains 
In contrast to other bacteria, Mtb strains are unable to undergo horizontal gene transfer. 
In addition, since Mtb strains present over 99 % similarity at their nucleotide sequence 
level and have identical 16S RNAs sequences, it was believed for a long time that there 
is limited genetic variation among Mtb strains
37
. However, later studies employing 
different molecular typing methods, such as spoligotyping, large sequence 
polymorphism (LSP), whole genome sequencing, have revealed genetic variations in 
Mtb genomes
37
. Such genetic diversity is attributable to the duplication, depletion or 
transposition of chromosome regions as well as single nucleotide polymorphisms 
(SNPs). Using these genetic markers, Mtb strains were further subdivided into different 
lineages. Currently the human–adapted Mtb complex including Mtb and M. africanum 
can be classified into seven main phylogenetic lineages
38
 (Figure 1.1). These lineages 
comprise Indo-Oceanic (also known as Lineage 1), East Asian/Beijing (also known as 
Lineage 2), East African-Indian (also known as Lineage 3), Euro-American (also known 
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as Lineage 4), M. africanum West Africa-1 (also known as Lineage 5), M. africanum 
West Africa-2 (also known as Lineage 6) and Ethiopian (lineage 7) lineages. Based on 
the presence or absence of a Mtb-specific deletion known as TbD1, Mtb complex can 
also be divided into ancestral or modern lineages respectively
39
. East Asian/Beijing, 
East African-Indian and Euro-American lineages are considered to be modern whereas 
Indo-Oceanic, M. africanum West Africa-1 and 2 lineages are ancient. Studies have also 
revealed a significant variation in phylogeographic distribution among major lineages, 
with each lineage being associated with a particular geographic region (Figure 1.2). The 
most widely distributed group is East Asian/Beijing lineage. This lineage occurs 
frequently in East Asian populations, but is also found to be present in Central Asia, 
Russia, and South Africa
40
. Euro-American lineage predominates in regions of Asia, 
Europe, Africa and America. The distribution of Indo-Oceanic and East African-Indian 
lineages is geographically limited to East Africa, Central-, South-, South-East Asia. The 
most geographically limited distributed groups are M. africanum West Africa-1 and 2 
lineages that exclusively occur in West Africa
40
 and Ethiopian lineage which to date has 
only been observed in Ethiopia or recent Ethiopian emigrants
41
.    
Among seven lineages, the East Asian/Beijing strain is considered to be emerging 
worldwide today
42
. This family represents 50 % of strains in East Asia and 13 % of 
isolates around the world. In Vietnam, there are three main lineages including Indo-
Oceanic, Euro-American and East Asian/Beijing. Among these, the East Asia/Beijing 
lineage is highly prevalent, being responsible for 40 % of tuberculosis cases
43,44
.  
Chapter 1 
 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Global phylogeny of human-adapted Mtb complex 
7 Mtb lineages were defined by the whole genome sequencing analyses. Node support 
after 1000 bootstrap replications is shown on the branches and the tree is rooted by the 
outgroup M. canetti.  Region of difference (RD) on Mtb genome were indicated along 
branches. Scale bar indicates the number of nucleotide substitution per site (Coscolla et 
al.
45
).  
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Figure 1.2 Global phylogeography of human-adapted Mtb complex  
Dots indicate the dominant Mtb lineages in the country. Panel (A) shows the most 
geographically widespread lineages, panel (B) the intermediately distributed lineages, 
and panel (C) the most geographically limited distributed lineages (Gagneux et al.
45
). 
1.2.3 Effect of genetic diversity of Mtb strains 
During the last decades, by using various experimental models, many studies have 
indicated that the genetic diversity of Mtb lineages has translated into significant 
differences in the bacterial virulence and immunogenicity. The effect of Mtb lineage 
variation on clinical phenotypes has also been established.    
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1.2.3.1 Difference in virulence 
Virulence can be defined by the ability of pathogen to cause the disease in the human 
host
46
. Since the development of TB disease is associated with the growth and 
replication of bacteria within the host, studies have assessed the virulence of Mtb strains 
by measuring the growth of bacteria in monocytes or macrophages in vitro
47,48
, or 
measuring the bacterial burden in organs as well as the morbidity and mortality in 
animal models including guinea pigs
49,50
, mice
51–53
 or marmosets
54
. 
Difference in virulence among various Mtb strains have been observed very early from 
many decades ago
49,50
. Later studies using different molecular typing methods have 
demonstrated lineage-associated virulence. In general, the modern lineages including 
East Asian/Beijing and Euro-American lineages are considered to be higher virulence 
than ancestral lineages M. africanum West Africa-1 and 2 lineages
51
. At the level of 
individual lineage, East Asia/Beijing lineage is consistently demonstrated to be 
hypervirulent compared to other lineages in different infection models
48,51–54
. Several 
studies have indicated a wide variation in virulence among strains in the same 
lineage
48,55–58
.  
The high virulence phenotype of East Asia/Beijing could have resulted from intrinsic 
biochemical properties. Beijing lineage is suggested to show increased expression of α-
crystallin and decreased expression of Hsp65, PstS1 and 47kDa protein. α-crystallin is 
known as a Mtb virulence factor while the other proteins plays a role as Mtb antigen. 
Such a reduced level of these antigen may allow Beijing lineage to evade the host 
response
59
. This lineage is also known to employ a different cell wall-associated lipid 
structure named polyketide synthase-derived phenolic glycolipid (PGL) that inhibits the 
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host protective immune response
60
. However, the genetic mechanisms for the lineage-
specific virulence are still not clear. 
1.2.3.2 Difference in host immune response 
Mtb genetic diversity has also been demonstrated to induce differences in host immune 
response. The modern lineages (East Asian/Beijing, East African-Indian and Euro-
American) induced lower inflammatory response compared to ancient lineages (Indo-
Oceanic and West Africa)
61
. East Asian/Beijing strains have been most widely studied 
and consistently reported to induce low levels of pro-inflammatory cytokines
47,53,62,63
. 
The modern lineages in general, and East Asian/Beijing in particular, are shown to be 
virulent and globally wide-spread, suggesting that the cytokine profile might link to an 
effective immune evasion of these lineages
64
. As a reduced inflammatory response in 
host can allow a rapid intracellular growth and spread to other cells or organs, the 
disease can develop and transmit to new hosts. Indeed, many studies on Mtb strains with 
different transmission dynamics have demonstrated high correlation of pro-
inflammatory cytokine production, virulence phenotype and transmissibility of the 
bacteria
65,66
. Specifically, strains that induce a low level of pro-inflammatory cytokines 
show increased virulence and transmission. 
As with virulence phenotype, there is the variation in ability to induce immune response 
among strains within the same lineage
51,67,68
. Some studies indicate the contrary results 
for East Asia/Beijing lineage; for example, in murine macrophage model Mtb strains of 
this lineage elicit equal or high level of Tumor necrosis factor alpha (TNF-α) and 
Interleukin (IL)-1β compared to Indo-Oceanic or Euro-America lineages67. The 
divergent results could come from the differences in strains examined in studies
69
.  
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1.2.3.3 Difference in clinical phenotype 
Apart from the difference in virulence in vitro, Mtb genotypic diversity is associated 
with the variable clinical outcomes. Studies in Vietnam have indicated that the Euro-
American lineage is more likely to cause pulmonary TB than meningeal TB
20
 and lung 
consolidation is found in a high proportion of TB patients infected with this lineage
70
. 
Among 6 lineages, East-Asian/Beijing is the most studied strain genotype and is 
demonstrated to be associated with rapid disease progression and severity. In the 
Gambia, individuals infected with East-Asia/Beijing lineage are more likely to progress 
to active TB disease compared to individuals infected with M. africanum
71
. Vietnamese 
patients with TBM caused by the East Asian/Beijing lineage present shorter duration of 
illness to treatment and fewer cerebrospinal fluid (CSF) leukocytes than those caused by 
the other lineages
70
. Studies in Russia have indicated an association between East-
Asian/Beijing lineage and chest radiological abnormalities
72
 or extra-pulmonary forms 
of TB
73,74
. Infection with this lineage has also induced rapid weight loss and led to 
higher bacterial load in  lung, liver and  spleen in non-human primate model
54
. In 
addition, East-Asia/Beijing lineage has been reported to be associated with drug 
resistance
70,75
, treatment failure
76,77
 and disease relapse
78,79
. Whereas some of the studies 
in European and African countries have shown no association of East-Asia/Beijing 
lineage and TB clinical presentation
80,81
. The discrepancy results on the genotype-
phenotype relationship could be due to the differences in sample size and patient 
ethnicity among the studies. 
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1.3 Host immune response against TB 
1.3.1 The innate immunity 
The innate immune response plays an important role in the protection against TB 
because it provides the first line of defense against Mtb. Many studies suggest that 
innate immunity could determine the outcome of infection by helping to control 
mycobacteria growth and shape the magnitude of adaptive immunity
82,83
. However, the 
innate immune response to Mtb is not yet completely elucidated, largely because of 
difficulties in studying immunity in the human lung. This part is a review on key innate 
cell types and processes implicated in innate host response to Mtb infection, which is 
derived mainly from in vitro studies or animal models.  
1.3.1.1 Initial recognition and phagocytosis of Mtb 
Alveolar macrophage is the primary cell type involved in the initial uptake of Mtb, after 
that dendritic cells and macrophages also come and take part in the phagocytosis 
process, mediating the subsequent host signaling to eliminate bacterial infection. The 
initial recognition and uptake of Mtb require a number of pathogen recognition 
receptors on the membrane of innate immune cell types, which either recognize Mtb 
directly via pathogen associated molecular patterns (PAMPs) or indirectly via opsonin 
with immunoglobin G (IgG) or complement on the bacterial surface. Mtb is an 
intracellular bacterium that can survive and multiply within macrophages, therefore the 
initial recognition and uptake is also exploited by Mtb for its entry into the cells and 
establishing infection. Below is a summary of surface receptors involved in the uptake 
of Mtb. It remains unclear whether different modes of entry into macrophage may lead 
to different subsequent events within the host as well as outcome of infection
84
.  
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a. Complement receptors 
The complement system comprises a number of soluble proteins that respond in a 
sequential manner, producing a cascade of reactions. The complement protein can be 
classically activated by its binding to an antigen-antibody complex or alternatively 
activated without antigen-antibody complex. The activated complement functions 
opsonizating pathogens to facilitate their phagocytosis, through chemotaxis to attract the 
phagocytes, or through lysis of antibody-coated bacteria. Macrophages possess various 
receptors for complement on their cell surface, including complement receptor (CR) 1, 
CR3 and CR4. Among CRs, CR3 is the principal receptor which is expressed 
dominantly on monocytes, macrophages, neutrophils, and natural killers. 
Mtb is able to activate the complement system through the alternative pathway, 
resulting in the opsonization of bacteria. The opsonized Mtb then can bind to CRs and 
be phagocytosed in the phagosome. The role of CRs on macrophages in the course of 
Mtb infection has been debated. Many works indicate that lack of or blocking of CR3 
results in the reduced phagocytosis of Mtb
85,86
; whereas other studies have shown that 
antibody blocking of CR3 has no effect on the binding of Mtb
87
, the induction of anti-
microbial effector mechanism or bacterial survival in macrophages
86
. Additionally, 
CR3-deficient mice have exhibited no defects in the control of Mtb infection compared 
to wild type
88
.  
b. C-type lectin receptors 
C-type lectin receptors (CTLRs) consist of carbohydrate-binding C-type domains that 
can recognize and bind to carbohydrate-rich molecules. In addition to participating in 
various processes such as cell adhesion and migration or lipid scavenging, CTLRs 
function in the pathogen recognition and phagocytosis
89
.   
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Mtb is recognized by a number of transmembrane CTLRs including mannose receptor 
(MR), Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin 
(DC-SIGN), MINCLE, and DECTIN-1. MR can be found on most types of tissue  
macrophages but not on circulating monocytes
90
. DC-SIGN is expressed mainly on the 
surface of dendritic cells (DCs) but also on the macrophage surface. These receptors are 
reported to bind lipoarabinomannan (LAM)
91
 or mannose-capped LAM (ManLAM)
92
, 
components on Mtb cell wall, to induce the bacterial phagocytosis. The binding of LAM 
or ManLAM are also reported to inhibit the phagosome-lysosome fusion in the infected 
macrophage
92
, prevent the T cell-mediated immune response by inhibiting the 
maturation of infected DCs, and induce the production of anti-inflammatory cytokine 
IL-10
93
. These conditions promote host immunosuppression and may contribute to Mtb 
survival. 
c. Scavenger receptors  
Scavenger receptors (SRs) comprise a large family of integral membrane proteins 
belonging to at least 8 different subclasses (A-H) based on their tertiary structure
94,95
. 
These receptors are known to bind a variety of ligands including modified or oxidised 
low-density lipoproteins, apoptotic cells and pathogens
94
. 
Both class A including scavenger A (SRA) and macrophage receptor with collagenous 
structure (MARCO), and class B SRs are involved in Mtb recognition and uptake. Many 
studies have indicated that these SRs participate in phagocytosis of mycobacterial 
species, including M. leprae
96
, M. avium
97
, M. bovis BCG
98
, and Mtb
87,99
 and are 
required for production of pro-inflammatory cytokines against mycobacterial infection. 
Blocking class A SRs almost abolishes all the Mtb binding and phagocytosis that persist 
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after CR and MR are blocked
87
. This also leads to a reduction in TNF-α production 
mediated by mycobacterial lipopeptides
100,101
.  
d. Fcγ receptors 
There are two types of Fcγ receptors (FcγRs), including activation receptors and 
inhibitory receptors that contain an immunoreceptor tyrosine activating motif or 
inhibitory motif, respectively. While DCs and macrophages express both activating and 
inhibitory receptors, natural killer (NK) cells only express activating FcγRs and B cells 
are limited to inhibitory FcγRs. All FcγRs mediate the internalization but the type of 
receptors will determine the subsequent processes. The internalization by activating 
FcγRs favors effector responses for antigen processing and presentation that results in 
activation of T cells, while the internalization by inhibitory FcγRs favors preserving the 
intact antigen for presenting to B cells
102
. 
The uptake of Mtb opsonized with antibody against TB via FcγRs is shown to lead to a 
rapid phagosome-lysosome fusion
103
, an enhanced oxidative burst and production of 
pro-inflammatory cytokine in infected macrophages
104
. There is no difference in the 
intracellular growth rate after internalization between opsonized and non-opsonized 
tubercule bacilli, indicating that entry by FcγRs or alternative does not affect the 
intracellular survival of bacteria
103
.  
e. Toll like receptors 
Toll like receptors (TLRs) are transmembrane proteins with an extracellular leucine-rich 
domain to recognize bacterial products. TLRs that are known to be involved in Mtb 
recognition include TLR2, TLR4, TLR9 and possible TLR8
36
. TLR2 can recognize a 
number of lipoglucans and lipids on mycobacterial cell walls, including LAM, LAM-
precursor lipomannan (LM) and mannosylated phosphatidylinositol (PIM). Such ability 
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to recognize different bacterial structures could be explained by the unique ability of 
TLR2 to cooperate with is co-receptors including TLR1, TLR6, CD14, or CD36
105,106
. 
Treatment of mice macrophages with PIM, LAM or LM leads to an increased 
production of pro-inflammatory cytokines
107
. TLR4, a receptor in concert with CD14 
binding to LPS of Gram negative bacteria, recognizes Mtb cell wall lipids, 
glycoproteins, and secreted proteins
108
. The intracellular TLR9 that is located on the 
phagosomal membrane can recognize Mtb DNA and induce TNF-α production109. The 
significant role of TLRs in TB infection is not always consistent in vivo. TLR2 and 
TLR4 are demonstrated to be required for the control of Mtb infection in mice
110,111
 but 
other studies have shown the unnecessary role of these receptors in immunity against 
Mtb infection
112,113
. Nevertheless, many genetic studies have shown the association of 
polymorphisms in TLR genes and TB susceptibility
114
. 
f. Other receptors 
In addition to these important receptors, other receptors and proteins can recognize and 
mediate the interaction of innate immune cells and Mtb. Surfactant proteins A in the 
lung can coat Mtb, enhancing macrophage binding and Mtb uptake by binding to 
surfactant protein A receptors on the macrophage
115
 or to other receptors such as FcγRs, 
complement receptors
116
, and probably mannose receptors
117
. CD14 can also recognize 
and bind Mtb via LAM
118
 and chaperonin 60.1
119
, which mediate the bacilli 
internalization of macrophages
120
. 
1.3.1.2 Innate immune cells 
The major innate immune cells that are studied in human TB include macrophages, 
neutrophils, DCs and natural killer cells.  
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a. Macrophages 
This is one of the first immunity cell types to encounter Mtb in the lung following 
aerosol inhalation. A range of macrophage activities for elimination of infection have 
been investigated, including bacterial phagocytosis, induction of antimicrobial pathways 
and cytokine production. However, macrophages also serve as a major cellular niche for 
bacterial proliferation during early infection as well as a reservoir for persistent bacteria 
within the lung granuloma during chronic infection. The multifaceted functions as well 
as the interaction of macrophages and bacteria in TB infection will be further discussed 
in the upcoming sections.  
b. Neutrophils 
Neutrophils are among the first cell types migrating to the site in response to infection. 
Dissection of mice infected with Mtb has revealed a number of neutrophils  in the lungs 
after one week of infection
121
. A number of studies in mice have demonstrated the 
protective role of neutrophils in TB infection
122,123
. When neutrophils encounter Mtb, 
the cells rapidly phagocyte bacteria and release antimicrobial molecules contained in 
their granules into the Mtb-containing phagosome following its fusion with granules, 
resulting in bacterial killing and digestion
124
. Neutrophils also kill bacteria efficiently 
via reactive oxygen species which are produced by a membrane-integrated enzyme, the 
phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the Mtb 
containing-phagosome
125
. Furthermore, neutrophils are known to function as a 
modulator for the effector mechanisms of macrophages. After macrophages 
phagocytose Mtb, contents of neutrophil granules are transferred to the Mtb-containing 
vacuole, which augments the antimicrobial activities of infected macrophage, reducing 
intracellular growth
126
. In addition, the release of heat shock protein (Hsp72) by 
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neutrophils has recently been found to be able to enhance the inflammatory response in 
the infected macrophage
127
. Neutrophils also produce a number of specific cytokines 
that help recruit and activate other immune cells, contributing to cellular immunity 
against Mtb.  
However, there is conflicting evidence on the role of neutrophils in protection against 
TB. Neutrophil accumulation is thought to contribute to the development of severe lung 
pathology. Gopal et al. has revealed that lung inflammatory lesions from patient with 
active TB harbor high number of neutrophils
128
. In vivo studies in mice show that 
numbers of infiltrating neutrophils correlate with the susceptibility of mice and with the 
necrotic pathology
121
. Thus, a strict regulation of neutrophil influx in infected tissues 
may be essential to prevent tissue damage
121
. 
c. Dendritic cells (DCs) 
DCs are the key immune cells involved in bridging innate and adaptive immunity due to 
their ability to capture, process and present antigen. The contribution of DCs in immune 
response against Mtb infection is well-studied. Following Mtb infection, DCs are 
quickly recruited to the  site of infection, which are even more dominant than alveolar 
or recruited macrophages, to phagocytose the bacteria
129
. Infection of DCs with Mtb has 
resulted in the upregulation of MHC class I and II and costimulatory molecules as well 
as high levels of cytokines such as TNF-α and IL-12 that help induce T cell 
proliferation
130
. Therefore, DCs can generate efficient adaptive immunity against Mtb 
infection through a successfully antigen presentation to T cells in lymph nodes
131
. In 
line with these findings, depletion of DCs significantly causes a delay in CD4
+
 T cells 
activation that in turn has impaired the control of bacterial replication, resulting in high 
bacterial burdens in the lungs and spleen
132
. On the contrary, Mtb has been shown to 
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develop mechanisms to prevent DC migration and maturation, reduce IL-12 production 
and inhibit ability of DCs to stimulate T cell immunity
133,134
. These findings highlight 
the complexities in the interactions between Mtb and the host innate immune system. 
d. Natural Killer (NK) cells 
NK cells are unable to phagocytose the pathogen but they can function in controlling the 
infection using cytotoxicity mechanisms. Various proteases and antimicrobial proteins 
inside NKs cytoplasmic granules are released into the target cytoplasm, resulting in 
directly lysis of the target cells (microbes or infected cells) or initiating apoptosis
135
.  
NK cells can also produce cytokines such as interferon-gamma (IFN-γ) and TNF-α136 
which not only enhance their lytic function,
137
 but also help to activate macrophages. 
A number of works have suggested the protective role of NK cells against 
mycobacterial infection. In mice whose NK cell activity is depleted by injection of anti-
NK antibody, increased M. avium growth in the spleens is observed
138
. NK cells from 
peripheral blood mononuclear cells (PBMC) of healthy donors have been shown to 
significantly reduce the bacterial intracellular growth in Mtb-infected monocytes
139,140
. 
This growth inhibition has been partially mediated by IFN-γ and TNF-α produced by 
NK cells
140
. NK cells have been shown to be capable of killing Mtb by releasing 
cytolytic proteins of granules, which requires the direct contact of NK cells and 
bacteria
141
. 
1.3.1.3 Cytokine production 
Recognition of Mtb by phagocytes leads to cell activation and cytokine production, 
which in turn induces further activation, cytokine production and effector functions of 
immune cells in both innate and adaptive immunity
14
. Cytokines could be categorized 
according to the immune response pathways where cytokines are produced, including 
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type-1 immunity driven by T helper 1 (Th1) cells and type-2 immunity driven by T 
helper 2 (Th2) cells
142
. Depending on the nature of infection Th1 or Th2 pathway will 
develop, with Th1 responding against intracellular pathogens and viruses while Th2 
protecting against extracellular pathogen such as parasites
143
. The Th1 pathway 
produces IFN-ɣ, IL-2 and TNF-α which activate macrophages and are responsible for 
cellular immunity, resulting in inflammatory and cytotoxic reactions. Whereas Th2 cells 
produce IL-10, IL-4, IL-5 and IL-13, which are responsible for production of antibody 
as well as inhibition of macrophage functions and inflammatory response. Over 
activation of a particular pathway can cause the disease, such as autoimmune 
disorder
142
. Therefore, cytokines from one pathway can cross-inhibit the response of 
other pathway, and vice versa, to keep the Th1/Th2 balance. Besides Th1 and Th2, there 
are several cytokines that are produced by other T cells that also function in the 
inflammatory or anti-inflammatory response
144
. 
As an intracellular pathogen, the efficient Th1 immune response is decisive for the 
protection against Mtb infection. However, the overexpression of Th1 cytokines such as 
TNF-α may result in tissue damage, which may advance the disease development145. 
Therefore, the balance between Th1 and Th2 response is very important in TB 
pathogenesis. Below is summary of several cytokines produced in response to Mtb 
infection, including TNF-α, IFN-ɣ, IL-1β, IL-6 and IL-10.  
TNF-α is a pro-inflammatory cytokine, which is induced by monocytes, macrophages, 
DCs
146
, NK cells, T cells
140
 when these cells are stimulated with mycobacterial 
products. TNF-α plays a key role in controlling Mtb infection by induction of reactive 
oxygen species
147
 or increasing phagosome-lysosome maturation macrophages
148,149
. 
TNF-α also recruits immune cells to the infection site, contributing to the granuloma 
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formation that may help in preventing disease progression
150,151
. The TNF level may 
determine the outcome of infection, since either too low or too high TNF levels are 
associated with necrosis of infected macrophages that result in the exuberant bacterial 
growth
152
. In humans, TNF-α is produced at a local infection site153 and its spillover 
correlates with the destruction of lung tissue
145
, suggesting the contribution of TNF-α in 
the immunopathology of TB.  
 IL-1β is a pro-inflammatory cytokine, which is also mainly produced by monocytes, 
macrophages, and dendritic cells. IL-1β is produced at the site of infection during TB, 
as shown by IL-1β expression in granulomas in the lungs of TB patients154 or in 
bronchoalveolar lavage cells obtained from the infected lung of TB patients
153
. Studies 
in mice have suggested important roles of IL-1β in host resistance to tuberculosis since 
an increased bacterial load and defective granuloma formation were observed in IL-1α 
knockout mice infected with Mtb
155,156
. In humans, IL-1β has been shown to induce 
rapid differentiation of monocytes into macrophages with enhanced phagocytic and 
antigen-presentation activities
157
. Genetic studies have shown the association of 
polymorphisms on IL-1β genes and pulmonary TB in African populations158,159. 
IL-6 is a cytokine that has both pro- and anti-inflammatory properties. Like TNF-α, IL-
1β, IL-6 is produced at the site of infection145,153 by macrophages, neutrophil and 
dendritic cells
131
. Many studies have supported the protective roles of IL-6 against Mtb; 
for example, absence of IL-6 leads to the increased bacterial loads in lungs
160
 and early 
death of infected mice
161
. Such functions of IL-6 could be involved in the early IL-6–
mediated IFN-ɣ production, which enhances the antimicrobial function of 
macrophage
160
. As with TNF-α, IL-6 may be involved in TB immunopathology because 
IL-6 levels in the lavage fluid of TB patients correlate with the  lung damage
145
. 
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IFN-γ is a pro-inflammatory cytokine that has been long known for protective function 
against Mtb. This cytokine is produced primarily by CD4
+
 and CD8
+ 
T cells and NK 
cells
162
. IFN-ɣ plays an essential role in macrophage activation which enables them to 
exert antimicrobial functions. IFN-ɣ-stimulated macrophages increase the phagosome-
lysosome fusion and production of intermediate nitrogen species, leading to efficiently 
killing of intra-macrophage mycobacteria
163–168
. Individuals bearing mutations in the 
IFN-γ or receptor gene have been shown to be extremely susceptible to TB 
disease
169,170
. Genetics studies also indicate the association of polymorphisms in the 
IFN-γ gene and TB.   
IL-10 is an anti-inflammatory cytokine, which is produced by macrophages and T 
lymphocytes during Mtb infection. IL-10 is demonstrated to limit T cell responses 
against Mtb infection  because this cytokine inhibits the production of pro-inflammatory 
cytokines such as IFN-γ, TNF-α and IL-12171. It also prevents the traffic of the 
complexes of Mtb peptide and MHC-II to the plasma membrane for CD4
+ 
T cell 
presentation
172
. In addition, IL-10 can inhibit the phagosome maturation, resulting in 
enhanced intracellular survival and growth of bacteria
173
. Taken together, the data have 
suggested that IL-10 suppresses the protective immunity and promotes the bacterial 
survival.  
1.3.2 The adaptive immunity 
The adaptive immune response to Mtb infection is delayed, starting after approximately 
two weeks in infected animals
14
 and 8-10 weeks in humans upon Mtb infection (based 
on the fact that skin test may be inaccurate before 8-10 weeks from exposure
174
). The 
adaptive immune response initiates following the antigen presentation of infected DCs 
to T cells in the lymph node
134
. Although DCs are infected from early, Mtb impairs the 
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antigen presentation and migration of DC, thereby leading to such a delay of adaptive 
immune response
134
. Following antigen presentation, naïve T cells are activated and 
proliferated into effector T cells, of which there are two main subsets with different 
functions, including CD8
+
 T cytotoxic cells and CD4
+
 T helper cells. Memory CD4
+
 T 
cells and CD8
+
 T cells also form upon Mtb infection
175
. These activated T cells then 
migrate to the site of infection by the attraction of cytokines that are produced by 
infected phagocytes.  
CD4
+ 
T cells play an important role in the protective immune response against Mtb, 
which is indicated by experimental studies. The primary role of CD4
+
 T cells in host 
immunity is thought to induce production of cytokines. Depending on the cytokine 
environment, the CD4
+ 
T cells can produce either Th1 response or Th2 response. The 
function of these responses in TB infection has been mentioned in Section 1.3.1.3. In 
practice, the increased risk of TB in HIV patients also establishes the critical role of 
CD4
+
 T cells in immunity to Mtb infection. Depletion of CD4
+ 
T cell has resulted in the 
increased severity of the primary disease
176
, failure in granuloma formation
177
, 
developing extra-pulmonary dissemination
176
, and causing disease reactivation in 
animals with latent TB
176,178
. Even though the amount of CD8
+ 
T cells increase to 
compensate for the lack of CD4
+
 T cell, the response of CD8
+ 
T cells has not been 
sufficient to control the bacterial burden in the lung of infected mice
178
.   
CD8
+
 T cells contribute in controlling Mtb infection since they function as killer cells 
for Mtb-infected cells
179
. The killing mechanism is dependent on the release of granular 
contents into the infected cell targets, which directly lyses the infected cells
173
. In 
addition, CD8
+
 T cells function by producing a variety of cytokines, including IFN-γ 
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and TNF-α, which enhance the antimicrobial activities of macrophages, resulting in 
reduced intracellular mycobacterial growth
174
. 
There is increasing evidence for the role of B lymphocytes and a humoral response in 
protection against TB, although functional variation in antibody responses exists
182
. 
Opsonization of Mtb with Mtb-specific IgG from person with latent TB enhances the 
bacterial killing of human macrophage by inducing phagosome maturation, suggesting a 
protective role for antibodies against active TB
104
. Recently Lu et al. have found that 
antibodies obtained from individuals with latent TB are more effective in inhibiting the 
growth of intracellular Mtb than those from persons with active TB
183
. However, by 
analyzing serum antibodies and recombinant monoclonal antibodies that are made by 
cells isolated from Mtb-exposed health workers and persons with pulmonary TB, 
Zimmermann et al. have indicated that Mtb-specific IgG promotes the infection of 
human epithelial-like and macrophage-like cell lines, whereas IgA opsonization inhibits 
the Mtb infection
184
. The difference in functional response of IgG could be attributed to 
different experimental cell types
182
. 
1.3.3 Granuloma 
Upon Mtb infection, the innate and adaptive immune cells migrate to the site of 
infection by the attraction of cytokines and chemokines, and locate around the infected 
macrophages. Such a structure is called a granuloma, which may help an infected 
person with Mtb remain in the stage of latency or may contribute to Mtb proliferation, 
dissemination and persistence
185
. There are many different cell types to form 
granulomas, including macrophages (main cell type), natural killer cells, neutrophils, 
DCs, T and B cells
129,186
, and epithelial cells
187
. At the early granuloma, uninfected 
macrophages continuously migrate to the site of infection, which in turn become 
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infected by phagocytosing the infected macrophages. At the late stage of granuloma 
formation, a fibrous cuff is present to surround and strengthen the structure
188
. In the 
heart of the granuloma, there is a necrotic and caseous structure that is thought to be the 
mixture of bacteria and the lipid released by the necrotic breakdown of Mtb-infected 
lipid-rich macrophages (foamy macrophages)
188
. Along with limiting the spread of 
infection by walling off the bacteria and infected macrophages, granulomas may contain 
and inhibit the bacterial growth by stressing them with starvation, reactive oxygen and 
nitrogen species, and hypoxia
189
. However, it has been revealed that mycobacteria can 
survive and overcome stresses by utilizing the host cell lipid as nutrition
188,190
. When the 
granuloma structure is weak under certain immune-comprising conditions such as 
depletion of CD4
+
 T cells
176–178
, bacteria can exit from granulomas, and spread through 
the body to cause clinical disease.  
1.3.4 Host genetic susceptibility to TB 
TB has high prevalence at some parts of the world such as South Asia, Africa and South 
Africa. The difference in the rate of TB occurrence among particular populations, 
ethnicities and families indicates the involvement of host genetics in TB susceptibility. 
Results from early twin studies showed higher TB incidence among monozygotic than 
dizygotic twins. Family-based genome-wide association studies showing the association 
of several loci on chromosome and TB susceptibility have supported the influence of 
host genetics on infection outcome
191
. Over the past decades, technical advances have 
allowed us to study the association of genetic variants and the disease at the level of 
whole genome. The use of different approaches such as candidate gene studies and 
genome wide association studies has led to a significant increase in understanding of the 
genetic basis of TB susceptibility. 
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1.3.4.1 Candidate gene studies 
There are up to 30,000 genes in the human genome and the probability that a gene 
selected randomly will influence TB disease is very low. Therefore, it is important to 
have genes selected for study
192
. The candidate genes are mostly selected based on their 
possible function on disease pathogenesis. For instance, genes of the TLR family, which 
play roles in Mtb recognition
193
, were examined for associations with TB
114
. Candidate 
genes are also discovered from experimental animal models. For example, through a 
genetic screen in zebrafish, lta4h has been identified as a susceptibility locus to 
mycobacterial infection. From this, the association of this gene and human TB was 
uncovered
194
. Host genetic variations can be identified by gene sequencing or SNP 
genotyping selected among hundreds of SNPs in the gene. Linkage disequilibrium (LD) 
is a phenomenon that indicates the non-random association of alleles at different loci on 
chromosome
195
. The SNPs that are in high LD will mainly be inherited together. These 
SNPs can be tagged and presented by a selected SNP among them, which can be 
referred to tag SNP
195
. In candidate gene studies, selection of tag SNP is very useful 
because genotyping a few but carefully selected tag SNPs can provide sufficient 
information about other SNPs remaining in the region of interest
196
. In addition, SNPs 
in the coding region which result in a change in encoded protein sequence and SNP in 
the regulatory region (such as promoter) of gene are considered for selection. SNP 
typing on candidate genes has been cheap and quick compared to different genetic 
association studies, comprising genotyping the gene variants (often SNPs) in candidate 
genes in unrelated cases (TB patients) and controls (healthy individuals). 
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1.3.4.2 Whole genome wide association studies  
The objective of whole genome wide association studies (GWAS) is to examine the 
genetic variants in the entire genome to identify variants associated with a trait (a 
disease or phenotype). In contrast with candidate gene association studies, GWAS is a 
non-candidate gene approach. This approach employs the different types of commercial 
chips which can be used to genotype up to 500,000, 600,000 or 250 million SNPs in 
human genome. The chip selection will take into account the level of genomic coverage, 
the possible sample size and the allowable budget
197
.  
1.3.4.3 Association of host genetics and TB 
By exploiting different approaches, variants in many genes involved in immune 
response to TB have been demonstrated to be associated with TB susceptibility
114,159,198–
201
. For example, as listed in Tables 1.1
202
, SNPs in receptor genes involved in 
recognition of TB including TLR family (TLR1, 2, 4, 8, and 9) or C-type lectin 
receptors (MR, DG-SIGN) are associated with TB susceptibility in different 
populations. For SNPs known to be associated with TB, there  is very limited 
understanding concerning the underlying molecular mechanisms of how these variants 
affect the disease susceptibility (Table 1.1
202
). The use of the latest approach of next 
generation DNA or RNA sequencing that provides the whole genomic data could 
advance knowledge on the influence of gene variants on disease susceptibility at the 
level of transcriptomics or proteomics
195
. A thorough understanding on host genetics 
could be translated to better diagnostic, prevention and treatment therapy for TB 
disease.
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Table 1.1 Association studies on host innate immune genes related to TB 
pathogenesis (extracted from the work of Azad et al.
202
) 
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1.4 Macrophages 
1.4.1 Function and activation 
Macrophages are large mononuclear cells and play an important role in the immune 
system. Macrophages function as professional phagocytes that have capacity to engulf 
particles larger than 0.5 μm, including microbes203. The term of macrophage means “big 
eater” in Greek. Monocytes are the precursors of macrophages, which circulates in the 
blood stream. When infection occurs, monocytes are recruited into sites of infection and 
then differentiate into macrophages that have increased phagocytic capacity, different 
morphology and adhesive properties
204
. In a resting state, the role of the macrophages is 
to phagocyte apoptotic cells and cell debris in a quiet manner without inflammation to 
minimize tissue damage
205
. During infection, macrophages function as immune effector 
cells that ingest and destroy pathogens, activate and recruit other immune cells, process 
and present antigens to T cells in adaptive immunity. In order to perform such activities, 
macrophages must first be activated. The classical activation of macrophages requires 
two signals: priming signal followed by triggering signal
206
. The role of priming signal 
is to enhance the responsiveness of macrophages to the triggering signal; without 
priming signal, the macrophages respond to the activating stimuli in a weaker capacity. 
The priming signal is typically IFN-γ while the triggering signal is bacterial products 
such as LPS. Upon activation, the macrophage induces competent microbial activity for 
effective bacterial elimination, although several intracellular pathogens, such as Mtb or 
Salmonella, have developed strategies to modulate this response
207–209
. 
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1.4.2 Phagocytosis 
Macrophages have evolved a number of strategies to uptake extracellular material, 
including pinocytosis, receptor-mediated endocytosis, and phagocytosis. Pinocytosis is 
the process to uptake fluid and solutes, while receptor-mediated endocytosis is used to 
uptake macromolecules, viruses, and small particles. These two pathways usually occur 
independently of actin polymerization
210
. 
Phagocytosis refers to the uptake of particles, cells or pathogens, which are larger than 
0.5 μm, into a plasma membrane-derived vesicle. Phagocytosis can be performed by 
professional phagocytes including macrophages, neutrophils and dendritic cells. These 
cells use similar mechanisms, however there are the important differences existing 
among them, which depend on the roles that each cell type performs in the immune 
response
210
. In general, phagocytosis process may be divided into two steps (1) 
internalization of particles into phagosome, and (2) phagosome maturation. Here I focus 
on the phagocytosis process performed by macrophages. 
1.4.2.1 Phagosome formation and particle internalization 
The first step of phagocytosis is mediated by PPRs that can recognize and bind 
pathogens directly via PAMPs comprising surface carbohydrates, peptidoglycans or 
lipoproteins, or indirectly via opsonization with IgG or components of the complement 
system. There is a diversity of receptors capable of stimulating phagocytosis on a 
macrophage surface, for example, receptors listed in the Section 1.3.1. Receptors are 
activated upon binding of particles, which produce signals to reorganize the actin 
network of the cell membrane. Subsequently the area around the particle is remodeled, 
to form a phagocytic cup. The cell membrane then extends over the particle to enclose 
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the cup, leading to the internalization of particles into the cytoplasm. The vesicle 
containing particle upon internalization is termed a phagosome. 
1.4.2.2 Phagosome maturation 
Maturation of phagosomes starts immediately once a phagosome is formed. After 
release from the surface membrane to cytoplasm, the phagosome sequentially fuses with 
early and late endosomes and finally with lysosomes to become a mature phago-
lysosome vesicle. During this phagosome development, there are changes in the 
phagosome’s content and membrane composition. It is suggested that the fusion 
between phagosome and the intracellular organelles is a kind of “kiss-and-run” 
interaction in which the content markers are transferred but the intermixing of 
membrane contents are limited
211
.  
There are three stages of phagosome during maturation: early phagosome, late 
phagosome, and phago-lysosome. The early phagosome indicates the new formed 
phagosome that are capable of fusion with sorting and recycling endosomes but not 
lysosomes
212
. An environment inside the early phagosome is mildly acidic with a pH 
around 6.3, poor hydrolytic, and contains membrane-bound proteins, such as the Rho-
GTPase Rab5, which are required for fusion of early phagosome with early 
endosomes
203,213
. After this fusion, the phagosome fuse with late endosome to form the 
late phagosome, which in turn undergoes a drop in pH caused by the pumping of H
+
 
into the phagosome due to the increasing number of vacuolar H
+
-ATPases (V-
ATPases)
203,214
. The late phagosome is acidic with pH of 5.5 and enriched in proteases 
that are acquired from the late endosome. The phagosome has loss of Rab5 and instead 
contains lysosomal-associated membrane proteins (LAMPs) and Rab7a, which are the 
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markers for this organelles and are known to mediate the fusion with a lysosome
203,214–
216
.  
The final stage of phagosome maturation is the formation of the phagolysosome that is 
generated by the fusion of phagosome with lysosome through a Rab7a-dependent 
process
203
. This organ is highly acidic with pH about 4.5-5 and filled with active 
hydrolases as well as other antimicrobial substances. These microbicidal properties 
grant the phagosome the ability to effectively kill an ingested microorganism. However, 
several intracellular pathogens are capable of circumventing the phagosome maturation, 
thereby evade the hydrolase-mediated destruction and are able to live within 
phagosomes
217,218
. Their mutants that fail to modulate the killing programme of 
macrophage have impaired intracellular growth
219,220
. 
1.4.3 Antimicrobial activities of macrophages 
The phagosome is central to macrophage activity against infection. During the 
maturation process, phagosomes acquire a number of microbicidal features, including 
acidification of the phagosome, activation of reactive oxygen and nitrogen species, as 
well as antimicrobial peptides and degradative proteins. The antimicrobial agents 
employed by macrophages can efficiently kill many pathogens, ranging from Gram 
negative and positive bacteria, fungi Candida sp, Cryptococcus neoformans, non-
tuberculosis mycobacteria
203,221,222
 to Mtb
223
. 
1.4.3.1 Acidification of the phagosome 
The acidification of phagosomes may be generated by the accumulation of V-ATPases 
in the phagosome membrane during its maturation
218
. V-ATPases are comprised of a 
membrane-bound sector and a cytosolic sector; the assembly of these components forms 
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an active enzyme that can hydrolyse the energy-rich adenosine triphosphate (ATP) and 
pump protons H
+
 into the phagosome
224
. Acidification is central for macrophage 
antimicrobial activity. An acidic environment itself directly destroys pathogens through 
an inhospitable environment where essential nutrient is extruded and microbial 
metabolism is impaired
203
. In addition, an acidic pH is required for the fusion of 
phagosomes with vesicles
218
 and favors the activity of phagosomal hydrolytic enzymes 
which have acidic pH optima
225
. An inhibition of the V-ATPase activity by 
concanamycin A affects the phagosomal acidification, formation of phagolysosome and 
the hydrolytic activity
226
. Furthermore, by pumping H
+ 
into phagosome, the V-ATPase 
facilitates superoxide production (O2
-
) as H
+
 can counteract the negative charges 
transported by the NADPH oxidase. The oxidase products can subsequently react with 
the phagosomal H
+
, generating more complex reactive oxygen species
203
. 
1.4.3.2 Reactive oxygen and nitrogen species 
Macrophages can destroy pathogens through reactive oxygen species generated by 
membrane-integrated NADPH oxidase NOX2 although this mechanism is the most 
prominent and well-studied in neutrophils
125,227
. The activation of NADPH oxidase 
requires the assembly of different subunits within the phagosome
228
. The activated 
NADPH oxidase donates electrons from NADPH at the cytoplasm surface to O2 in the 
phagosome, thereby producing a superoxide anion (O2
-
). This superoxide serves as a 
precursor for other toxic reactive oxygen species such as hydrogen peroxide (H2O2), 
hypochlorous acid (HOCl) and hydroxyl radical, which can kill the pathogens  
effectively
229,230
. 
Inducible nitric oxide synthase (iNOS) is synthesized upon stimulation of 
macrophages with bacterial products
231
. The function of this enzyme is to catalyze the 
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production of nitric oxide (NO) from L-arginine and O2
232
. Unlike superoxide, NO is 
synthesized in the cytoplasm, outside of phagosome but it later can be delivered into the 
phagosome
231
. In the phagosomal lumen, when NO encounters oxygen species it is 
subsequently converted to reactive nitrogen species. Reactive oxygen and nitrogen 
species can synergize to produce highly toxic effects on intraphagosomal pathogens, by 
which the microbe is damaged, protein is inactivated and lipid is converted
203
. The 
importance of reactive nitrogen species in protection against infection of different 
pathogens in mouse macrophages has been well studied
163,229,233
. The role of these 
antimicrobial substances in human macrophage infection is controversial because it is 
difficult to detect the expression of iNOS or NO in human macrophages
234,235
. 
1.4.3.3 Antimicrobial peptides and proteins 
The phagosome after maturation possesses many microbicidal peptides and proteins 
which contribute to the destruction of intraphagosomal pathogens. These agents can 
either prevent microbial growth by limiting the nutrient source inside the phagosome or 
compromise the integrity of microbes
203
. 
For instance, iron scavenger lactoferrin and cation exporter natural resistance-associated 
macrophage protein 1 (NRAMP1) extrude iron and other cations such as Zn
2+
 and Mn
2+
 
from phagosomal lumen, thus affecting the activity of bacterial enzymes required for 
their DNA synthesis and mitochondrial respiration
236
. Antimicrobial agents that are 
more directly to disrupt the integrity of microbes by inducing microbial membrane 
permeabilization include defensins, cathelicidins, hepcidin, lysozymes, and lipases and 
various proteases
203,237
. These hydrolases can also help degrading the pathogen. In 
neutrophils, these antimicrobial agents are packed in granules while in macrophages 
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they are delivered to phagosome from multiple vesicles through the phagosome 
maturation process or from other cell types such as neutrophils upon activation
126,222
. 
1.4.4 Interaction of macrophages and Mtb 
Macrophages are thought to be the first host defense against Mtb infection. As discussed 
in Section 1.3.1, there are a wide range of receptors on macrophage surface that 
facilitate the internalization of Mtb. Following entry, the phagosome undergoes a 
maturation process, where after Mtb in phagosomes is exposed to a range of 
antimicrobial mechanisms to kill or inhibit the intracellular growth of mycobacteria. 
However, Mtb has been found to have developed different strategies to escape the 
killing mechanisms within phagosomes, exploiting macrophages as a niche for its 
survival and replication.  
1.4.4.1 Controlling intracellular mycobacterial growth 
A number of studies indicate that the antimicrobial mechanisms of macrophages are 
able to inhibit the growth of Mtb and other mycobacterial species in macrophages. 
Activation of monocytes or macrophages by cytokines such as IFN-ɣ or microbial 
product of LPS, results in the reduced intracellular bacteria burden
121,164,166,233,238
. It has 
been shown that the mycobacteria are efficiently killed by the production of reactive 
oxygen and nitrogen species
233
, or by successful maturation of phagosome that delivers 
bacteria to a hostile acidic environment enriched with numerous hydrolases
164–166,223
. A 
recent study has indicated that the Mtb-containing phagosome is even more toxic with 
enhanced superoxide burst
239
 that contributes to the killing of bacteria.  
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1.4.4.2 Inhibition of microbicidal mechanisms 
a. Inhibit phagosome maturation 
The inhibition of phagosomal maturation mediated by Mtb is well-characterized, which 
results from its ability to interfere with the recruitment of V-ATPase
218,240,241
 and the 
fusion events of phagosomes. Mtb is shown to be capable of preventing the fusion of 
phagosomes with vesicles through modulating the delivery or elimination of proteins 
required for phagosome maturation to or from the phagosome membrane
242,243
. Mtb-
containing phagosomes in mice and human macrophage cell lines shows a delayed 
acidification that maintains at pH of ~ 6.4 compared to pH ~ 4.5-5 in successfully 
acidified phagosome
244
. In the clinical setting, Mtb-containing phagosomes of Mtb-
infected alveolar macrophages from patients with TB and HIV co-infection fail to fuse 
with the lysosome and are not acidified 
245
.  
The arrest of phagosome maturation seems to have a correlation with the viability of 
infecting bacteria. In the infected mouse macrophage, Mtb carrying mutants that are 
defective in arresting phagosomal acidification have reduced growth 
219,220
. Several 
molecules of Mtb have been indicated to modulate the maturation of phagosomes. For 
instance, cell wall ManLAM
246
 and trehalose 6,6'-dimycolate (TDM)
247
 are able to 
block phagolysosome fusion. Stimulation of human or murine macrophages with 
cytokines override the arrest of maturation of the mycobacterium-containing 
phagosomes, resulting in a reduced intracellular growth of mycobacteria and increased 
antigen presentation
164,165,248,249
.  
b. Escape from phagosome 
Mtb was believed to reside exclusively in the membrane-enclosed vacuole in the 
macrophage for a long time but this consensus has been changed due to advances in 
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technology. Previous study has shown that at early time point Mtb is localized in the 
phagosome that is not acidified, but at least two days after infection, Mtb is found to 
translocate from phagolysosome to the cytosol of DC and macrophages in a manner 
dependent on 6kDa early secretory antigenic target (ESAT-6) protein produced by 
Mtb
250
. This phenomenon was argued not merely due to the outgrowth of bacteria in 
phagosomes and not a result of membrane disruption during apoptosis of infected cells. 
Later studies utilizing the fluorescent-based methods have indicated that at the late stage 
of infection, Mtb is capable of rupturing the phagosomal membrane to translocate to 
cytosol where it can mediate the host cell death
251
. ESX-1- dependent translocation 
could be the factor that determines the virulence of the mycobacteria
252
. By exploiting 
transmission electron microscopy (TEM),  the cytosolic translocation of Mtb is shown 
to occur at very early stage of infection and there is the strain-specific heterogeneity in 
ability to induce phagosomal escape
253
. In addition host factors could affect the 
translocation of Mtb. Mice deficient in functional Nramp-1, a phagosomal bivalent 
cation transporter who functions in phagosomal acidification and pH regulation, leads to 
an enhanced Mtb-mediated phagosomal rupture
254
. 
c. Other survival strategies 
Apart from strategies employed by Mtb to avoid antimicrobial properties of macrophage 
described above, there are several other strategies. In hMDM, Mtb favors its 
intracellular survival by down-regulating the expression of Cathepsins, one of proteases 
who have many functions in protection against the infection, including  pathogen 
killing, protein processing and antigen presentation
255
. Mtb also reprograms the host 
lipid metabolism by accumulating lipid droplet in the Mtb-containing phagosome that 
could be served as bacterial nutrition
239
. Furthermore, Mtb can inhibit the expression of 
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MHC class II in mouse macrophages to prevent antigen presentation to CD4
+
 T cells, 
thereby avoiding an Th1 immune response
256
.   
1.4.4.3 Mtb-induced macrophage cell death 
In response to Mtb infection, the initial purpose of immunity response is to help the 
body defend against and recovery from the infection through activation of inflammatory 
pathways, complement system, production of antimicrobial mechanisms and 
recruitment of different immune cell types to the site of infection. However, if the 
condition is unresolved, infected cells may undergo cell death.  
There are two common types of cell death following productive Mtb infection of human 
or murine in vitro: apoptosis and necrosis
257
. Apoptosis is a form of death in which cell 
is shrunk, nuclear is condensed and fragmented but plasma membrane integrity is 
preserved; whereas necrosis is characterized by the plasma membrane disruption
257
. 
Recently, it has become apparent that the mode of death of infected host cells has 
decisive role in the control of Mtb infection and, later on, in the development of 
disease
47,258
. Apoptosis is generally considered to be a part of protective mechanism of 
host immune response since the apoptotic Mtb-infected macrophages are engulfed by 
uninfected macrophages through efferocytosis, in which Mtb are effectively killed
258
. 
Whereas, necrosis is considered to provide first a niche for Mtb replication, then cause 
cell lysis and facilitates bacterial dissemination
47,259
. It is suggested that Mtb strains 
differ in their ability to induce the mode of cell death. The virulent Mtb strains are able 
to induce the necrosis rather than apoptosis
47,260
. Mtb is shown to be able to manipulate 
host cell death by multiple mechanisms. Mtb can inhibit host cell apoptosis by 
upregulation of host cell anti-apoptosis signaling proteins such as Bcl-2 or suppression 
the apoptosis signaling pathway
261
. In addition, Mtb is capable of causing EXS-1 
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dependent phagosome rupture which results in the host cell necrosis
251
. Another 
pathway Mtb exploits to induce necrotic death of host cell is involved in the increased 
level lipid mediator lipoxin A4 (LXA4)
262
. Zebrafish model shows that increased level of 
LXA4 inhibits the production of TNF-α. As a result, there is an exuberant number of 
Mtb, leading to the necrosis of infected cells
194
.  
1.5 Aims of the thesis 
Although there have been many studies on host genetics, immune response against Mtb 
and its genome related to TB susceptibility, a number of critical questions remain, that 
require clear answers to improve the prevention and treatment of TB. Some of the 
critical questions are (1) why do only 10% of individuals among 2 million people with 
latent TB develop active disease and (2) what markers predict disease severity and 
treatment outcomes? 
Macrophages are important for the defense against TB infection. They play an essential 
role in regulating the recruitment and the activation of other immune cells through 
cytokine and chemokine secretion. More importantly, macrophages can phagocytose 
Mtb and function as an effector cell. Phagosomes are known to be central to the 
antimicrobial function of macrophages, where they can kill pathogens by producing 
reactive oxygen and nitrogen species, delivering internalized microbes to low-pH, 
hydrolytically active environment during the phagosome maturation. With such 
important roles, defects in macrophage antimicrobial function may have major 
consequences in TB infection. However, to date there is limited understanding of the 
influence of macrophages to clinical outcomes of TB infection.  
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Substantial data have shown the influence of genetic variations of host immune genes 
on the susceptibility to TB. Phagocytosis of Mtb by macrophages is mediated by a 
variety of membrane receptors on macrophage that can recognize different molecular 
structures on pathogens. But knowledge is lacking whether the genetic variation of these 
receptors influences the recognition of Mtb, phagosomal function of macrophages and 
thus outcomes of Mtb infection.  
In view of the knowledge lacuna above, I hypothesized that the impairment of 
macrophage phagocytic function under the influence of host genetics could explain the 
different clinical phenotypes of TB. I established intracellular assays to directly measure 
the extent of antimicrobial capacity of macrophage from TB patients to examine the 
association between phagosomal activities and TB clinical phenotypes.  
Many studies demonstrate that Mtb is able to arrest the phagosome maturation to avoid 
multiple antimicrobial responses inside the phagosome. As a consequence, Mtb can 
survive and proliferate inside the macrophage, which could result in infection 
establishment and progression to clinical complications. There is mounting evidence for 
the influence of diversity of Mtb strains on their virulence, modulation of host 
immunity, clinical phenotype and disease transmission. Most of the studies examined 
lab strains or clinical isolates but in a limited number, resulting in certain discrepancy in 
the results. Therefore, it is important to investigate, with a large number of clinical 
isolates, how the strain variation influences their virulence and modulates host immune 
response, which will lead to better understanding of TB pathogenesis. The aims of my 
thesis are: 
1. To establish intracellular assays to measure antimicrobial function of macrophages 
from TB patients  
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2. To investigate the association of macrophage antimicrobial function and TB clinical 
phenotypes.  
3.  To determine whether polymorphisms in phagocytic function genes are associated 
with TB susceptibility and underlying molecular mechanism of the association 
4. To study the virulence of different Mtb strains and its association with host immune 
response and Mtb genotype 
  
46 
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METHODOLOGY 
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2.1 Subjects with TBM, PTB and LTB 
The subjects were recruited for the macrophage study in chapter 4 and the genetic case-
control study in chapter 5. The detail of recruitment is described in detail in each 
chapter. In general, they could be divided into 4 groups: subjects with TBM, subjects 
with PTB, subjects with LTB and controls. All subjects with TBM, PTB and LTB were 
adults and HIV negative.  
2.1.1 Subjects with TBM 
TBM patients, as previously described
263,264
 had clinical meningitis, which was defined 
as the combination of nuchal rigidity and abnormal cerebrospinal fluid parameters, 
and/or acid fast bacilli seen in the cerebrospinal fluid by Ziehl-Neelsen stain or culture.  
2.1.2 Subjects with PTB  
 PTB patients had sputum positive with acid fast bacilli by Ziehl-Neelsen stain and chest 
X-rays that were consistent with active PTB, but not miliary or extra-pulmonary TB. In 
study of antimicrobial activity of macrophages in chapter 4, PTB patients had no 
previous history of TB treatment. 
2.1.3 Subjects with LTB 
These subjects had no history of active disease and were recruited from healthy 
Vietnamese volunteers who are working at OUCRU. They had positive tests in ESAT-6 
and CFP-10 specific IFN-ɣ T-SPOT.TB assays (see section 2.4). 
2.1.4 Controls  
The controls for the genetic association study were newborn babies born in 2003 and 
between 2006 and 2007 at Hung Vuong Obstetric Hospital, HCMC, which were a 
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subset of our laboratory’s collection of 1000 umbilical cord blood samples. This group 
was also used as a genetic control for Vietnamese population to assess the association of 
human genetic factors and other infectious diseases
265–267
. 
2.1.5 Ethical approval and informed consent 
All study protocols related to this research were approved by Ethics and Scientific 
Committees at hospitals where the human subjects were recruited, including Hospital 
for Tropical Diseases, Pham Ngoc Thach Hospital and Hung Vuong Hospital. Ethical 
approvals were also granted by the Oxford Tropical Research Ethics Committee UK. 
Prior enrollment to any study in this research, written informed consent was obtained 
from each participant or an accompanying relative if he/she could not provide consent 
independently. 
2.2 Media for cell culture and bacteria growth 
2.2.1 Media for cell culture 
In this study, I used three different cell types, including macrophage cell lines from 
murine J774 and human THP1 as well as primary human monocyte-derived 
macrophages (hMDM). The macrophage cell lines were used for optimizing the 
experimental conditions because cell lines are easy to culture, sustain and they have 
constant genetic and phenotypic features which may differ from their original tissues. 
Unlike cell lines, the primary hMDM are able to maintain most of cellular functions and 
used to examine antimicrobial activity of macrophage in response to Mtb infection. The 
cells were cultured in optimal medium. All cell culture media were sterilized by using 
vaccuum filtration system through 0.22 µm membrance (Merk Millipore, Germany).  
Chapter 2 
49 
a. Medium for J774 and THP1 cell lines: RPMI (Sigma, Germany) was suplemented 
with 2 mM L-glutamine (Sigma, Germany), 100 units of penicillin and streptomycin 
(Sigma, Germany), 10% (v/v) Fetal Bovine Serum (FBS, Sigma, Germany). This 
medium was used for culturing J774 and THP1 cells.   
b. Antibiotic-free medium for J774 and THP1 cell lines: This medium was prepared 
as described in (a.) without adding antibiotics and was used to infect cell lines with Mtb.  
c. Serum-free medium for PBMCs: RPMI was suplemented with 2 mM L-glutamine, 
100 units of penicillin-streptomycin, 1 mM Sodium pyruvate. This medium was used 
for monocyte isolation by adherence.  
d. Complete medium for hMDM: RPMI was suplemented with 2 mM L-glutamine, 
100 units of penicillin-streptomycin, 1 mM Sodium pyruvate, 10 % (v/v) heat-
inactivated FBS. This medium was used for culturing hMDM.  
e. Antibiotic-free medum for hMDM: This medium was prepared as described in (d.) 
without adding antibiotics and was used to infect hMDM with Mtb.  
2.2.2 Media for Mtb growth 
a. 7H9T: 4.7 g 7H9 (BD Diagnostic System) was dissolved in 900 ml, then 0.5 ml 
Tween 80 (Sigma) was added. This suspension was autoclaved at 121 
o
C, 10 min, then 
let to cool at room temperature. When media temperature was about 50 
o
C (that could 
be touched by hand), 100 ml Middlebrook OADC Growth Supplement (BD Diagnostic 
System) was added.                
b. 7H9G: The preparation of 7H9G medium was similar to that of 7H9T. However, 2 
ml of glycerol was added into the medium instead of using 0.5 ml Tween 80. This 
medium is mainly used to culture Mtb for archive.         
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c. Selective medium 7H10 agar plates: 2.35 g 7H10, 0.85 g Glucose (Merck), 0.5 g 
Casitone (Merck), and 10 g Agar powder (BD) were dissolved in 500 ml, then 0.5 ml 
Tween 80 was added. This suspension was autoclaved at 121 
o
C, 10 min, and then let to 
cool at room temperature. When medium temperature reached about 50 
o
C, 50 ml 
Middlebrook OADC was added, and Kanamycin was also added to a final concentration 
of 30 µg/ml. This medium was used to screen Mtb colonies transformed with mCherry 
plasmid (see Section 2.8.1).    
d. LJ: was provided by BD Diagnostic System. The components of this medium contain 
2.5 g monopotassium phosphate, 0.24 g magnesium sulfate, 0.6g sodium citrate, 3.6 g 
L-asparagine, 30 g potato flour, 0.4 g malachite green, 12 ml glycerol, 1000 ml whole 
egg and 600 ml purified water. This medium is often used to isolate and cultivate Mtb. 
2.3 PBMC isolation 
PBMC were separated from heparinized whole blood by Lymphoprep (Asix-Shield, 
Norway) gradient centrifugation in accordance with the manufacture’s protocol. 20 ml 
of blood was diluted in 20 ml of PBS (ratio of 1:1), then slowly added to the tube 
containing 20 ml of Lymphoprep (ratio of 2:1), and centrifuged at 1300 g for 24 min at 
room temperature without brake (brake adjusted to zero). The buffy coat layer of PBMC 
was transferred to a new tube and washed 3 times with cold PBS supplemented with 3 
% FBS at 4 
o
C, 600 g for 7 min to remove platelets.  
2.4 T-SPOT.TB assay 
This assay is used as an aid in diagnosis of Mtb infection based on the principle that T 
cells of individuals, who get infected with Mtb, have ability to produce IFN-γ in vitro 
when they are stimulated with Mtb antigen. In this assay, individual TB-specific 
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activated T cells can be enumerated by using a simplified ELISPOT method that is 
remarkably sensitive because IFN-γ is captured directly around the secreting cell, before 
it is  captured  by  receptors  of  neighboring  cells  or  degraded in the supernatant
268
. In 
this assay, Mtb antigens used are ESAT-6 and CFP-10 peptides that are specific for the 
Mtb complex (Mtb, M. bovis, M. africanum, M. microti, and M. canetti). Therefore, the 
assay only detects Mtb complex and reduces cross-reactivity to the BCG vaccine and to 
most environmental mycobacterium. The assay was performed in accordance with the 
manufacturer’s instructions (TSPOT.TB, Oxford Immunotec, UK). The 96 wells coated  
with  a  mouse monoclonal antibody against IFN-γ were allowed to equilibrate to room 
temperature. Each patient sample required the use of 4 individual wells, namely Nil 
control, Panel A, Panel B, and a Positive Control. 50 μl of complete media for PBMCs, 
50 μl solution of ESAT-6 antigens, 50 μl solution of CFP-10 antigens, and 50 μl 
solution of phytohaemagglutinin were respectively added to the assigned well for Nil 
control, Panel A, Panel B, and Positive Control. 2 x 10
5
 PBMCs in serum-free media 
were added to each well of the 4 wells to be used for a patient sample. The plate was 
incubated in a humidified incubator at 37 °C with 5 % CO2 for 16-20 h, and then 
washed 4 times with 200 µl PBS per well to remove nonspecific binding. 50 µl of 
alkaline phosphatase-conjugated mouse monoclonal antibody to IFN-γ diluted 200 fold 
in PBS (150 mM NaCl, 7 mM Na2HPO4, 2.8 mM NaH2PO4 at pH 7.2) was added to 
each well. After 2 h incubation at 2-8 
o
C, the plate was washed again with 200 µl PBS 
per well for 4 times, and the antibody-cytokine-antibody sandwich complex was 
detected by incubating in 50 μl of substrate solution at room temperature for 7 min. The 
plate was then thoroughly washed with distilled or deionized water to stop the detection 
reaction and was air-dried. The number of distinct and dark blue spots in each well was 
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counted by using a dissecting microscope: positive test wells would have at least 20 
spots while the negative control wells would have less than 10 spots. T-SPOT.TB test 
results were interpreted by subtracting the spot count in the Nil Control well from the 
spot count in each of the Panels, the result was positive when (Panel A minus Nil 
Control) or (Panel B minus Nil Control) would have at least 8 spots, and negative when 
(Panel A minus Nil Control) or (Panel B minus Nil Control) would have less than 5 
spots. If the highest of (Panel A minus Nil Control) or (Panel B minus Nil Control) was 
5, 6, and 7 spots, the result was considered borderline and it is recommended to re-test 
the individual
268
. In our study, the results were read independently by two researchers 
following the manufacturer’s manual. 
2.5 Preparation of resting macrophages 
2.5.1 Human primary monocyte-derived macrophages 
For phagocytosis, 9x10
5
 PBMC were plated in each well of cell culture treated 48-well 
plates (Corning, USA) in serum-free media to screen adhered monocytes. Cells were 
incubated at 37
o
C, in 5 % CO2 for 2 h and the non-adhered cells were gently washed off 
twice with warm PBS containing 3 % FBS. Then, cells were re-suspended in 0.4 ml 
complete media containing 10 ng/ml human m-CSF (R&D Systems, USA), and 
incubated at 37 
o
C, 5 % CO2 for 6 days to derive macrophages. The complete media 
containing 10 ng/ml human m-CSF were changed at day 4, and phagocytosis assay was 
performed at day 7. 
For other assays, the remaining PBMCs were plated in cell-culture treated 60 mm x 15 
mm petri dishes (Corning, USA) with 6 – 8 x 106 cells per dish. Cells were incubated at 
37 
o
C, in 5 % CO2 for 2 h and the non-adhered cells were gently washed off 3 times 
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with PBS containing 3 % FBS. Then, cells were re-suspended in 2 ml complete media 
containing 10 ng/ml human m-CSF, and incubated at 37 
o
C, 5% CO2. On the following 
day, they were gently washed off twice with PBS containing 3 % FBS, harvested in 1 
ml cold PBS using scrapper, then centrifuged at 4 
o
C, 600 g for 7 min. The pellet was 
re-suspended in 2 ml complete media supplemented with 10 ng/ml human m-CSF. Then 
some of the cells were plated in cell culture-treated black flat bottom 96-well plate 
(Corning, USA) at 8x10
4
 cells per well for acidification and proteolytic assays, the 
remaining cells were cryopreserved in FBS containing 10 % dimethyl sulfoxide 
(DMSO) (Sigma-Aldrich) for further Mtb infection. The adhered cells in 96-well plate 
were incubated for 6 days at 37 
o
C, 5 % CO2 to differentiate into macrophages. The 
complete media was changed at day 4, and acidification and proteolysis assays were 
performed at day 7. 
For Mtb infection, frozen monocytes were rapidly thawed at 37 
o
C and washed twice in 
the complete media. Cells were then plated in cell culture-treated black flat bottom 96-
well plate at 8x10
4
 cells per well and derived as described above. Macrophages were 
infected with Mtb at day 7 after thawing. 
2.5.2 Cell lines 
J774 murine (ATCC® TIB-67™) and THP1 (ATCC® TIB-202™) human macrophages 
were obtained from ATCC (USA) and maintained in the media at 37 
o
C, 5 % CO2. 
THP-1 cells were non-adherent cells, which were passed 1:4 dilution into new media 
every 3 to 4 days with the final concentration of 2x10
5
 cells/ml
269
. To prepare cells for 
experiments, THP1 monocytic cells were transferred to 96-well plates at 6 x 10
4
 cells 
per well to establish a confluent monolayer. These cells were incubated with 50 ng/ml 
phorbol 12-myristate 13-acetate PMA (Sigma) for 2 days for macrophage 
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differentiation. Cells were then washed and incubated in fresh media for at least 12 h 
before experiment.  
J774 cells were cultured in a 75 cm
2
 flask. These cells are adherent to tissue culture-
treated surface; hence, subcultures are prepared by scrapping. To subculture cells, 10 ml 
of culture media were removed. Cells were then incubated in cold PBS for 5 min, then 
scraped and collected by centrifugation at 600 g for 5 min. Subsequently, cells were 
dispensed into new flasks with a subcultivation ratio of 1:3 to 1:6. Media was replaced 
or added two or three times weekly
270
.  To prepare cells for the experiments, they were 
plated to 96-well plate at 4 x 10
4 
cells, or to 48-well plate at 8 x 10
4
 cells per well one 
night before conducting the experiments.  
2.6 Preparation of phagosomal beads  
To investigate phagocytosis, acidification and proteolysis activities of macrophages 
from TB patients, phagosomal bead-based assays have been adapted and modified for 
our purposes. 
In general, the carboxylated 3 µm diameter silica beads were used because of their high 
density and homogeneity which ensures the synchronized contact with the macrophage 
monolayer at the bottom of the test well
271
. Acidification and proteolysis beads were 
constructed with chemical coatings which always contain three elements: a fluorogenic 
substrate, a fluorophore of calibration and a ligand while phagocytosis beads were only 
constructed with the two latter components (Figure 2.1). The roles of these three 
elements are as follows.  
(1) A fluorogenic substrate or reporter is used to specifically detect the enzymatic 
activity of interest or change of phagosomal pH. In line with previous protocols 
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published by Yates et al.
244
, I used pH-sensitive fluorochrome carboxyfluorescein-
succidinimyl ester (CF-SE) for measuring phagosomal acidification and DQ green 
bovine serum albumin (DQ-BSA) for proteolysis. In presence of proteases, DQ-BSA 
gets easily digested to release fluorescent fragments that can be measured. 
(2) A fluorophore of calibration or calibrator remains unchanged through the assay 
and is used to normalize the readout in case of measuring acidification and proteolysis. 
There are a number of fluorescent dyes to select according to the compatibility of the 
existing measuring instrument. It is necessary to ensure that the excitation-emission 
spectra of fluorogenic substrate and the calibrator do not overlap. For acidification 
assay, the emission intensity of fluorogenic substrate when excited at pH-insensitive 
wavelength was used to normalize the readout. For phagocytosis beads, the labeling 
with calibrator facilitates the bead visualization that helps to discriminate the cell 
population internalizing or not internalizing the beads. 
(3) A ligand is to facilitate phagocytosis and to programme the pathway of the innate 
immune response through its receptor. 
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Figure 2.1. A schematic diagram for preparation of phagocytosis, proteolysis and 
acidification beads.  
All three kinds of bead were coated with ligands (either IgG, TDM or β-glucan) that 
were coupled with carboxylate-modified silica beads through covalent binding, 
mediated by crosslinker cynamide. In addition, phagocytosis beads were labeled with 
calibrator Alexa 594SE. Similarly, proteolysis beads were coated with fluorogenic 
substrate DQ-BSA and a calibrator Alexa 594SE. Acidification beads were coated with 
CF-SE that was used as both fluorogenic substrate and calibrator. More clearly, the 
emission intensity of this substrate when excited at pH-insensitive wavelength was used 
to normalize the readout. The location of different components on bead was for 
illustrative purpose only. 
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2.6.1 Phagocytosis beads 
In protocol published by Yates et al. in 2005
244, the beads are coated with IgG or α-D-
mannosylated-PITC-albumin, two ligands recognized by FcɣR and mannose receptors 
on the macrophage surface, to facilitate the bead uptake by phagocytosis. Then the bead 
phagocytosed is visualized by labeling with Alexa Fluor 594 succidinimyl ester (SE). In 
this study, beside IgG, the beads were coated with either TDM (a cord factor derived 
from Mtb, Enzo Life Science) or β-glucan (derived from S. cerevisiae, InvivoGen), 
which are recognized by specific receptors, to study the phagocytosis induced by 
different pathways. The cells with internalized beads were detected by the fluorescent 
dye Alexa Fluor 594. Below is our detailed protocol for preparation of phagocytosis 
beads. 
Five hundred microliter of 3 μm carboxylate-modified silica particles (Kisker Biotech, 
Germany) were washed three times in 1 ml of PBS by vortexing and centrifuged at 2000 
g for 1 min. The beads were re-suspended in PBS with 25 mg/ml of the crosslinker 
cynamide (Sigma-Aldrich, USA), which works as a cross-linker, and agitated for 15 
min at room temperature. Following this, the beads were washed twice in 1 ml of PBS 
and once in 1 ml of coupling buffer (50 mM borate buffer in PBS, pH 8.0) to remove 
excess cynamide. Next, they were re-suspended in 0.5 ml coupling buffer with 1.0 mg 
defatted BSA (Sigma-Aldrich) and 0.1 mg human IgG (Molecular Probes) or 0.25 mg 
ligands [TDM (Enzo Life Sciences) or β-glucan/ whole glucan particles (Invitrogen)] 
then incubated for 12 h with agitation. Next, the beads were washed three times in 1 ml 
of quenching buffer (250 mM glycine (Sigma-Aldrich) in PBS, pH 7.2) to quench 
unreacted cyanamide. The beads were then re-suspended in 1 ml coupling buffer 
containing 10 µl of 5 mg/ml Alexa Fluor 594 SE (Molecular Probes) in DMSO and 
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agitated for 1 hr. Then, the beads were washed three times in 1 ml quench buffer, re-
suspended in 1 ml PBS with 0.02 % sodium azide and stored at 4 
o
C. 
2.6.2 Acidification beads 
Our acidification beads were prepared similarly to that in studies by Yates et al.
244
. 
However, I generated the bead by coating with not only IgG, but with TDM or β-glucan 
ligands to study the acidification via different pathways. Our procedure to generate 
acidification beads were detailed as below. 
First steps to prepare the cynamide-bound beads were followed exactly as described in 
the procedure above for the preparation of phagocytosis beads. The cynamide-bound 
beads were re-suspended in 500 μl of coupling buffer with 1 mg defatted BSA, 0.1 mg 
human IgG or 0.5 mg/ml of ligands (either TDM or β-glucan), and incubated with 
agitation for 12 h. Then, they were washed twice with 1 ml of quenching buffer to 
quench unreacted cyanamide and twice with 1ml of coupling buffer. Following this, the 
beads were re-suspended in 1 ml of coupling buffer containing 10 μl of the 5 mg/ml 
stock of the CF-SE (Molecular Probes) dissolved in DMSO. The beads were agitated for 
2 h to allow the albumin-bound particles to be sufficiently labeled with the amine-
reactive fluor, and then were washed three times in 1 ml of quenching buffer. The 
acidification beads were stored in 1 ml of PBS with 0.02 % sodium azide at 4 
o
C.  
2.6.3 Proteolytic beads 
Proteolysis beads were prepared similarly to that in published protocol
272
. Instead of 
coating the beads with ligands of IgG and mannose as Yates et al. did, I generated the 
proteolysis beads by coating with either IgG, TDM or β-glucan ligands to study the 
proteolysis via different pathways. 
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The cyanamide-bound beads were prepared as describe above in Section 2.6.1. The 
beads were then re-suspended in 500 μl of coupling buffer with 1mg of DQ-BSA 
(Molecular Probes, USA) and 0.1 mg human IgG or 0.5 mg/ml of ligands (either TDM 
or β-glucan), and were incubated with agitation for 12 h. Next, they were washed three 
times in 1 ml of quenching buffer to quench unreacted cyanamide, and were re-
suspended in 1 ml of coupling buffer containing 10 μl of the 5 mg/ml stock of the 
calibration fluor Alexa Fluor 594-SE (Molecular Probes, USA) in DMSO. Following 
this, the beads were agitated for 1 h to allow the albumin-bound particle to be 
sufficiently labeled with the amine-reactive fluor, and then they were washed three 
times in 1 ml of quenching buffer. The proteolytic beads were stored in 1 ml of PBS 
with 0.02 % sodium azide at 4 
o
C.  
2.7 Phagosomal beads assays 
2.7.1 Phagocytosis assays 
Resting macrophages in 48-well plate were checked by microscope to ensure that a 
monolayer with about 80 % confluence had been achieved. New media was changed 
with 200 µl per well. Stored phagocytosis beads were washed three times in PBS with 
vortexing, then 10 µl of beads was added into each well with concentration to achieve 
an average of 1–2 beads internalized per macrophage244. Binding and uptake of the 
beads were performed by incubating of macrophages with a suspension of the beads at 
37 
o
C, 5 % CO2 for 10 min. The cells were washed three times in PBS with 3 % FBS to 
remove unbound beads, then were harvested by scraping in cold PBS with 1 % para-
formaldehyde and transferred into a tube for flow cytometry analysis. 
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Phagocytosis of macrophages was determined by the percentage of phagocytes which 
internalized Alexa Fluor 594 SE-labeled beads. Samples were run using BD FACS 
Canto II and FACS Diva acquisition software, and fluorescent intensity was analyzed 
using FlowJo analysis software (FLOWJO, LLC). 
2.7.2 Acidification and proteolysis assays 
Stored acidification or proteolysis beads were washed in PBS twice with vortexing, and 
were re-suspended in PBS
273
. Confluent monolayer of resting macrophages was washed 
and 50 µl assay buffer (1 mM CaCl2, 2.7 mM KCl, 0.5 mM MgCl2, 5 mM dextrose, 10 
mM HEPES, 10 % FBS in PBS) were added. Next, 10 µl of the beads were added into 
each well with concentration to achieve an average of 4–5 beads internalized per 
macrophage
239
. Subsequently, cells were transferred to 37 
o
C in a fluorescent microplate 
reader (SynergyH4, BioTek) to initiate the fluorescence data acquisition in real-time. 
This acquisition lasted 90 min for acidification assay and 210 min for proteolytic assay. 
During this time period, data were collected with an interval of 1.30 min. The relative 
pH within phagosome was calculated by the ratio between fluorescent intensities 
emitted at 520 nm when excited at pH-sensitive 490 nm and at pH-insensitive 450 nm. 
Proteolysis was expressed by the calibrated fluorescent intensity of hydrolyzed DQ-
BSA substrate emitted at 520 nm when excited at 490 nm. To compare the macrophage 
acidification or proteolysis activity between different groups of patients, activity index 
was used as reported previously
274,275
. Acidification Activity index of macrophages at 
30, 60, 70, and 90 min was calculated by ratio of relative pH at 10 min over that at 30, 
60, 70, and 90 min respectively. Likewise, proteolysis Activity index at 60, 120, 180 
and 210 min was calculated by dividing proteolysis at these time-points respectively by 
that at 10 min. 
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Three wells were used for each experimental condition and the mean was determined. 
Three independent experiments were conducted for testing consistency of proteolysis 
and acidification activities of J774 murine macrophage and the mean was determined. 
Proteolysis activity of hMDM infected with Mtb was assessed at day 2 post infection 
(see Section 2.8.3). 
2.8 Macrophage and Mtb interaction 
The interaction of macrophage and Mtb was assessed by the intracellular growth of 
bacteria and the Mtb-induced cell death of macrophages. 
2.8.1 Preparation of Mtb reporter strain  
The gold standard method to examine the growth of Mtb within the macrophages is 
lysing macrophages, plating then counting colony-forming units CFU. However, this 
method is laborious and time consuming. Alternatively, fluorescent reporter strains can 
be used to assess the bacterial intracellular growth because of rapid detection, high 
sensitivity and real time detection
276
. Therefore, to study antimicrobial function of 
macrophages from TB patients, I generated the Mtb reporter strain that enables to 
express mCherry fluorescent protein. Correlations of mCherry intensity and bacterial 
growth measured by optical density (OD) at 600nm (OD600) or CFU were assessed and 
presented in chapter 3.  
a. Generating Mtb reporter strain  
Plasmid pVV16 containing hsp60 promoter and a gene encoding for fluorescent protein 
mCherry (pVV16-mCherry plasmid) was kindly provided by Professor DG. Russell 
(Cornell University, USA). This construct was transformed to Mtb by using a 
Micropulser Electroporator (Biorad, USA). To prepare the competent cells for 
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electroporation, Mtb clinical strain isolated from TB patient was cultured with shaking 
in 10 ml 7H9T medium at 37 
o
C to log phage OD600 0.5 - 1 for 15 - 18 days. 1 ml of 2 
M glycine solution was added to culture 24 h before harvesting the cells. Bacteria were 
harvested at 3200 g for 10 min at room temperature. The cells were washed in 50 ml of 
pre-warmed 10 % glycerol, re-suspended well in 500 µl of 10% glycerol through a 
sterile syringe equipped with 23-gauge needle to form single cell suspension, then 
aliquoted and kept at -20 
o
C as glycerol stocks until further use. 0.2-0.5 µg of pVV16-
mCherry plasmid were mixed with 200 µl competent cells and left for 10 min at room 
temperature. Then, this mixture was transferred to a 0.2 cm electroporation capped 
cuvette. Electroporation was conducted at a pulse of 2.5 kV, 25 µF. Cell suspension was 
transferred to pre-warmed 7H9T and incubated at 37 
o
C for at least 48 h. Cell 
suspension was then plated on selective media containing 30 µg/ml kanamycin and 
incubated at 37 
o
C for 3 weeks. Mtb carrying the pVV16-mCherry plasmid was selected 
from pink colonies growing in the selective media (Figure 2.1) and cultured in 7H9T 
media containing kanamycin at 37 
o
C with shaking until OD600 0.8 – 1 for 15 – 18 
days. Bacteria were harvested at 3200 g for 10 min at room temperature, washed in 50 
ml of pre-warmed 10 % glycerol, re-suspended in 10% glycerol, aliquoted and stored at 
-20
o
C for further use. 
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Figure 2.2 Generating Mtb reporter strain  
(A) Mtb carrying the pVV16 plasmid (white colonies) as a negative control. (B) Mtb 
carrying the pVV16-mCherry plasmid (pink colonies) 
b. Culture of Mtb reporter strain  
Mtb reporter strain was cultured from -20 
o
C stock above in 7H9T containing 30 µg/ml 
kanamycin at 37 
o
C with shaking to OD600 of 1 - 2 for 15 - 20 days. The bacteria was 
sub-cultured in 7H9T containing 30 µg/ml kanamycin at 37 
o
C with shaking, and was 
ready for infection experiment when OD600 reached 0.5 – 1. 
c. CFU of Mtb reporter strain 
The bacterial culture having OD600 of 0.5 - 1 was serially diluted 10-fold from 10
-1
 up to 
10
-4, 
then two-fold from 2
-1
x10
-4 
to 2
-4
x10
-4
. 100 µl of each dilution from 10
-4 
to 2
-4
x10
-4 
was transferred to plate of selective medium containing 30 µg/ml kanamycin and spread 
onto the plate. The plates were incubated at 37 
o
C for 3 weeks for CFU counts. Within 
3-4 weeks after plating, the plates were taken out and CFU was calculated from the 
number of colonies of Mtb on the plates, taking into account the dilution factors. 
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d. Fluorescent intensity of Mtb reporter strain  
The bacterial culture having OD600 of 0.5 - 1 was serially two-fold diluted. 100 µl of 
each dilution was transferred to black flat-bottom plate and mCherry intensity was 
measured at emission wavelength of 620 nm after excitation at 575 nm using the 
fluorescent microplate reader.  
2.8.2 Isolation of Mtb from sputum sample 
Sputum (N= 159) were collected from patients who had less than three days of TB 
treatment. To decontaminate the sputum sample, an equal volume of N-acetyl-L-
cysteine and 2% NaOH were added to the sputum (approximately 10 ml each), mixed in 
screw capped tube and vortexed. The mixture was incubated at room temperature for 15 
min with occasional shaking. PBS (pH 6.8) was added to the mixture to get a final 
volume of 50 ml, then the mixture was centrifuged at 3200 g for 15 min. Supernatant 
was discarded carefully and the pellet was dissolved in 0.5 to 1 ml of PBS. This 
suspension was used for culturing Mtb on LJ medium at 37 
o
C, then after 3-4 weeks, 
Mtb was sub-cultured in 7H9G from single colony. When the culture reached OD600 of 
0.5-1, it was centrifuged at 1800 g for 15 min, then the pellet was re-suspended in 
7H9G, aliquoted and stored at -20 
o
C for further experiments.  
To prepare culture for infection, Mtb was re-cultured from -20 
o
C stock above in 7H9T 
at 37 
o
C with shaking to OD600 of 1 - 2 for 15 - 20 days. The bacteria were sub-cultured 
in 7H9T at 37 
o
C with shaking, and were ready for infection experiment when OD600 
reached 0.5 – 1. 
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2.8.3 Experimental infection of macrophage with Mtb 
Resting macrophages were recharged with 100 µl antibiotic-free medium. Cells then 
were infected with Mtb at different desired MOI of 1, 2, or 3 and incubated at 37 
o
C, 5 
% CO2. Four hours after infection, macrophages were washed with pre-warmed medium 
without antibiotics and incubated at 37 
o
C, 5 % CO2. Next, infected cells were incubated 
at 37 
o
C, 5 % CO2, and cell supernatants were collected at 24 h after infection for 
cytokine measurement. Infected cells were then further incubated in new media at 37 
o
C, 5 % CO2 to examine the bacterial growth or phagosomal activities. 
2.8.4 Measurement of in vitro bacterial growth rate 
To assess the bacteria growth rate of 159 clinical Mtb isolates, 6x10
6 
bacilli were 
cultured in 10 ml 7H9T at 37
 o
C without shaking. The OD600 was measured every two 
days during 20 days of culture. The log2 of OD600 value of each isolate was plotted and 
the bacterial growth rate was expressed as the slope of this line. 
2.8.5 Measurement of intracellular bacterial growth 
The intracellular growth of Mtb reporter strain was assessed over 5-7 days, by using the 
fluorescence microplate reader, through fluorescent intensity of mCherry protein, 
emitted at wavelength of 620 nm after excitation at 575 nm. Three wells were used for 
each Mtb strain and the mean was determined. 
2.8.6 Observation of macrophage lysis 
The interaction of macrophage and Mtb clinical isolates was assessed by macrophages 
lysis. The percentage of lysed macrophages was daily estimated using conventional 
microscopy. The result was read by two independent staff without noticing sample 
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position on the plates. Three wells were used for each Mtb strain and the mean was 
determined. 
2.9 Molecular and Immunological assays 
2.9.1 Stimulation for mRNA gene expression and cytokine production 
For mRNA expression, monocytes from healthy volunteers were plated to 24-well plate 
at concentration of 10
6
 cell per well. Cells were incubated at 37 °C with 5% CO2 
overnight in the complete media. Following day, media was changed and cells were 
subsequently stimulated with either whole cell lysis (WCL) of Mtb H37Rv (Colorado 
State University, USA) at 5 µg/ml, lipopolysaccharides (LPS) from Escherichia coli 
(Sigma-Aldrich) at 100 ng/ml or media. After 5 h of incubation at 37 °C with 5 % CO2, 
the old medium was removed and 0.5 ml Trizol (Life technologies
TM
) was added in 
order to disrupt the cells, dissolve the cell components and release RNA. This 
suspension was transferred to the 1.5 ml RNA-free tube and stored at -80 
o
C for further 
extraction (see Section 2.9.2). 
For cytokine production, PBMCs from healthy volunteers were plated in 96-well plates 
at concentration of 10
5
 cells / well in the complete media. Cells were stimulated with 
either H37Rv WCL at 25 µg/ml, TDM at 100 µg/ml, LPS 100 ng/ml or media. For 
stimulation, TDM was coated on the plate and air-dried in the cabinet the day before, 
while other ligands were added directly into the medium after cell plating. Cells were 
incubated at 37 
o
C, 5 % CO2 for 24 h and supernatants were collected, kept at -80 
o
C. 
All samples were then processed and cytokines were measured from stored supernatants 
at the same time.  
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2.9.2 mRNA gene expression 
a. mRNA extraction 
mRNA was extracted by Trizol method following the manufacturer’s instruction 
(Ambion, Life technologies
TM
). Briefly, the samples stored at -80 
o
C were thawed, then 
cell suspension was transferred to 1.5 ml tube; 100 µl of chloroform was added to 
separate the solution into an aqueous phase and an organic phase by centrifugation at 
10000 g, 4 
o
C for 15 min. The aqueous phase which contained RNA was transferred to a 
new tube. 500 µl of isopropanol was added to precipitate the RNA by centrifugation at 
12000 g for 10 min at 4 
o
C. Then the supernatant was discarded and the RNA pellet was 
washed with 1 ml of 75% ethanol by centrifugation at 7500 g for 5 min at 4 
o
C, air-
dried, dissolved in 10 µl RNase- free water and stored at -80 
0
C until use.  
RNA concentration was measured by absorbance at 260 nm using a spectrophotometer 
(Nanodrop ND-1000, Germany). The nucleotide bases absorb UV light of 
approximately 260 nm of wavelength. An OD of 1 corresponds to 40 ng/µl for RNA at 
260 nm. The ratio between the reading of 260 nm and 280 nm (OD260/OD280) shows an 
estimate of the purity of the nucleic acid. Pure preparation of RNA has an OD260/OD280 
value of 2. 
 b. Reverse transcription 
I synthesized cDNA from total RNA template by reverse transcription. 10 µl RNA were 
mixed with 1µl of 50 ng/µl random primers (Roche) and 1 µl of 10mM dNTPs on ice. 
This sample mixture was incubated at 65
o
C for 5 min by Mastercycler and immediately 
incubated on ice for at least 1 min. Master mix was prepared on ice for each reaction 
with 1 µl of 200 U/ µl of SuperScript
™
 III RNase H Reverse Transcriptase (Invitrogen), 
4 µl of 5X First-Strand buffer (Invitrogen), 2 µl of 100 mM DTT (Invitrogen), and 1 µl 
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of 40 U/µl RNAase OUT (Invitrogen). The master mix was added to the sample 
mixture, mixed well and incubated at 25 
0
C for 10 min, 50 
o
C for 1 h, 72 
o
C for 15 min 
and held at 4 
o
C for 2 min. After thermal cycling, all cDNA samples were stored at -20 
o
C until use. 
c. Preparing and running Taqman® real-time PCR 
Glyceraldehyde-3-phosphate dehydrogenase GAPDH was used as a house-keeping gene 
to normalize the samples. The primers and probes of MARCO and GAPDH adapted 
from previous study
277
 and PhD thesis of Dr. Thuong Nguyen (Open University, 2008) 
respectively were listed in Table 2.1. Real-time PCR reaction was performed in 20 µl 
master mix consisting of 1 µl of 10 µM of each primer, 0.5 µl of 5 µM of each probe, 10 
µl of 2X reaction buffer (LightCycler480 Probe Master, Roche), 2.5 µl distilled water 
and 2.5 µl of cDNA from reverse transcription product. 
Table 2.1 MARCO and GAPDH primers and probes 
Type Gen Sequence (5’-3’) 
Primers 
(Sigma) 
MARCO- 
forward 
CTGGTGGTCCAAGTTCTGAATCT 
MARCO-reverse TCAGCCGCCAGAGTGTCA 
GAPDH-
forward 
CCACATCGCTCAGACACCAT 
GAPDH-reverse ACCAGGCGCCCAATACG 
Probes 
(Tib 
Molbiol) 
MARCO 
Cyan500-CTCCGGGTCCTGGAGATGTATTTCCTCA-
BHQ1' 
GAPDH Cy5-CAAATCCGTTGACTCCGACCTTCACCTT-BBQ' 
 
The reaction was loaded to a thermocycler (LightCycler480, Roche) and run as follow: 
95 
o
C for 5 min; and 45 cycles of 95 
o
C for 15 seconds, 60 
o
C for 45 seconds. The 
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fluorescent signals were read at wavelengths of 440-488 nm and 618-660 nm for 
MARCO and GAPDH, respectively. 
d. Data analysis 
I used relative quantification to determine a change in the expression of the MARCO 
mRNA in ligand or WCL-stimulated monocytes relative to an untreated-monocyte 
MARCO mRNA expression. Each reaction was repeated twice and the mean was 
calculated. Analyses were performed using LightCycler 480 release 1.5.1.62 Relative 
Quantification software (Roche). The expression of target genes was normalized to 
GAPDH expression.  
2.9.3 Measurement of cytokine production 
a. Using Bio-Plex Precision Pro Assays 
The concentrations of TNF-α, IL-1β and IL-10 from stimulated PBMC (see section 
2.9.1) were quantified using Bio-Plex Precision Pro Assays, Human cytokine 10-Plex 
(Biorad). This is a bead-based immunoassay whose principle is similar to sandwich 
ELISA. A wide range of fluorescent dyed-beads are used to quantify the level of 
different cytokines in the sample. Each kind of dyed-bead is coated with monoclonal 
antibodies specific for a desired target cytokine. After several washes, bound cytokine is 
detected by a biotinylated detection antibody specific for a different epitope. Then 
streptavidin- PE is added to bind to the biotinylated detection antibodies; the fluorescent 
intensity produced indicates the relative quantity of target cytokine. 
The procedures were carried out in accordance with the manufacturer’s instructions. 
Briefly, after 96-well filter plate was pre-wetted with 200 μl of assay buffer, 50 μl of the 
beads were added to each well and vacuum-filtered. After washing the plate twice, 50 μl 
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of standard or sample were added to each well and incubated with gentle shaking for 1 h 
in the dark at room temperature. Then, the plate was washed and incubated with 25 μl 
1X detection antibody at room temperature in the dark for 30 min with gentle shaking. 
The bead-cytokine-antibody complex was detected by incubating with 50 μl of 1X 
streptavidin-PE for 10 min in the dark at room temperature. Following this, 125 μl of 
assay buffer were added to each well and the assay plate was shaken for 30 seconds at 
1100 rpm before acquiring data using a multiplex array reader from Luminex Systems 
(Luminex-200 system from Luminex). 
The cytokine concentrations were calculated using Bio-Plex Manager Software 
(Biorad). The limits of detection for TNF-α, IL-1β, and IL-10 were 0.14, 0.23 and 0.96 
(pg/ml), respectively. 
b. Using DuoSet® ELISA 
Concentration of TNF-α, IL-1β, and IL-6 secreted by macrophages infected with Mtb 
(see section 2.8.3) were measured using the DuoSet® ELISA for desired cytokines 
(R&D). The procedure of this assay was performed in accordance with the 
manufacturer’s manual. First, 96-well plate was coated with 100 μl of diluted mouse 
antibody to particular cytokine at working concentration in PBS and incubated 
overnight at room temperature. After 3 times of washes with wash buffer to remove the 
unbound antibody, the plate was blocked by adding 300 μl of PBS containing 1% BSA 
to each well and incubated at room temperature for a minimum of 1 h. After washing 3 
times, 100 μl of samples or recombinant standards were added and incubated with 
gentle shaking at room temperature for 2 h. The plate was washed 3 times to remove 
unbound materials, and then incubated with 100 μl of the biotinylated goat antibody to 
particular cytokine with gentle shaking at room temperature for 2 h. After washing, to 
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detect the cytokine-antibody complex, 100 μl of the working dilution of Streptavidin-
HRP were added and incubated for 20 min at room temperature in the dark. The 
unbound streptavidin-HRP was washed away and the plate was added with 100 μl of 
Tetramethylbenzidine (TMB) substrate solution, incubated for 20 min at room 
temperature in the dark. A blue color developed in proportion to the amount of targeted 
cytokine present in the sample. 50 μl of stop solution was added, turning the color in the 
well to yellow. The optical density of well was determined using a microplate reader 
(680XR, Biorad) at the wavelength of 450 nm together with a correction wavelength of 
540 nm.  
The cytokine concentrations were calculated using Microplate manger version 5.2.2 
(Biorad). The limits of detection for TNF-α, IL-1β and IL-6 are 15.6, 3.91 and 9.38 
(pg/ml), respectively. 
2.10 Human SNP genotyping 
2.10.1 SNP selection  
At the time of conducting this study, the whole genome sequence of Vietnamese 
population in project of 1000 Genomes was still ongoing, hence I used genetic 
information from Han Chinese Beijing (CHB) population as our reference. All SNPs 
across entire MARCO, DECTIN1, and MINCLE genes and 20 kb from their upstream 
and 10 kb from downstream region were obtained based on the HapMap reference data 
(has been retired from June 2016) for CHB population. Criteria I used to choose SNPs 
for genotyping were allele frequency, tag SNPs and functionality of SNPs. Tag SNPs 
were selected to serve as multi-marker tagging algorithm with the criteria of r
2 
cut off of 
0.8 for linkage disequilibrium and a minor allele frequency (MAF) cut off of 5 %. 
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Haploview 4.2 (Broad Institute of MIT and Harvard, USA) was used to calculate r
2
 and 
D’ for linkage disequilibrium. Functional information of SNPs was obtained from 
Genome Bioinformatics Site of University of California Santa Cruz (UCSC, 
http://genome.ucsc.edu/cgi-bin/hgGateway), from Genome Variation Server 147 (GVS, 
http://gvs.gs.washington.edu/GVS147/) or from SNP database (dbSNP, 
https://www.ncbi.nlm.nih.gov/snp/?term=). SNPs that were known to change amino 
acids of protein (missense SNPs) were also selected to be genotyped.  
2.10.2 Procedure of SNP genotyping 
a. Human genomic DNA isolation 
DNA from blood samples was extracted by Qiagen DNA extraction kits (Qiagen, UK) 
or Nucleon BACC Genome DNA extraction kits (GE Healthcare, Sweden) in 
accordance with manufacturer’s instruction.  Briefly, 3 ml blood was diluted to 5 ml in 
PBS then 6 ml lysis buffer were added to the blood mixture. Such mixture was 
thoroughly mixed and left at 70 
o
C for 10 min. Next, 5 ml of ethanol (96-100%) was 
added and the sample was mixed well to increase the efficient binding. This lysate was 
then loaded twice to the QIAamp Maxi column and centrifuged at 1200 g for 3 min. The 
column was washed two times, then 600 µl elution buffer or distilled water was added 
to elute DNA binding to the membrane. The column was incubated at RT for 5 min and 
then centrifuged at 5000 g for 5 min to obtain DNA. For Nuleon BACC kit, 3 ml blood 
was incubated with 12 ml reagent A for 20 min at RT to lyse the red blood cell. The 
pellet was collected after centrifugation of sample at 1700 g for 7 min. The white blood 
cells were further disrupted by incubating the pellet with 1ml buffer B for 10 min at 37 
o
C. Next, 400 µl of sodium perchlorate solution were added for deproteinization. Next, 
2 ml chloroform was added to denaturate proteins and the sample was mixed thoroughly 
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by inverting the tube. Following, 220 µl of nucleon resin was added and the mixture 
was centrifuged at 1500 g for 7 min. The upper phase of nucleon layer was harvested 
and two volumes of cold absolute ethanol was added to precipitate DNA. The solution 
was mixed well, then centrifuged at 13000 g for 5 min at 4
o
C. DNA was washed in cold 
70% ethanol and then air-dried to remove the ethanol. DNA was then re-dissolved in 
400 µl of distilled water.  
b. SNP genotyping 
Genotyping of SNPs was performed in collaboration with Professor Thomas Hawn 
(University of Washington, USA) using GoldenGate assay (Illumina, San Diego, USA). 
The principle of this method has been well described
278
. Firstly, genomic DNA is 
activated by biotinylation to bind to paramagnetic particles, then the activated DNA is 
combined with the assay oligonucleotides, buffer for hybridization, and paramagnetic 
particles in the hybridization step. Three oligonucleotides are designed for each SNP 
site. Two oligos are specific to each allele of the SNP site and are called Allelic-Specific 
Oligos (ASOs). A third oligo hybridizes several bases downstream from the SNP site 
and is called the Locus-Specific Oligo (LSO). All these oligos contain regions of 
genomic complementarity and universal PCR primer sites allowed PCR reaction to 
occur; the LSO also contained a unique address sequence that targeted a particular bead 
type. The next step was the extension reaction of ASO towards the LSO, which was 
then ligated. The product after ligation was amplified by PCR with fluorescent labeled 
primers. The dye-labeled PCR products were hybridized to beads carrying the 
complementary sequence to their unique address sequence. After hybridization, a high-
throughput scanner was used to detect the fluorescent beads and decode the information 
used to generate genotype clustering and calling. 
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2.10.3 Quality control for genotyping  
The controls do not have the disease so they should follow Hardy–Weinberg 
equilibrium (HWE) principle, which states that allele and genotype frequencies in a 
population will remain constant from one generation to the next in the absence of other 
evolutionary influences. The influences include mate choice, mutation, selection, gene 
flow, genetic drift, and meiotic drive. In the population, if frequency of allele A is a and 
allele B is b = 1- a, then the frequencies of AA, AB and BB genotypes should be a
2
, 2ab 
and b
2
. Deviation from HWE in controls could result from genotyping problems (such 
as a mutation in the PCR primer or miscalling heterozygotes as homozygotes
279
) or 
different biases in sampling, such as heterozygous population (the controls may 
comprise different populations with different allele frequencies) or small sample size
280
. 
Therefore, the HWE should be checked, particularly in the control group. SNPs on 
DECTIN1, MINCLE and MARCO were tested for HWE in control subjects using a Chi-
square test. SNPs were excluded if they had > 5% missing genotype calls, MAF < 10 % 
or HWE P value < 0.05. 
2.11 Chest radiography 
Chest X-rays (CXR) were examined at the time of TB diagnosis, with reports provided 
by clinicians from district TB control units. Abnormal features on a chest radiograph 
were recorded comprising of nodules, infiltrates, consolidation, cavities and miliary TB. 
To grade chest radiograph severity, the abnormal features were assessed and classified 
as mild if abnormal features were present in one lobe, intermediate if abnormal features 
were present in one lung, and severe if abnormal features were present in both lungs. 
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2.12 Mtb lineage identification 
Mtb lineages were identified by large sequence polymorphism (LSP) typing that has 
been shown to classify isolates to geographical-related clades
40
. 
Firstly, Mtb DNA was extracted from cultures on LJ media (BD, USA) by 
cetyltrimethyl ammonium bromide (CTAB) method which kills bacteria by heat then 
lyses the microorganisms by a combination of heat, lysozyme, proteinase and detergent. 
CTAB solution (5% CTAB and 0.5M NaCl) forms an insoluble complex with nucleic 
acid and selectively precipitates DNA, which can be separate from carbohydrates, 
proteins and other components. Briefly, bacteria were dispersed in 600 µl TE buffer (10 
mM Tris pH 8.0 and 1 mM EDTA), followed by heating the tube at 80
o
C for 20 min. 50 
µl lyzozyme 10mg/ml was added; the cell suspension was mixed well by vortexing and 
incubated overnight at 37
o
C. Next, to denature the proteins 10l proteinase K 
(10mg/ml) and 35l of SDS 20% were added and incubated at 55 oC for 30 min. 
Following this, the suspension was added with 100 l 5M NaCl and 100 l 5% CTAB 
solution, and incubated at 60 
o
C for 15 min. Two phases of DNA and protein-cell debris 
were separated by adding 700 µl chloroform and centrifugation at 12000 g for 5-10 min. 
The DNA phase was taken and precipitated with 0.6 volume of isopropanol by 
centrifugation at 13000 g for 15 min. DNA was washed with 70% ethanol, air-dried and 
re-suspended in 40-80 µl TE buffer or distilled water.  
LSPs were then defined following the method of Tsolaki et al.
20,281
. Isolates were first 
characterized for RD239 and RD105 deletion by PCR as the majority of isolates were 
anticipated to contain one of these two deletions. Isolates bearing RD239 deletion were 
defined as Indo-Oceanic genotype while isolates bearing RD105 deletion were defined 
as East-Asia/Beijing genotype. The primers used to screen RD239 were RD239F 5’-
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GGCCAACATCGACCACCTACCC-3’ and RD239R 5’-
ATCCTCGCTACCGGCACCTCAT-3 while for RD105 deletion were RD105F 5’-
GGAGTCGTTGAGGGTGTTCATCAGCTCAGTC-3’ and RD105R 5’-
CGCCAAGGCCGCATAGTCACGGTCG-3’. The PCR reaction for RD239 deletion 
contained 0.5 mM each primer, 0.2 mM dNTPs, 1.5 mM MgCl2, 0.5U Taq polymerases 
(Bioline), 1x buffer, 10.25 µl ELGA water and 15 ng DNA  in a final volume of 15 µl. 
The PCR programme started with a denaturation of 95 
o
C for 3 minutes, followed by 25 
cycles of 94 
o
C for 30 seconds, 64 
o
C for 30 seconds and 72 
o
C for 30 seconds, finished 
with an extension of 72 
o
C for 6 minutes. The PCR mix for RD105 deletion was 
prepared similarly with RD239, except that 0.3 mM each primer and 1U Expand™ 
High Fidelity enzyme (Roche) was used. The PCR programme for RD105 started with a 
denaturation of 95 
o
C for 3 minutes, followed by 25 cycles of 94 
o
C for 15 seconds, 64 
o
C for 15 seconds and 72 
o
C for 4 min, finished with an extension of 72 
o
C for 6 min. 
The amplification using RD105 primers produced a product of 4 kb in the control 
H37Rv while it was shorter with 850 kb in isolates bearing RD105 deletion. Likewise, 
product from amplification using RD239 primers was 1.8 kb in control H37Rv and was 
shorter in isolates bearing RD239 deletion. Isolates without RD105 or RD239 were 
further  defined  for the Euro-American lineage by PCR to detect the deletion of 7 bp in 
the pks 15/1 gene using primers pks1i 3’-GCAGGCGATGCGTCATGGGG-5’ and 
pks1j 3’-TCTTGCCCACCGACCCTGGC-5’ and an internal primer pks1insR 3’-
ACGGCTGCGGCTCCCGATGCT-5’20. The PCR reaction contained 0.1 mM pks1i, 
0.1 mM pks1j, 0.2 mM pks1insR, 0.2 mM dNTPs, 1.5 mM MgCl2, 0.5 U Hotstart Taq 
(Qiagen), 1x buffer, 10.85 µl ELGA water and 15 ng DNA in a final volume of 20 µl. 
The PCR programme started with a denaturation of 95
 o
C for 15 minutes, followed by 
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30 cycles of 94
 o
C for 30 seconds, 67
 o
C for 30 seconds and 72
 o
C for 30 seconds, 
finished with an extension of 72
 o
C for 2 minutes. Isolates bearing a deletion of 7 bp 
produced 2 bands of 520 bp and 259 bp whereas isolates without the deletion produced 
a single band of 520 bp. 
2.13 Statistical analysis 
2.13.1 Association of host genetic variants and disease susceptibility 
For alleles of SNPs, the majority allele is coded by 1, the minority allele by 2. Hence for 
genotypes, the majority homozygote is 11, the minority homozygote is 22 and the 
heterozygote is 12. In order to assess the association of single SNP and disease 
susceptibility or clinical presentation or infecting Mtb strains, I primarily performed 
genotypic model that compared the genotype frequencies (11, 12, and 22) and allelic 
model that compare allele frequencies (allele 1 and 2) in cases and controls. In 
secondary analysis, SNPs were investigated for associations under the additional genetic 
models (dominant, recessive and heterozygote). Dominant model is used to compare the 
frequencies of the 11 and 12 combined versus 22 genotype in cases and controls. 
Recessive model is used to compare the frequencies of the majority homozygote 11 
versus 12 and 22 combined in cases and controls. Heterozygous advantage model is 
used to compare the frequencies of 12 versus 11 and 22 combined in cases and controls. 
These 5 models were based on the Chi-squared test using R program, version 3.3.1 
(https://www.r-project.org/). The association is considered statistically significant when 
the P value is ≤ 0.05. For multiple SNPs comparisons, Bonferroni correction was 
applied by multiplying the P value by the number of SNPs. 
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2.13.2 Other comparisons 
For continuous variables with normal distribution, student t-test or ANOVA test was 
used for comparison of two or three groups respectively. Continuous variables without 
normal distribution were analyzed using Mann-Whitney U test or Kruskal-Wallis test to 
compare the 2 or 3 groups respectively. Categorical variables were analyzed using Chi-
square test. P value ≤ 0.05 was considered statistically significant. Correlations between 
acidification and proteolysis activity index were calculated by use of Spearman’s rank 
correlation coefficient imputed by GraphPad Prism version 6.04 for Windows, 
(GraphPad Software, La Jolla California USA, www.graphpad.com). 
2.13.3 Graphs 
Graphs were generated using GraphPad Prism version 6.04 (www.graphpad.com) or R 
program, version 3.3.1 (https://www.r-project.org/).  
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Chapter 3 
DEVELOPMENT AND EVALUATION OF INTRACELLULAR 
ASSAYS TO MEASURE MACROPHAGE ANTIMICROBIAL 
ACTIVITIES 
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3.1 Introduction 
Macrophages play a central role in innate immunity via the phagocytosis process that is 
initiated by recognizing and internalizing the invading pathogen into its phagosome. 
The recognition can be promoted either directly by utilizing conserved structures on the 
pathogen surface, such as LPS or peptidoglycan, or indirectly by opsonization of the 
pathogen with serum complement, and immunoglobulins
203
. Once formed after 
pathogen engulfment, the phagosome undergoes a process termed maturation, in which 
both its membrane and lumen contents were modified by the means of fission and 
fusion with other cellular compartments
203
. During this process, phagosome develops 
into a toxic environment by acidifying, acquiring a range of hydrolytic enzymes and 
producing toxic radical compounds. Phagosome acidification is prerequisite to optimal 
function of hydrolytic enzyme and degradation of phagosomal content. Furthermore, 
acidic pH establishes a hostile environment for an internalized pathogen. Acidification 
commences early in phagosome maturation and predominantly results from recruitment 
of V-ATPase to the phagosomal membrane. The hydrolytic enzymes can directly kill 
bacteria by interrupting the integrity of mycobacterium membrane but also help in 
degrading the pathogen. Antigen generated from such degradation is presented to T 
lymphocyte via MHC class II molecule, bridging the innate and adaptive immunity. 
It is reported that an impairment in phagocytic capacity of macrophages could lead to 
the development of several pulmonary diseases that are caused by Haemophilus 
influenza, Streptococcus pneumoniae
282,283,284
, or Coxiella burnetii
285
. Several 
professional intracellular bacteria such as Mtb, Listeria monocytogenes, and  Legionella 
pneumophila have evolved the mechanisms to avoid phagosome maturation, so that 
bacteria can replicate within macrophage and establish the infection
203
. It is likely that 
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the outcome of infection depends on the innate interaction between bacteria and 
macrophage
286
; any defects in the phagosomal function of macrophage could have 
major impact on the establishment of the infection. Therefore, it is important to assess 
the macrophage phagosomal function, which may help to understand not only the 
contribution of macrophage in host defense and susceptibility to the disease but also the 
macrophage manipulation by the pathogen. 
Many assays have been developed to examine the phagosome maturation within 
macrophages. Most approaches use immunofluorescence colocalization with well-
characterized markers
285,287,288,289
. The most common markers are Ras-related proteins 
(Rab5 or Rab7 for early and late endosomal markers), LAMP-1, LAMP-2 (phagosomal 
markers), and Cathepsin D (lysosomal marker). The expression of these markers in a 
compartment indicates how aggressive this compartment might be towards an invading 
microbe. These methods have been widely used, however they are very subjective, have 
low sensitivity and do not completely reflect the environment within the phagosome 
205,290
. 
To overcome these disadvantages, Russell and colleagues have developed the platform 
of different assays to measure directly and quantitatively functionally-relevant 
parameters of  phagosomal luminal biology, allowing researchers to design their own 
experiments to address the interesting biological questions on phagosomal maturation in 
response to microbial infection
271,273,275,291
. These assays exploit the model of beads 
coated with microbe-derived ligands that facilitate particle uptake and also mimic the 
conditions of infection in vivo. Different phagosomal activities in live macrophages can 
be quantified using specific fluorogenic substrates that are coated on the particles. For 
example, pH-sensitive fluorochromes such as CF-SE or Oregon Green can be used to 
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access phagosomal acidification while DQ-BSA that is highly sensitive to the digestion 
of various proteases is used to detect the proteolysis. The fluorescent output can be 
assessed on different analytical platforms, including (i) flow cytometry, (ii) confocal 
microscopy, and (iii) fluorescence microplate; each has both strengths and limitations. 
The flow cytometry provides detail at individual cell level within and between cell 
populations. Visualization by microscope provides excellent spatial and temporal details 
at the level of single phagosome. These methods are time-consuming, lacking statistical 
power, and only handle limited experiment conditions at a time; whereas the microplate 
reader can allow monitoring of multiple conditions with many replicates. Depending on 
the research question and the existing infrastructure, single platforms can be used or 
different platforms can be combined to complement one another for speed, sensitivity, 
and resolution
271
.   
The efficiency of phagosomal functions of macrophages could be also evaluated by 
measuring the bacterial killing ability of macrophages upon infection
292
; hence counting 
the viable bacterial numbers becomes an important read-out for the host response. 
Viable bacteria have the capacity to form colonies, hence the most commonly used 
method for measuring the viable bacterial numbers after infection is by plating and 
culturing defined volumes of lysed cells followed by the counting of colony-forming 
units (CFU) on agar plates. To analyze colony-forming units, bacteria need to replicate 
multiple times before colonies start to appear. However, this becomes a major drawback 
when studying very slow-growing bacteria such as Mtb, since it takes 2-3 weeks for a 
colony of Mtb to appear. Furthermore, CFU plating is rather labor-intensive and it is 
difficult to handle a large number of samples. Therefore, fluorescent reporter strains of 
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bacteria can be used as a valuable alternative tool in intracellular growth studies because 
of rapid detection, high sensitivity and real time detection
276
. 
In order to study the association of macrophage phagosomal functions and susceptibility 
to TB disease, in this chapter I generated the beads and established the bead-based 
assays to measure the macrophages’ activities including phagocytosis (uptake ability), 
acidification and bulk proteolysis. I also generated the Mtb reporter strain that expresses 
fluorescent protein mCherry to study the outcome of interaction between macrophages 
and bacteria to measure the bacterial survival. 
3.2  Results 
3.2.1 Generation of beads for assays measuring macrophage antimicrobial 
activities 
The resting macrophage plays vital homeostatic roles, including daily clearance of 
erythrocytes and removal of tissue debris or apoptosed cells; such processes occur 
quietly with little or no production of cytokines
275
. When macrophages are classically 
activated by immunogenic components from the pathogen or by IFN-ɣ, the cells 
function as immune effectors which have enhanced microbicidal activities and antigen 
presentation. These immune responses are accompanied with the induced inflammatory 
signals
275,293
. In an attempt to study the phagosomal functions of macrophages in 
response to Mtb infection, I have adapted the bead construction from the Russell group 
for our purposes. The beads are principally coated with three components, including a 
fluorogenic substrate, a fluorophore of calibration, and a ligand (see Section 2.6). 
However to study macrophage antimicrobial activities regarding different signaling 
pathways, I modified the beads by coating them separately with two ligands including 
TDM from Mtb and β-glucan from yeast that are recognized by scavenger receptor294 
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and C-type lectin
36,295
 respectively. IgG-coated beads are used to assess macrophages 
activities in resting state.  
Following the instructions (see section 2.6), the beads were incubated in an excess of 
IgG, TDM and β-glucan that ensure the coating of these ligands on the bead surface244. 
To examine coating efficiency of components on the beads, fluorogenic substrate and 
fluorophore of calibration were analysed by flow cytometry. For phagocytosis beads, I 
observed a complete shift toward the higher fluorescence signal of ligands-beads coated 
with Alexa 594 SE compared to the control uncoated bead (Figure 3.1A), indicating that 
the phagocytosis beads were successfully coated. The proteolysis beads exhibited the 
signal of proteolysis substrate DQ-BSA (FITC) and signal of the calibrator (Alexa 594) 
in comparison with the control uncoated beads, indicating the successful attachment of 
these components to the proteolysis beads (Figure 3.1B). Likewise, the acidification 
beads were completely coated with fluorogenic carboxylated-SE indicated by increased 
FITC signal on the bead surface (Figure 3.1C). 
Next, I tested the consistency of the assays exploiting the beads generated above. I used 
J774 murine macrophages for this purpose since cell lines are genetically stable and 
easy to handle. The flow cytometry was used to examine the phagocytosis while the 
microplate reader was used to measure the proteolysis and acidification.  
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Figure 3.1 Cytometry analysis of phagocytosis, proteolysis and acidification beads  
(A) Phagocytosis beads are beads coated with a ligand including IgG, TDM or β-glucan 
and Alexa 594 SE dye. The dots represent beads only or phagocytosis beads, and were 
plotted against side-scattered light (SSC) and APC channel for Alexa 594. (B) 
Proteolysis beads are beads coated with a ligand, proteolysis substrate and calibrator 
Alexa 594 SE. The dots represent beads only or proteolysis beads, and were plotted 
against APC channel (for Alexa 594) and FITC channel (for proteolysis substrate). (C) 
Acidification beads are beads coated with a ligand and CF-SE. The dots represent beads 
only or acidification beads, and were plotted against SSC and FITC channel for 
acidification indicator CF-SE. 
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3.2.2 Evaluation of consistency in phagocytosis assay 
Previous studies that exploit bead-based assay to measure macrophage activities by flow 
cytometry have revealed that the phagocytosis by macrophages occurs efficiently during 
10 min after adding of beads so that the change of macrophage phagosomal activities 
can be easily assessed
274,275
. Therefore, in this study I also examined the phagocytosis 
(bead uptake) of J774 macrophages at 10 min after feeding the cells with phagocytosis 
beads at the concentration of 1-2 beads per cell
244
. As shown in Figure 3.2A, flow 
cytometry of cells treated with beads revealed two discriminated populations. By 
comparing with un-treated J774 (negative signal for Alexa 594) and phagocytosis beads 
alone (positive signal for Alexa 594), the population of J774 that was positive for Alexa 
594 SE was considered as population of cells that phagocytose the beads. The 
phagocytosis ability of J774 macrophage was indicated by the proportion of this cell 
population. After 10 min of bead incubation, approximately 92.5% ± 2.1% of cells 
phagocytosed the IgG beads, 88.2% ± 2.7 % of cells phagocytosed the TDM beads and 
86.9% ± 4.0 % of cells phagocytosed the β-glucan beads (Figure 3.2B). These results 
were averaged from three repeated experiments; the SD was small, indicating the 
consistency of the assay. There was no significant difference in the phagocytosis ability 
of J774 in response to IgG, TDM or β-glucan beads (P = 0.17).  
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Figure 3.2 Phagocytosis assays in J774 murine macrophages 
J774 cells were treated with Alexa 594 beads coated with either IgG, TDM or β-glucan 
and phagocytosis was assessed by flow cytometry. (A) Signals of Alexa 594 (detected 
by APC channel) were plotted against SSC. The dots represent J774 cells alone, 
phagocytosis beads alone or J774 treated with beads. The phagocytosis ability was 
determined by the percentage of J774 positive with Alexa 594 dye (gated cells and 
named “cell with beads”). (B) Proportion of J774 cells phagocytosed beads. Data are 
mean ± standard deviation (SD) from 3 independent experiments. P value was 
determined using Kruskal-Wallis test for comparison across three groups. 
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In the phagocytosis assay, the phagocytosis ability of macrophages was identified by the 
percent of cells positive for Alexa 594 after 10 min of bead treatment. This method 
could be argued to not distinguish the fluorescent signal produced by beads attached to 
the cell surface from that produced by bead ingestion (phagocytosis). However, the 
unbound or loosely attached beads were removed by washing the cells three times 
before harvesting for the analysis. The bead location was then verified using phase 
contrast microscope, and I found that the majority of the beads were engulfed after 10 
min. Our observation was further confirmed by little increase in population of cells 
positive with Alexa 594 when I examined the phagocytosis of macrophages after 30 min 
of bead treatment (10 min vs. 30 min: 90- 93 % vs. 90.4- 94.6 % (IgG beads), 85-91 % 
vs. 85.5- 90.9 % (TDM beads), 82- 90 % vs. 82.9- 90.9 % (β-glucan beads)). The 
uptake of beads after 10 min of bead treatment was further examined by proteolysis 
assay to measure the proteolysis of macrophage following the bead uptake using flow 
cytometry. In this assay, after 10 min of incubation to allow bead uptake, the unbound 
beads were washed three times and proteolysis of macrophage was examined at 180 min 
later (Figure 3.3). The percentage of cells with beads (that were positive with Alexa 
594) after 10 min and 180 min were not much different (88 % vs. 86 %), indicating that 
beads were ingested early at 10 min. The increase in FITC fluorescent intensity after 
180 min (Figure 3.3) once again added more evidence for beads ingestion after 10 min, 
since the signal was only produced when the beads were internalized into the 
phagosome and the fluorogenic substrate coated on the beads were cleaved by proteases 
there.  
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Figure 3.3 Assessment of hMDM for phagocytosis and proteolysis by flow 
cytometric analysis  
Beads were coated with (1) Alexa Fluor 594 [y axis] and (2) DQ Green BSA substrate 
(Molecular Probes) [x axis]. Bright green fluorescence is achieved when beads are 
internalized by hMDM and DQ Green BSA substrate is cleaved by proteolysis to 
release green fluorescent protein fragments. hMDM were incubated with beads for 10 
minutes to allow uptake, then the cells were washed three times to remove loosely 
attached or unbound beads. Green fluorescence was measured at early (10 minutes) and 
late (180 minutes) time points.  
Since I wanted to study the phagocytosis ability of macrophages from individuals with 
different TB outcomes, I next examined whether the phagocytosis assays worked in 
hMDM model. hMDM from three independent healthy volunteers were fed with 
phagocytosis beads coated with either IgG, TDM or  β-glucan. Proportions of 
macrophages phagocytosed the beads were ~ 95% for IgG, 75- 80 % for TDM and ~ 80 
% for β-glucan beads (Figure 3.4). I also observed small variations in phagocytosis 
ability of macrophages from different individuals, especially in response to TDM coated 
beads.  
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Figure 3.4 Phagocytosis in hMDM 
hMDM from 3 independent healthy volunteers were treated with phagocytosis beads. 
Phagocytosis ability was indicated by percentage of cells with beads via flow cytometry 
analysis. Data are mean and ± SD of triplicated wells. 
3.2.3 Evaluation of acidification assay in macrophages 
Microplate reader allows many samples to be simultaneously measured with many 
replicates which help to increase the accuracy of the measurement; hence I used 
microplate reader to measure acidification and proteolysis of macrophages from TB 
patients and LTB in different experimental conditions simultaneously. At first, I 
examined the stability and consistency of acidification assay using microplate reader.  
J774 murine macrophages were treated with the acidification beads at a concentration of 
4 beads per macrophage as per previous study
239
; the pH change in the phagosomal 
lumen was measured in real-time during 90 min. The relative pH in phagosome was 
expressed by the ratio of fluorescent intensity at pH-sensitive and -insensitive 
wavelengths, with a decreased ratio indicating a drop in pH (Figure 3.5A). Conversion 
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from the fluorescent ratio value to pH could be achieved through polynomial regression 
of a standard curve generated by the calculation of the fluorescent ratio in environments 
of known pH (Figure 3.5B). In macrophages treated with beads, pH reduced 
significantly within an hour from pH 6.9 to 5.5, and had slightly changed afterwards 
(Figure 3.5A). To compare acidification activity, I used an activity index that was the 
ratio of relative pH at early time point of 10 min (when most of the macrophages 
phagocytosed beads) over that at time-points of interest. After 30 min of bead treatment, 
or later time points of 60 or 90 min, I did not observe any difference in acidification 
capacity among J774 mouse macrophages treated with IgG- and TDM- and b-glucan-
coated beads (Kruskal-Wallis test, 30 min: P= 0.19, 60 min: P= 0.73, and 90 min: P= 
0.73) (Figure 3.5C). These experiments were repeated three times independently and the 
results were similar, which confirmed the consistency of the assays.  
I next examined the acidification assay in an hMDM model. hMDM from three 
independent healthy volunteers were treated with acidification beads coated with either 
IgG, TDM or β-glucan. As in J774 macrophages, bead-treated hMDM from all three 
subjects showed a decreased phagosomal pH by time and the bead-containing 
phagosomes were acidified completely after 60 min of bead treatment (Figure 3.6 A, C, 
E). Consistently, by calculating the activity index, I observed an increased activity at 60 
min and 90 min compared to 30 min in bead-treated macrophages from all three 
subjects (Figure 3.6 B, D, F). For example, from subject 1 the activities at 30 min, 60 
min, and 90 min in IgG-treated macrophages were 1.087 ± 0.016, 1.183 ± 0.016 and 
1.209 ± 0.028 respectively.  
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Figure 3.5 Acidification activity of J774 murine macrophages  
Macrophages were treated with acidification beads coated with either IgG, TDM or β-
glucan. (A) The kinetics of phagosomal pH, plotted as the ratio of fluorescence emitted 
at 520 nm upon excitation wavelengths of 490 nm and 450 nm. Bead: pH beads in assay 
buffer without macrophages. (B) The relationship of fluorescent ratio and pH of 
acidification beads when beads were added in standard pH solutions. (C) Acidification 
activity index of macrophages at selected time points 30, 60 and 90 minutes, calculated 
by the ratio of relative fluorescent unit (RFU) at 10 min over RFU at 30, 60 or 90 min. 
The data in (C) were expressed as the mean ± (SD) from 3 independent experiments. P 
value was determined using Kruskal-Wallis test for comparison across three groups. At 
30 min, P= 0.19; at 60 min, P= 0.73; at 90 min, P= 0.56.  
Beads 
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Figure 3.6 Phagosomal pH in hMDM 
hMDM macrophages from 3 independent healthy volunteers were treated with 
acidification beads coated with either IgG, TDM or β-glucan. (A, C, E) The kinetics of 
phagosomal pH was plotted as the ratio of fluorescence emitted at 520 nm upon 
excitation with wavelengths of 490 nm and 450 nm. (B, D, F) Acidification activity 
index of hMDM, that was calculated by the ratio of relative fluorescent unit (RFU) at 10 
min over RFU at 30, 60 or 90 min. The data were expressed as the mean ± SD from 
triplicated wells. 
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3.2.4 Evaluation of proteolysis assay in macrophages 
To measure the proteolytic activity, ligand beads coated with fluorogenic substrate DQ 
green BSA were added to J774 macrophages at 4 beads per macrophage. The increase 
in fluorescence generated by cleavage of substrate indicated the more proteolytic 
activity. Macrophages treated with beads showed an acquisition of proteolysis at 40-50 
min, followed by an increase in activity (Figure 3.7A). To compare the proteolysis in 
response to different ligand coated beads, I then calculated the activity index that was 
the ratio of proteolysis at time-points of interest over early time point of 10 min when 
most of macrophages had phagocytosed the beads. J774 macrophage treated with TDM 
and β-glucan beads showed a decrease in proteolytic activity index at 60 min or 
afterwards after bead treatment compared to resting macrophages treated with IgG 
beads (Kruskal-Wallis test, P= 0.05, 0.03, 0.03, 0.03 at 60, 120, 180 and 210 min 
respectively)  (Figure 3.7B). The macrophage treated with TDM-coated beads showed 
the lower activity compared to macrophage treated with β-glucan beads (paired t-test, P 
= 0.01, 0.01. 0.01, and 0.02 at 60, 120, 180 and 210 min) (Figure 3.7B), suggesting the 
pathway-dependent variation of cell proteolysis. These experiments were repeated three 
times independently and the results were similar, indicating a consistent tendency in 
proteolytic activity.  
As with other assays, I also examined the proteolysis beads in the hMDM models. 
hMDM from three independent healthy volunteers were treated with proteolysis beads 
coated with either IgG, TDM or β-glucan. There was an increased proteolysis in bead-
treated hMDM from all three subjects (Figure 3.8A, C, and E), indicating the 
proteolysis assays also worked in hMDM. Variations in the activity of hMDM from 3 
donors at 180 min or 210 min (IgG, subject 1: 14.760 ± 0.450, subject 2: 16.520 ± 
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0.484, and subject 3: 20.296 ± 4.660; TDM, subject 1: 14.250 ± 0.987, subject 2: 14.220 
± 0.920, and subject 3: 21.700 ± 5.680; and β-glucan, subject 1: 15.045 ± 0.234, subject 
2: 14.511 ± 1.376, and subject 3: 26.440 ± 0.511) suggested a possible diversity activity 
among individuals (Figure 3.8B, D, F). 
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Figure 3.7 Proteolytic activity of J774 murine macrophages 
 J774 macrophages were treated with proteolytic beads coated with either IgG, TDM or 
β-glucan. (A) The kinetics of proteolysis, plotted as the ratio of DQ-BSA green 
fluorescence and calibration fluorescence. Beads: beads in assay buffer without 
macrophages. (B) Proteolysis activity index at different time-points, which was 
generated from (A). Activity index was calculated by the ratio of RFU at 60, 120, 180, 
or 210 min over RFU at 10 min. The data in (B) were expressed as the mean ± SD from 
3 independent experiments. P value was determined using Kruskal-Wallis test for 
comparison across three groups or paired t-test for comparisons two groups of TDM and 
β-glucan.  
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Figure 3.8 Proteolysis in hMDM 
 hMDM macrophages from 3 independent healthy volunteers were treated with 
acidification beads coated with either IgG, TDM or β-glucan. (A, C, E). The kinetics of 
proteolysis, plotted as the ratio of DQ-BSA green fluorescence and calibration 
fluorescence. (B, D, F) Proteolysis activity index of hMDM. The data were expressed as 
the mean ± SD from triplicate wells. 
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3.2.5 Mycobacterial killing capacity of macrophages 
To study the variations in Mtb killing capacity of macrophages from patients with 
different TB phenotypes, I generated Mtb reporter strain expressing fluorescent protein 
so that the intracellular growth of bacteria could be assessed by the fluorescent intensity. 
mCherry is very bright, shows no photobleaching, being stable during continuous 
excitation
276,296
 and tolerant to acidic pH
297
. Due to the acidic environment within 
phagosome, this fluorescence is an optimal option for constructing intracellular bacteria 
expressing fluorescence. Mtb Beijing strain is known to have high prevalence in 
Vietnam. In this study, I used a clinical Beijing strain isolated from a TB patient to 
investigate the interaction between bacteria and macrophages. The mCherry plasmid 
was transformed to this Mtb strain. As described previously
276
, the strains bearing 
mCherry were shown to bear no defect in growth or virulence (data not shown). To 
examine whether mCherry could be used as an indicator for intracellular bacterial 
growth, I firstly tested the correlation of mCherry fluorescence and bacterial viability. 
The bacterial culture was serially diluted 2-fold and the fluorescent intensity of mCherry 
was measured at emission wavelength of 620 nm when excited at 575 nm using 
microplate reader. I found that there is a linear correlation between intensity of mCherry 
and bacterial cell density with a goodness-of -fit value R
2 
of 0.9994 (Figure. 3.9A). The 
fluorescence was still measurable at mycobacterial cell density as low as 4x10
5
 cells 
(OD600 = 0.015). By quantifying CFUs per volume unit of bacteria, our data showed that 
optical density was likely to be correlated with the number of viable bacteria in linear 
regression with a R
2
 value of 0.9043 (Figure. 3.9B). Altogether, these results 
demonstrated that the fluorescent intensity of mCherry could be used to measure the 
number of viable bacteria. 
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Figure 3.9 mCherry fluorescence and Mtb viability 
(A) Correlation of fluorescent intensity and bacterial number. (B) Correlation of optical 
density and the number of viable bacteria. Data were mean and ± SD of triplicated 
wells. 
The infection of murine macrophage with virulent Mtb commonly leads to the necrosis-
like death of infected cell
260
; cells first swell, and then the cell membrane collapses and 
cells are rapidly lysed
298
. In this study, I assessed the lysis of infected cells by 
examining the cell lysed under conventional microscopy. To investigate the interaction 
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between bacteria and macrophages through bacterial growth and macrophage lysis, I 
infected mouse J774 and human THP1 macrophages with the Mtb reporter strain at 
different MOI of 1, 2, and 3. The intracellular growth of bacteria was assessed by the 
increase of fluorescence intensity of mCherry over time and the time-point when 
macrophage lysis occurred was noticed. Infection of macrophages with Mtb at different 
MOI resulted in variations in bacterial intracellular growth and the fate of infected cells. 
When J774 macrophages were infected with Mtb at MOI 1, the bacteria replicated 
slowly and infected macrophages still remained viable during 5 days post infection; 
whereas infection at higher MOI resulted in rapid bacterial replication and cell lysis 
(Figure 3.10A). The two times increase of mCherry intensity in macrophages infected 
with Mtb at MOI 2 in comparison to that in macrophages infected at MOI 1 suggested 
the double number of intracellular bacteria in macrophage infected at MOI 2, which 
may also resulted in the commencement of cell lysis at day 4. Infection at MOI 3 
resulted in effective bacterial replication that killed cells very early at day 2 (Figure 
3.10A). Similar scenarios were observed in THP1 human macrophage infected with Mtb 
(Figure 3.10B). There was a rapid increase in bacterial number overtime in cells 
infected with Mtb at MOI 2 and 3 while a slow increase in bacterial number was seen in 
those infected at MOI 1. Cell death occurred rapidly in infected human cell lines that 
could be observed at day 1 after infection at MOI 3, at day 2 at MOI 2 and day 3 at MOI 
1 (Figure 3.10B). These results were reproducible for three independent experiments. 
Infection of murine and human cell lines suggested that the susceptibility of these cell 
lines to Mtb is different, with THP1 being more susceptible than J774. As MOI 1 did 
not cause cell lysed in short period of time like other higher MOI, which allowed us to 
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study the host-bacterial interaction over a long time period, I decided to infect 
macrophages with bacteria at MOI 1 for further infection experiments.  
I then tested the killing capacity of hMDM from several healthy subjects by infecting 
macrophages with Mtb reporter strain at MOI 1 for 5 days (Figure 3.10C). I observed 
variations in the mCherry intensity from inoculation of Mtb-infected hMDM from 
different subjects, with hMDM from subject 1 being highest and subject 2 being lowest. 
The lysis of infected macrophages from subject 1 and 3 occurred at day 3 while it 
occurred at day 5 for subject 2. Altogether, these results suggested the variations in the 
killing capacity of human macrophages from different individuals. 
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Figure 3.10 Intracellular replication of Mtb strain in macrophages  
Mouse J774, human THP1 macrophages and hMDM were infected with Mtb expressing 
mCherry for 5 days. The growth of bacteria was assessed by the fluorescent intensity of 
mCherry that was measured every day using microplate reader. (A, B and C) The 
intracellular growth curves of bacterial infection with J774 cells (A) and THP1 cells (B) 
at MOI of 1, 2, and 3. (C) The intracellular growth curve of bacteria in infected hMDM 
from 3 individuals at MOI 1. The figures showed the mean and ± SD of fluorescence 
intensity from 4 repeated wells. The arrow indicated the day when the cell lysis 
occurred. 
3.3 Discussion   
In this chapter I established the bead-based assays to measure the phagocytosis ability 
of macrophage as well as its antimicrobial activities including acidification and 
proteolysis. At first I successfully generated the beads coated with ligands and 
substrates specific for assays of interest. I then exploited the stability of macrophage cell 
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line to use it as a model to set up and optimize the bead-based assays. In such models, 
the assays were shown to work well giving consistent results. I observed the decrease in 
phagosomal pH and the occurrence of proteolysis in macrophage treated with beads. I 
found that stimulation of macrophages with TDM or β-glucan led to a significantly 
decreases in proteolytic activities in comparison to resting macrophage. Interaction 
between macrophages and bacteria could be investigated by infection of macrophages 
with Mtb expressing mCherry. Our assays also worked in the hMDM model which 
displayed variations in antimicrobial activities of macrophages from different subjects. 
The bead-based assays were originally developed to study the physiological changes in 
phagosome of macrophage that can help to explain its plastic functions in both 
homeostasis and during immune response. Therefore, it is suggested that this new 
approach can be applied in clinical settings to identify the macrophage-associated 
pathologies
275,273,226,299
. The bead-based measurement of antimicrobial activities of AM 
in HIV patients have suggested the possible association of the impairment in AM 
activities and the increasing susceptibility to upper respiratory disease
274
. Furthermore, 
this new approach has helped to provide the insight to the global modification in 
hMDM activities in response to Mtb infection
239
.  
The beads used in these studies were only opsonized with IgG to facilitate the uptake by 
macrophages. It remains unclear whether different routes of entry into macrophages 
may lead to differences in subsequent events within the host such as signal transduction, 
immune activation, and intracellular survival of Mtb as well as outcome of infection
14
. 
The beads developed in our study were novel since they were coated with specific 
antigens such as TDM and β-glucan, which could further help us to dissect the 
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contribution of the signaling pathways specific for these ligands in controlling 
macrophage antimicrobial activities in response to Mtb infection. 
By exploiting the beads labeled with pH-sensitive fluorochrome carboxyfluorescein SE, 
I have seen a rapid redution in phagosomal pH, which had been observed in previous 
studies
239
, from neutral to 5.5 within 1 h in resting macrophage. The bulk protease 
activity of macrophages was assessed by the beads coupled with DQ green BSA. I 
observed an increase in fluorescence signal generated by degradation of this substrate 
overtime, indicating the occurrence of proteolysis in phagosome. J774 macrophages 
treated with TDM- or β-glucan- coated beads showed a reduced proteolysis activity 
compared with resting macrophage. The beads are coated with an excess amount of 
ligands (IgG/TDM or β-glucan) so that they are optimal for recognition and 
phagocytosis which is further indicated by the comparable phagocytic ability of 
macrophages towards IgG, TDM or β-glucan beads. Therefore, the variations in 
proteolysis activity of macrophages treated with different ligands-coated beads could 
come from the nature of ligands. Different ligands mediate their specific pathways that 
would induce different macrophage responses. The decreased activity in macrophages 
treated with TDM- or β-glucan beads was similar to that observed previously upon 
activation of macrophages with LPS
272
. These results suggest a shift in macrophage 
function from its role in homeostasis to the role in immunity. More clearly, the 
homeostatic function of macrophages is to remove dead cells or cell debris, hence their 
hydrolytic activity is programmed to occur with high efficiency for complete 
degradation of those materials. Whereas, under activation by cytokines or bacterial 
components the hydrolytic activity is reduced to ensure the balance of effectively killing 
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and efficient antigen processing for presenting to T cells. The consistency in our data 
and previous data also provided a validation for the reliability of our bead-based assays. 
The Mtb strain expressing mCherry provided a sensitive and rapid tool in a study of 
macrophage-mycobacterial interaction. As other reporter Mtb strains generated in 
previous study, our strain showed a strong correlation between mCherry intensity and 
bacteria viability
276
. mCherry signal was very sensitive, so the signal  could be detected 
at a very low cell density of Mtb. It has been revealed that the fate of Mtb-infected 
macrophage is different due to the intracellular burden of bacteria
300
, cells with heavily 
burden progressing to necrosis. The reporter fluorescence in our study facilitated the 
assessment the correlation of intracellular growth of Mtb and the macrophage lysis 
when bacteria were infected to murine and human macrophage cell lines at different 
MOI. In consistent with the previous study
290
, I also observed the rapid increase of 
intracellular Mtb growth at MOI 2 and 3 that leads to early host cell lysis in comparison 
to MOI 1 in both J774 and THP1 models. Because of slow bacterial growth and delay in 
host cell lysis, I propose that the infection of macrophage at MOI 1 is applicable for 
examining the host-pathogen interactions in detail. 
In summary I have successfully established the assays to examine the phagosomal 
antimicrobial activities as well as killing ability of macrophages; these assays showed 
consistent results during experimental replications. In the next chapter, I apply these 
assays developed here to study the association of macrophage antimicrobial activities 
and different manifestations of TB. 
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4.1 Introduction 
Mtb is an intracellular bacterium whose infection leads to different scenarios and 
manifestations. One third of the human population is infected with Mtb, of which 5-10% 
develop TB within 2-5 years from first infection
301,302
 and 90% of the remaining have 
latent TB that mostly lasts during the person’s life time without any symptoms. The 
primary site of TB is in lung, however it can disseminate by the bloodstream to form 
extra-pulmonary TB in other organs. TBM is the most severe form, causing many 
deaths or neurological sequelae in survivors. The factors that lead to containment of 
infection or progression to the disease are multifactorial
303
 and not well understood.  
Alveolar macrophages in the lung are one of the first immune cell types to encounter 
Mtb when the bacilli are inhaled. After the bacterial recognition via various receptors on 
the surface, macrophages phagocytose the bacteria into the phagosome, which is central 
to its antimicrobial function. During a maturation process, the phagosome is acidified by 
recruitment of V-ATPases and sequentially fuses with multiple intra-vesicles. At the last 
stage of this endocytic pathway, the phagosome fuses with a lysosome to form a phago-
lysosome which is well-known for antimicrobial properties. The environment inside this 
vesicle is very acidic, with pH of 4.5, and enriched with an assortment of 
endopeptidases, exopeptidases and hydrolases, which can kill bacteria and process 
antigens for presentation to T cells. Indeed, a previous study has shown the association 
between phagosomal acidification and Mtb growth restriction
290
. Inhibition of 
acidification or protease activity within the phagosome using V-ATPases or protease 
inhibitors, respectively, results in an increased Mtb replication
290
. An increased 
maturation of phagosomes in macrophages activated with IFN-ɣ leads to an efficiently 
mycobacterial killing
164,166,233,238
.  
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Many previous works indicate that the phagosome maturation is modulated in Mtb 
infection
205,218,245,304,305
. Mtb prevents the incorporation of V-ATPases into the 
phagosomal membrane as well as the fusion of phagosome-lysosome. Therefore Mtb 
can reside in the phagosome with pH of 6.3 and low content of mature lysosomal 
hydrolases. These evasion mechanisms allow bacteria to replicate efficiently and 
subsequently to spread to other cells. As a consequence, active TB (ATB) may ensue. In 
contrast, Mtb strains that are defective in arresting acidification and phagosomal 
maturation have reduced intracellular growth
219,220
. The fact that Mtb develops evasion 
mechanisms to modulate the phagosome maturation for its survival and replication 
again emphasizes the importance of phagosomal function of macrophages in controlling 
Mtb infection.  
Although macrophages have the capacity to defend the host early in the Mtb infection, 
how variation in their innate antimicrobial activity influences TB development has not 
been previously investigated. I hypothesized that the antimicrobial function of 
macrophages is associated with different TB clinical phenotypes. By using the bead-
based assays developed in chapter 3, I assessed the phagocytosis, acidification and 
proteolytic activities of resting versus activated monocyte-derived macrophage from 
Vietnamese individuals with LTB or ATB. Ability of macrophages in killing Mtb was 
investigated in LTB and ATB by infecting macrophages with Mtb reporter strain as 
described in chapters 2 and 3. 
4.2 Human subjects and study design 
Individuals with LTB and ATB, comprising of PTB and TBM, were recruited to this 
study (Figure 4.1). TBM patients originated from a clinical trial conducted at HTD, 
HCMC, Vietnam from Sep 2014 to Feb 2016. PTB patients were recruited from two 
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District Tuberculosis Units (DTUs), HCMC from Jan 2015 to Feb 2016. The inclusion 
criteria for TBM and PTB were detailed in Section 2.1. To identify LTB, 99 healthy 
volunteers, who had no history of TB and were working at OUCRU, were screened for 
latent Mtb infection using T-SPOT.TB assays (see Section 2.4). 46 (46.5%) individuals 
were positive while 32 (32.3%) had negative results. The test scores of 21 (21.2%) 
individuals were borderline (see Section 2.4). Because of limited numbers of LTB 
subjects (n= 37) (others leave  OUCRU), among those with borderline results, 8 people 
whose test scores were nearest to the positive cut-off (see Section 2.4) were recruited to 
the study in the LTB group (Figure 4.1). Finally, I recruited 45 LTB and 147 ATB 
subjects that included 70 with PTB and 77 with TBM. Among them, baseline data were 
missing for 13 individuals with LTB.  
The demographics of subjects with LTB and ATB are described in Table 4.1. The 
majority of ATB patients were male (71.4%), with a median age of 43 (range 32-50) 
while LTB group had an equal male to female ratio, and were younger with a median 
age of 36 (range 32 - 42.5). ATB patients had a significantly higher absolute number of 
WBC, neutrophils and monocytes than LTB subjects (all P< 0.0001). The absolute 
lymphocyte number of ATB patients was lower than that of LTB subjects (P< 0.0001). 
There was a slightly difference in other blood elements count between LTB and ATB 
subjects. 
To minimize the influence of plate-to-plate variation on the comparison among groups, 
TBM, PTB and LTB subjects were recruited simultaneously as much as possible. That 
is, when I received a TBM sample I arranged to also obtain a PTB and LTB sample on 
the same day and ran the assays on the three samples at the same time. From 20 ml 
blood taken, PBMCs were isolated and monocytes selected (Figure 4.1). Approximately 
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25 x 10
5
 monocytes were differentiated to hMDM to assess phagocytosis and 
antimicrobial functions using bead-based assays (see Section 2.5, 2.6 and 2.7). The 
remainder were cryopreserved for further killing assays (see Section 2.8). The number 
of individuals with LTB or ATB for the assessment of phagocytosis, acidification, 
proteolysis and bacterial control were detailed in Figure 4.1.  
 
Figure 4.1 Study design of antimicrobial function of macrophage from LTB and 
ATB  
   
Chapter 4 
111 
Table 4.1 Baseline characteristic of study population 
 TB phenotypes LTB (n= 32) PTB (n= 70) TBM (n= 77) ATB (n= 147) P 
Male sex - no. (%) 16 (50) 58 (82.8) 47 (61) 105 (71.4) 0.019 
Age - yr 36 (32-42.5) 45 (33-51) 41 (32-50) 43 (32-50) 0.069 
White blood cells - K/µl 5.90 (5.03 - 6.88) 9.73 (8.06 - 11.72) 9.42 (7.20-12.03) 9.44 (7.74-11.75) <0.0001 
           Neutrophil - K/µl 3.38 (2.95-3.88) 6.57 (5.31 -8.33) 7.27 (4.82 -9.96) 6.87 (5.05-9.59) <0.0001 
           Lymphocyte - K/µl 1.89 (1.64 - 2.35) 1.82 (1.48 - 2.40) 1.13 (0.73-1.66) 1.55 (0.98-2.02) <0.0001 
           Monocyte - K/µl 0.33 (0.27 - 0.46) 0.71 (0.55 - 0.93) 0.60 (0.46-0.82) 0.62 (0.50-0.86) <0.0001 
Red blood cell - M/µl 4.94 (4.46 -5.25) 4.94 (4.36 - 5.41) 4.69 (4.11-4.99) 4.77 (4.28-5.23) 0.3867 
Hemoglobin - g/dL 14.20 (12.68 - 15.55) 13.50 (12.20 - 14.75) 12.90 (12.10-14.20) 13.10 (12.20-14.35) 0.017 
Hematocrit - % 42.15 (38.23 - 45.60) 41.55 (37.98 - 44.45) 39.50 (36.70-42.10) 40.30 (37.15-43.45) 0.061 
Platelets - K/µl 263.50 (219.50 - 287.00) 316.00 (264.75 - 391.25) 244.00 (193.00-342.00) 294.00 (219.50-371.50) 0.0714 
Data for age and blood cell types were expressed as median (interquartile range) 
P: P value, was determined using Mann-Whitney U test for comparisons of LTB and ATB 
ATB: data combined from PTB and TBM 
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4.3 Results 
4.3.1 Phagocytosis of macrophages was not associated with TB phenotypes  
Phagocytosis facilitates the delivery of pathogens into phagosomes where pathogens are 
killed by antimicrobial activities during phagosome maturation. Therefore, impairment 
in macrophage phagocytosis could result in the failure of macrophages to clear the 
pathogen, which may influence the outcome of Mtb infection. To examine whether there 
was association between the macrophage phagocytosis and TB, I assessed the 
phagocytosis ability of macrophages isolated from individuals with LTB (N= 39) and 
ATB (N= 84) using bead-based internalization assays. IgG-, TDM- or β-glucan-coated 
beads were added to hMDM and at 10 min after adding beads the percentage of 
macrophages with or without beads was measured using flow cytometry (Figure 4.2). 
The phagocytosis ability was expressed by the percentage of cells with beads. 
Regardless to the disease phenotypes, I observed a high proportion of hMDM that 
internalized the IgG bead. There was a wide heterogeneity in phagocytosis of hMDM 
incubated with TDM- or β-glucan beads, ranging from 60 % to 95 % cells with beads.  
I then compared the phagocytosis of IgG-, TDM-, and β-glucan-coated beads between 
macrophages from LTB and ATB. I did not find any significant association between 
phagocytic activity and TB phenotype (IgG bead, P= 0.46; TDM bead, P= 0.88; β-
glucan bead, P= 0.86) (Figure 4.2). The hMDM from individuals with either LTB or 
ATB phagocytosed more IgG-coated beads than β-glucan and TDM-coated beads (P< 
0.0001). This result was different with the observations in J774 whose phagocytosis was 
similar in response to IgG-, TDM- and β-glucan-coated beads. 
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Figure 4.2 Phagocytosis of macrophages from LTB and ATB subjects  
Monocyte-derived macrophages from subjects with LTB (n= 39), ATB (n= 84) at day 7 
were treated with reporter beads that were coated with either IgG, TDM or β-glucan. 
Phagocytosis ability was assessed by percentage of cells with beads, analyzed using 
flow cytometry. Bars in the plot represent median values. P-value was determined using 
Mann-Whitney U test. 
4.3.2 Deactivation of hMDM from TB patients after in vitro differentiation  
To study antimicrobial activities of macrophages in different TB clinical forms, it is 
important to understand the state of hMDM from TB patients. Macrophages isolated 
from ATB could be still activated by Mtb infection. I hypothesized that after 7 days in 
culture, hMDM from ATB patients before treatment were deactivated and have returned 
to resting state. To test this I compared the macrophage Activity index for proteolysis 
and acidification from TBM patients (n= 19) at their enrollment to study and after 8 
months of TB treatment (Figure 4.3). I did not observe any difference in the 
acidification or proteolysis Activity index before and after treatment in response to any 
kind of beads (Figure 4.3A, B). These results suggested that after in vitro culturing, 
hMDM from ATB patients before treatment were in the same status as cells after 
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treatment and that the cell status was not influenced by the disease stage. Hence the role 
of hMDM activities in TB development can be studied by comparing across TB clinical 
forms. 
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Figure 4.3 Acidification and proteolysis of MDMs from TBM subjects before and after anti-TB treatment  
hMDM from TBM subjects (n= 19) before and after  8 months of  TB treatment  at day 7 of culturing were treated with acidification or proteolysis 
beads. The acidification Activity index (A) and proteolysis Activity index (B) at different time-points upon bead treatment were plotted. 1: TBM 
patients before TB treatment, 2: TBM patients after 8-month TB treatment. Bars in the plot represent median values. P-value was determined using 
paired student t-test; P > 0.05 in all comparisons.  
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4.3.3  Increased macrophage acidification and proteolytic activities associated with 
ATB 
Next I examined the antimicrobial activities which were comprised of acidification and 
proteolysis of macrophages between LTB and ATB groups. hMDM from subjects with 
LTB (n= 43) and ATB (n= 114), who were recruited simultaneously by phenotype as 
much as possible, were treated with pH-sensitive carboxyfluorescein-coated beads and 
DQ-BSA–coated beads. After 10 min of bead treatment, approximately 80% of 
macrophages internalized these beads (Figure 4.4). In macrophages from LTB 
individuals, the onset of acidification was ranging from first 10 min to 15 min upon the 
treatment of either IgG-, TDM- or β-glucan-coated beads. The similarity was observed 
in hMDM from ATB treated with beads (Figure 4.4). Most of hMDM took 75- 90 min 
to acidify completely, which were indicated by the stabilization of the kinetics curves. 
However, in both LTB and ATB groups, macrophages from different individuals 
showed heterogeneity in the acidification activity, reflected by readouts varying from 
0.6 to 0.8 RFU when treated with either IgG-, TDM- or β-glucan-coated beads (Figure 
4.4). I then compared the acidification Activity index, where the activity at later time-
point is normalized with the activity at early time-point of 10 min (see Section 2.7.2), of 
macrophages from groups of LTB and ATB at different time-points across the 
acidification kinetics (Figure 4.6A). When the acidification of phagosomes started 
entering a stabilization phase around 60 min, I observed a significantly higher activity in 
resting macrophages (IgG-bead treatment) from ATB groups compared to that from 
LTB group (P= 0.01). This difference was still observed when acidification was in 
stable phase at 70 min (P= 0.02) or 90 min (P= 0.04) (Figure 4.6A). However, I did not 
observe any difference in acidification activity of macrophages from groups of LTB and 
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ATB when macrophages were treated with TDM beads (P= 0.32, 0.08, 0.17, 0.09 at 30, 
60, 70, and 90 min respectively). As with resting macrophages, macrophages treated 
with β-glucan beads from ATB had higher acidification activity than that from LTB (P= 
0.02, 0.03, 0.03 for 60, 70, and 90 min respectively). 
Unlike the rapid process of acidification, proteolysis in hMDM occurred slowly within 
first 60 min, then rapidly increased and likely became saturated after 180 min upon bead 
treatment (Figure 4.5). The readout for proteolysis varied from 0.5 to 4.0 RFU, showing 
the heterogeneity in proteolytic activity between individuals from either LTB or ATB 
groups. The difference in proteolysis activity of macrophages from LTB and ATB was 
assessed using Activity index where the activity at later time-point is normalized with 
the activity at early time-point of 10 min (see Section 2.7.2). At time-point of 60 min 
there was not difference in activity of resting macrophages treated with IgG beads from 
ATB and LTB groups (P= 0.07) (Figure 4.6B). At later time-points across the 
proteolysis kinetics, I found a significantly increased activity in resting macrophages 
from ATB patients compared to that from LTB subjects (120 min, P= 0.04; 180 min, P= 
0.02; 210 min, P= 0.02) (Figure 4.6B). The difference in macrophage activity between 
ATB and LTB was also observed in the late stage of proteolysis when macrophages 
were treated with TDM- or β-glucan-coated beads (TDM beads, P= 0.05, 0.05, 0.03; β-
glucan beads, P= 0.06, 0.04, 0.03 at 120, 180 and 210 min respectively) (Figure 4.6B). 
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Figure 4.4 Kinetics of acidification in phagosomes of macrophages from LTB and 
ATB subjects  
hMDM from subjects with LTB (n= 43) and ATB (n= 114) at day 7 were treated with 
reporter beads coated with either IgG, TDM or ß-glucan. The kinetics of acidification 
was plotted from LTB (A) or from ATB (B) subjects during 90 minutes. The red line 
represents the smoothed median, while each grey line represents an individual’s values. 
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Figure 4.5 Kinetics of proteolysis in phagosome of macrophages from LTB and 
ATB subjects 
hMDM from subjects with LTB (n= 42) and ATB (n= 111) at day 7 were treated with 
reporter beads coated with either IgG, TDM or β-glucan. The kinetics of proteolysis was 
plotted from LTB (A) or from ATB (B) subjects during 210 minutes. The red line 
represents the smoothed median, while each grey line represents an individual’s values. 
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Figure 4.6 Acidification and proteolysis of macrophages from LTB and ATB subjects  
(A) Acidification Activity index at 30, 60, 70 and 90 min across kinetics presented in Figure 4.2 
(B) Proteolytic index at 60, 120, 180, and 210 min across kinetics presented in Figure 4.3 
Bars represent median values. P value was determined using Mann-Whitney U test.  
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Since acidification is a prerequisite for the fusion of phagosome with lysosome, which 
is enriched with hydrolases as well as many proteases to have optimal working 
condition at acidic pH, the acidic environment within phagosome directly affects the 
acquisition and the activities of phagosomal hydrolytic enzymes. In mice, incubation of 
IgG bead-treated macrophages with concanamycin A that blocks lysosomal 
acidification reduces proteinase activity
226
. This prompted us to examine whether there 
was a correlation between acidification and proteolytic activity in macrophages of ATB 
patients or LTB individuals. The acidification process within phagosome saturated 
around 90 min after bead treatment (Figure 4.4), accordingly I assessed the correlation 
of acidification activity and proteolysis at this time-point. I found a moderate positive 
correlation between these two activities in IgG bead-treated macrophages from either 
LTB or ATB groups or when two groups were combined (Spearman’s correlation r= 
0.55, 0.58 and 0.59 respectively) (Figure 4.7A, B, C). The similar level of correlation 
was observed in macrophages treated with TDM (r= 0.58, 0.58 and 0.55 for LTB, ATB 
and combined respectively) (Figure 4.7D, E, F) or β-glucan beads (r= 0.61, 0.57 and 
0.56 for LTB, ATB and combined respectively) (Figure 4.7G, I, J).  
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Figure 4.7 Correlation between proteolysis and acidification activities in macrophages treated with beads coated with either IgG (A-C), 
TDM (D-F) or β-glucan (G-I) 
Macrophages were from subjects with LTB (A, D, G), or ATB (B, E, I) or both LTB and ATB combined (C, F, J). r: correlation coefficient. P: P 
value, P <0.05 indicating that the observed correlation between acidification and proteolysis is not due to a randomly sampling.
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4.3.4  Influence of Mtb infection on the proteolytic activity of macrophages from 
ATB and LTB subjects 
To advance their intracellular survival, Mtb is able to delay macrophage acidification 
and proteolysis, as well as prevent the phagosome-lysosome fusion
239,245
. I next 
examined how the macrophages from LTB and ATB subjects respond to Mtb infection. 
Because of limited cell numbers, only proteolysis activity was assessed. Macrophages, 
differentiated from cryopreserved monocytes that were isolated from LTB subjects (n= 
32) and ATB patients (n= 92), were infected with Mtb reporter strain at MOI 1 for 48 h 
then treated with proteolytic beads coated with IgG to measure the activity. Activity 
index of macrophages was calculated at 210 min upon bead treatment. I first tested 
whether cryopreservation of monocytes influence the macrophage activity. In both LTB 
and ATB groups there was a slightly reduced activity in uninfected macrophages 
derived from cryopreservation compared to fresh macrophages (data obtained from 
Section 4.3.3) but this reduction was not significant (Mann-Whitney U test; LTB group, 
P= 0.24; ATB group, P= 0.07) (Figure 4.8). I then compared the activity of uninfected 
macrophage derived from cryopreserved monocytes isolated from LTB and ATB 
individuals (Figure 4.8). I again observed a lower proteolytic activity in macrophages 
from LTB subjects than that from patients with ATB (P= 0.02), which confirmed the 
above finding. Upon Mtb infection, the activity of macrophages from the two groups 
decreased approximately a half compared with uninfected cells (LTB group: 5.87 vs. 
10.21; ATB group: 6.87 vs. 12.44; P< 0.0001) (Figure 4.8). Surprisingly, the observed 
difference in activity of uninfected macrophage from LTB and ATB individuals was 
abolished upon Mtb infection (P= 0.12). The reduction in activity from infected 
macrophages was not due to cell death, as macrophages of both ATB and PTB 
Chapter 4 
124 
individuals were still viable at day 2 post infection, as evident by the cell survival assay 
mentioned below. These data demonstrated that Mtb has the capacity to manipulate the 
host cell defense. The reduction of proteolysis activity to the same extent, driven by Mtb 
infection, in macrophages from ATB and LTB individuals, showed no difference in 
macrophage proteolysis function in response to the Mtb infection between ATB and 
LTB.  
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Figure 4.8 Proteolytic activity of Mtb-infected macrophages from LTB and ATB 
subjects 
The first two columns were Activity index at 210 min upon IgG-bead treatment of 
monocyte-derived macrophages from LTB and ATB individuals. For the remaining 
columns, macrophages derived from cryopreserved monocytes from subjects with LTB 
(n= 32), and ATB (n= 92) were infected with Mtb reporter strain at MOI 1 or left 
uninfected. At day 2 post infection, macrophages were treated with reporter beads 
coated with IgG and the proteolytic activity index was assessed at 210 min upon bead 
treatment. (-): macrophage derived from fresh monocytes, (+): macrophage derived 
from cryopreserved monocytes. Bars in the plot represent median values. P: P value, 
determined using Mann-Whitney U test. 
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4.3.5 Survival of Mtb in macrophages from LTB and ATB subjects 
Upon Mtb infection, macrophages from LTB individuals showed similar proteolysis 
activity as compared to macrophages from ATB patients, hence, I further examined the 
bacterial control of macrophages from these two groups (26 LTB and 105 ATB). 
Macrophages derived from cryopreserved monocytes were infected with the Mtb 
reporter strain at MOI 1. The lysis  of infected macrophages in both LTB and ATB were 
20% by day 6 of infection, and the extracellular bacteria interfered with the mCherry 
intensity of intracellular bacteria. Hence, I assessed the bacterial intracellular growth 
through mCherry intensity along with macrophages viability for the first 5 days of 
infection (Figure 4.9A, B). During first two days after infection I observed an 
intracellular replication of bacteria indicated by the increase of mCherry intensity 
(Figure 4.9A). There was also no difference in control ability of macrophages between 
LTB and ATB subjects; all macrophages remained adherent and intact (Figure 4.9B). 
From day 3 of infection, Mtb growth from LTB group seemed to be higher than ATB 
group but it was not a significant difference (day 3, P= 0.4; day 4, P= 0.7; day 5, P= 
0.07) (Figure 4.9A).  The macrophage lysis from LTB and ATB was observed from day 
3 post infection. There was even more macrophage lysis among LTB subjects than 
among ATB patients at day 4 or 5 (P= 0.02) (Figure 4.9B), which could have resulted 
from differences in the interaction of bacteria and macrophages from LTB compared to 
ATB. In conclusion, there was no difference in control of intracellular Mtb growth in 
macrophages from individuals with LTB and ATB.    
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Figure 4.9 Intracellular replication of Mtb in macrophages from LTB and ATB 
subjects 
hMDM from subjects with LTB (n= 26) and ATB (n= 105) were infected with the Mtb 
reporter strain at MOI 1. The bacterial intracellular growth during 5 days of infection 
was assessed by the mCherry intensity readout (A) and the viability of infected 
macrophages (B). Bars in the plots represent median values. P value was determined 
using Mann-Whitney U test.  
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All antimicrobial activities of macrophages were shown above to be associated with 
ATB group that includes both PTB and TBM, I then examined whether there was any 
difference in antimicrobial functions between localized PTB and disseminated TBM. 
The activities of macrophages from PTB were similar to that from TBM in all 
measurements; including phagocytosis, acidification, and proteolysis (see 
Supplementary figure 4.1). There was also no difference in proteolysis activity of 
macrophages as well as their ability in controlling intracellular Mtb growth between 
PTB and TBM individuals (see Supplementary figure 4.2). 
4.3.6 Macrophage antimicrobial activities were modulated by different ligands 
triggering phagocytosis 
To study the phagocytosis and phagosomal functions of macrophages, I generated the 
reporter beads that were coated with different ligands including IgG, TDM and β-
glucan. IgG is recognized by FcγRI, TDM is recognized by MINCLE and MARCO 
receptors
294,306
 while β-glucan is recognized by DECTIN-1295. These receptors then 
induce signaling to facilitate the phagocytosis and further activities inside the 
phagosome. The beads were coated with an excess amount of ligands so that the ability 
to be recognized and bind to their receptors was similar. In fact, there was no difference 
in phagocytosis of these ligand beads in J774 (Chapter 3), suggesting that there would 
be equivalency of attachment among ligands and receptors. Hence, the ligand-coated 
beads could allow us to study the variations of macrophage antimicrobial activities 
facilitated by different phagocytic receptors. 
The data for phagocytosis, acidification and proteolysis were pooled from LTB and 
ATB individuals from above (n= 179) and stratified by each kind of ligand coated to the 
beads. There was difference in the macrophage activities induced by distinct ligands 
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coated on the bead (phagocytosis and acidification, P < 0.0001; proteolysis, P= 0.01) 
(Figure 4.10A, B, and C.). In a closer look, macrophages treated with IgG beads 
phagocytosed more beads (Figure 4.10A) and induced higher acidification (Figure 
4.10B) as well as proteolysis (Figure 4.10C) compared to macrophages treated with 
other ligand coated beads. The phagocytosis of macrophages against β-glucan beads 
was higher than TDM beads (75% vs. 80%, P< 0.0001) (Figure 4.10A). Likewise, the 
acidification and proteolysis activity were higher in macrophages treated with β-glucan 
than with TDM beads (acidification, P= 0.06; proteolysis, P= 0.01) (Figure 4.10B and 
C). There was no correlation between the phagocytosis activity and acidification or 
proteolysis activities against specific ligands (see Supplementary figure 4.3). These 
results altogether suggested that the phagosomal activities of macrophages were 
regulated by ligands and the corresponding receptors. 
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Figure 4.10 Phagocytosis and antimicrobial activities of macrophage treated with 
different ligand beads  
hMDM combined from subjects with LTB and ATB at day 7 were treated with reporter 
beads coated with either IgG, TDM or β-glucan. (A) Phagocytosis stratified by ligand in 
macrophages from 123 individuals, (B) Acidification Activity index at 60 min in 
macrophages from 157 individuals, and (C) Proteolysis Activity index at 210 min in 
macrophages from 153 individuals. P value was determined using Kruskal-Wallis test 
for comparison across three groups or using Mann-Whitney U test for two groups. 
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4.4 Discussion 
Macrophages are thought to play an essential role in controlling the bacterial clearance 
of Mtb, however whether the efficiency of this performance is related to the 
establishment and development of different manifestations of TB infection is unknown. 
To understand the contribution of macrophages in TB pathogenesis, I examined the 
phagocytosis and phagosomal function of macrophages including acidification and 
proteolysis from individuals with LTB and ATB. I found that although the phagocytosis 
ability remained similar between LTB and ATB macrophages, the macrophages from 
LTB had reduced acidification and proteolytic activity compared to ATB in resting state 
(IgG–bead treatment) or in activated state (by immunologic component β-glucan307). In 
case of TDM beads treatment, I observed only reduced proteolytic activity in LTB than 
ATB macrophages. However, when macrophages were infected with live Mtb, 
proteolysis of macrophages from individuals with LTB and ATB were modulated to the 
same extent. The infected macrophages from LTB individuals did not show any 
difference in controlling Mtb intracellular growth compared to macrophages from ATB 
patients. Besides, I did not observe any difference in the phagosomal activities as well 
as ability to control Mtb in macrophages from localized PTB and disseminated TBM. 
These results suggest that macrophage antimicrobial functions were not associated with 
different TB clinical phenotypes. In addition, our study also indicated that different 
ligands had distinct effect on the phagocytosis and antimicrobial activities of human 
macrophages.  
For acidification, I only observed reduced macrophage activities in LTB compared to 
ATB when cells were treated with either IgG or β-glucan beads. Whereas, I observed 
the reduced proteolysis activity in macrophages from LTB in treatment of IgG, TDM or 
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β-glucan beads. Although I observed a moderate correlation between acidification and 
proteolysis activities of macrophages, and acidification has been suggested to be 
requisite for hydrolytic activity within phagosomes, there could be other factors which 
may independently regulate proteolysis activity and show different level of activity 
between LTB and ATB. A previous study has indicated the phagosomal proteolysis 
activity of macrophages could be regulated by NADPH oxidase in an pH-independent 
manner
308
. 
Along with the ligand-coated beads model, I also used the live Mtb infection model to 
study the antimicrobial activities of macrophages. In the ligand bead model, the beads 
were coated with single immunogenic components from Mtb, hence this model can help 
us understand how specific ligand and its corresponding pathway influences the 
antimicrobial functions. The approach is also important to understand the link of host 
genetic association and macrophage antimicrobial functions. That is, whether the 
polymorphisms in receptor gene are associated with the susceptibility of TB because 
they alter the macrophage antimicrobial functions induced by its ligand. But ligand 
beads are limited as the antimicrobial functions of macrophages against the ligand beads 
may be different with macrophage functions in response to live Mtb. Using 
macrophages infected with the live Mtb enables us to highlight the complicated 
interaction of Mtb and macrophage by its ability in manipulating the functions of 
macrophage. The proteolysis activity in Mtb-infected macrophages from LTB and ATB 
were reduced by 50% compared to the level in resting macrophages, resulting in no 
difference between LTB and ATB in proteolysis activity.  
 In this study, macrophages from LTB and ATB showed similarity in their proteolysis 
activity in response to Mtb infection as well as in the ability of Mtb control that was 
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indicated by the same extent of Mtb intracellular growth. It is observed that T cell 
response can activate antimicrobial functions of macrophage and contribute to 
protection against TB, as HIV-infected people who have low CD4 count have high risk 
of getting active TB from latent infection. Similarly, recent studies have shown that 
humoral immune response is different between individuals with LTB and ATB, and 
specific antibody in LTB persons can enhance the phagocytosis of Mtb by 
macrophages
183
. Our results further confirm these observations as macrophage 
antimicrobial functions alone cannot determine for TB protection to remain in LTB 
stage or for TB development. The macrophage infection model may be further 
improved by the inclusion of other adaptive immune components from individuals with 
LTB and ATB. For example, Mtb could be opsonized with the antibodies specific for 
LTB and ATB, then were infected to macrophages from individuals with LTB and ATB 
to determine the macrophage antimicrobial functions of two groups. 
Our results from ligand-coated beads model suggest for a possible ligand-specific 
antimicrobial functions of macrophages. The reduction in antimicrobial function of 
macrophages treated with TDM compared to IgG or β-glucan suggests for a survival 
mechanism of Mtb which may contribute to the disease development. Reduced 
phagocytosis mediated by TDM may prevent Mtb from the antimicrobial activities 
within macrophage phagosome. Likewise, the decrease in proteolysis and acidification 
against the TDM-coated beads may favor bacterial intracellular growth to establish the 
infection. In line with our results, previous studies show that TDM may inhibit 
phagosome - lysosome fusion events to enhance intracellular survival of Mtb during 
infection
247,309
. Removal of surface lipids of Mtb leads to enhanced trafficking of 
bacteria to acidified compartments and reduced number of intracellular bacteria while 
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reconstitution of delipidated Mtb with purified TDM is sufficient to restore ability to 
delay phagosome acidification and fusion
309
.  
Our study is the first study assessing the macrophage phagosomal function from 
individuals with different TB phenotypes, which contributes to the understanding of the 
contribution of macrophages in TB control. The bead-based models suggest that the 
antimicrobial functions of macrophages from both ATB and LTB vary regarding to 
specific ligands and their pathways. While using live Mtb model, I found that Mtb is 
able to modulate antimicrobial functions of macrophages for its survival, resulting no 
difference in antimicrobial function as well as the bacterial control of macrophages from 
LTB and ATB. Further study on interaction of humoral response and macrophages in 
controlling Mtb between LTB and ATB could provide the insights into the TB 
development and progression. 
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ASSOCIATION OF PHAGOCYTIC GENES AND TB 
SUSCEPTIBILITY 
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5.1 Introduction  
In Chapter 4, I observed that there was a wide range of phagosomal activity in 
macrophages from different individuals (Figure 4.2 and 4.6). These results suggest an 
involvement of host genetic variation, especially in genes involved in phagocytosis, in 
the heterogeneity of phagosomal activity which may influence the susceptibility to TB 
disease. 
A number of studies provided strong evidences for the crucial roles of receptors 
comprising DECTIN-1, MINCLE and MARCO in mycobacterial recognition, 
phagocytosis and initiating immunity against mycobacteria infection. DECTIN-1 is 
encoded by DECTIN-1 or aliases C-type Lectin Receptor 7A (CLEC7A) on 
chromosome 12. This receptor is expressed not only on monocytes but also on 
macrophages, dendritic cells and neutrophils
310
. It is found to be a phagocytic receptor 
for β-glucan-containing particles, including zymosan and live Candida albicans295. In 
fungal infection models, binding of ligands to DECTIN-1 is shown to induce a number 
of cellular process, including ligand phagocytosis, respiratory burst, production of 
cytokines and chemokines
311,312
. DECTIN-1 can recognize Mtb but the precise PAMP 
has been uncharacterized yet. Several studies show that DECTIN-1 in concert with 
TLR2 is required for phagocytosis of nontuberculous M. abcessus
313
 and M. ulcerans
314
. 
Mtb internalization by human alveolar cells is partially blocked when DECTIN-1 
expression is silenced by siRNA
315
. In addition, DECTIN-1 is found to be the key 
receptor for the induction of pro-inflammatory cytokines and antimicrobial effects in 
response to mycobacterial infection in both mice and humans
315–317
. Blockage of 
DECTIN-1 receptor results in the enhanced survival and growth of Mtb
315
. MINCLE is 
encoded by MINCLE, also named as C-type Lectin Receptor 4E (CLEC4E), on 
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chromosome 12p31 and predominantly expressed on  macrophages, neutrophils and 
DCs
318,319
. The role of MINCLE in host response to mycobacterial infection was 
investigated in both in vitro and in vivo analysis. The expression of this receptor on the 
alveolar macrophage surface was up-regulated following exposure to mycobacteria
320
. 
MINCLE was identified as a main receptor recognizing mycobacterial cord factor 
TDM, which in turn activated the inflammatory pathway and induced antimycobacterial 
immunity
306,320,321
. Macrophages from mice deficient of Mincle show impaired 
production of pro-inflammatory cytokines and nitric oxide after stimulation with TDM 
or its synthetic analog, trehalose 6,6-dibehenate (TDB)
306
. Moreover, treatment of 
Mincle knockout mice with TDM results in significantly reduced TNF-α and IL-6 
production. In other studies, Mincle-deficient mice exhibited an increased bacterial 
loads in lung after BCG or Mtb infection
320,322
, suggesting a role of MINCLE in 
mycobacterial clearance.  
Another surface receptor, MARCO, a class A SR, has been implied for the host defense 
against mycobacterial infection. MARCO is encoded by MARCO gene located on 
chromosome 2. MARCO is shown to be highly expressed on the macrophages in mice 
BCG-induced granuloma from very early stages during infection with BCG
323
. In 
another study, MARCO-expressing macrophages appear to phagocytose more BCG 
than the neighboring macrophages that do not express MARCO
324
. This observation 
suggests that MARCO functions as a receptor to recognize mycobacteria, facilitates the 
uptake and induces immune response. More specifically, it has been demonstrated that 
Mtb is captured by MARCO in vivo via its cell wall cord factor (TDM), which increases 
pro-inflammatory cytokine response through the interaction with Toll-like receptors and 
CD14
294
. As such, macrophages from Marco-deficient mice produce less cytokines in 
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response to Mtb infection than wild type
294
. The experiment with M. marinum in 
zebrafish further supports the hypothesis that the phagocytosis of mycobacteria is 
MARCO-dependent
325
. Recently, MARCO is shown to associated with the increased 
susceptibility to TB
326,327
.  
Despite the important role of DECTIN-1, MINCLE, and MARCO in TB pathogenesis, 
the role of these phagocytic genes in TB susceptibility is not fully understood or 
specifically clarified in different populations including ones with high prevalence of TB, 
such as the Vietnamese. Our previous studies have revealed the association of 
polymorphisms on a number of innate immune genes on TB susceptibility and I found 
that these associations are predominant to either PTB or TBM
114,198,199,328
. Therefore, in 
this study I aimed to investigate the association of phagocytic gene variants and 
different clinical forms of TB.  
I hypothesized that (1) the polymorphisms in phagocytic genes including DECTIN-1, 
MINCLE, and MARCO are associated with susceptibility to tuberculosis and influence 
clinical presentations and treatment failure, (2) the associated polymorphisms if 
available in (1) could regulate the macrophage phagocytosis, gene expression and 
cytokine response. A number of results related to the work presented in this chapter 
have been recently published with the title of “MARCO variants are associated with 
phagocytosis, pulmonary tuberculosis susceptibility and Beijing lineage”329. 
5.2 Study design 
I used tagging SNP to select SNP markers on MINCLE, MARCO, and DECTIN-1 genes 
for association studies (see Section 2.10). To examine the association of gene variants 
with clinical TB, I used a case-control study. I genotyped candidate polymorphisms 
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across DECTIN-1, MINCLE, and MARCO in 900 cases including 450 TBM and 450 
PTB, and 450 cord blood controls (see Section 2.10). TBM patients were recruited for 
several clinical trials and observational studies from 2001-2013 from either Pham Ngoc 
Thach Hospital for Tuberculosis and Lung Disease or the HTD, HCMC. PTB patients 
were recruited through the network of district TB control units from 2003-2011
114,199,329
. 
Criteria for recruitment of TBM, PTB and controls were detailed in Section 2.1.  
The association between gene variants and clinical presentations in TB patients (see 
Section 2.11) as well as genotypes of infecting Mtb strains (see Section 2.12) were 
examined. The phagocytosis, cytokine response and mRNA expression of MINCLE, 
MARCO, and DECTIN-1 were determined in macrophages from a cohort of individuals 
with healthy volunteers (N= 41) (Section 2.7.1 and 2.9). The influence of gene variants 
on macrophage phagocytosis, cytokine production and gene expression was then 
examined. 
5.3 Results 
5.3.1 Selection of candidate SNPs for genotyping DECTIN-1, MINCLE and 
MARCO 
A tagging SNP represents for a groups of SNPs that have strong linkage with each 
other, hence genotyping tagging SNPs in the region can predict genetic association of 
the remaining SNPs in the region. I selected tagging SNPs for DECTIN-1, MINCLE and 
MARCO as detailed in Section 2.10.1. The SNPs in the gene region that showed the 
association with TB in other population from previous works were also considered. In 
addition, functional nonsense or missense SNPs that change the amino acid sequence of 
protein encoded by the gene were investigated.  
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5.3.1.1 Selection of DECTIN-1 SNPs 
DECTIN-1 has a length of 14,492 bp and includes 5 exons. This gene is located on 
chromosome 12 from position of 10,116,777 to 10,130,258 (GRChr38.p10) (Figure 
5.1). Because regions surrounding the main gene could contain promoter or enhancer 
that have effect on the gene function, I investigated the SNPs across this gene and span 
of 20 kb extra from the upstream (toward the 5’end) and of 16 kb from the downstream 
(toward 3’ end) of the gene. There were 108 SNPs genotyped within this region from 
HCB population, many of them (n= 37) were present in the DECTIN-1 gene and 
distributed throughout the gene (Table 5.1 and Figure 5.1A). However, around half of 
the SNPs within the gene region as well as surrounding areas were monomorphic or had 
low MAF (< 5 %) (Table 5.1). I then investigated the association of 48 SNPs with MAF 
≥ 5 %. By setting the cut off of r2 for LD of 0.8, I found 6 tagging SNPs. I also selected 
two SNPs which showed potential association on our previous study (rs7137840, 
rs11053624) and two SNPs in the upstream region. Finally, ten SNPs in DECTIN-1 
region were selected for genotyping (Table 5.1 and Figure 5.1B).  
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Figure 5.1 Chromosomal location and polymorphisms across DECTIN-1 region 
(A) DECTIN-1 gene region and its 20 kb upstream and 10 kb downstream on chromosome 12 . SNPs across the region from HCB population from 
International HapMap Project were presented as lines; the SNP line lengths are proportional to the minor allele frequency in the population. Figure 
was originated from http://gvs.gs.washington.edu build 147 based on human genome assembly GRCh38.p10. (B) Chromosomal map of candidate 
SNPs in DECTIN-1 region for genotyping. Tagging SNPs and other potential SNPs in Table 5.1 were mapped. Boxes showed exonic regions. 
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Table 5.1 SNPs information on DECTIN-1 region from HCB population 
Location with 
respect to gene 
Function 
Total SNPs 
(N=108) 
Monomorphic 
SNPs (N= 55) 
Rare SNPs  
(MAF< 5 %) 
(N= 5) 
Common SNPs  
(≥ 5 %)  
(N= 48) 
Tagging SNPs  
(No. of tagged 
SNP) 
Other potential 
SNPs for 
genotyping 
Downstream Intergenic 29 12 4 13 rs11053589 (5) 
 
3'-UTR 3'-UTR 6 1 - 5 rs7959451 (2) 
 
Gene region Intronic 28 14 - 14 
rs12829123 (6) 
rs11053613 (11) 
rs11053608 
rs7137840
a
 
5'-UTR 5'-UTR 3 1 - 2 rs11053623 (3) 
 
Upstream Intergenic 42 27 1 14 rs10845051 (8) 
rs11053624
b
 
rs7959064 
MAF: Minor allele frequency 
Intergenic: A variant located in the intergenic region, between genes 
   
3'-UTR: A variant of the 3' Untranslated  region 
    
5'-UTR: A variant of the 5' Untranslated  region 
    
Intronic: A transcript variant occurring within an intron 
    
a 
GWAS, P= 0.013 
      
b 
data from
 
our collaboration showed association of this SNP with TB 
Monomorphic SNP: a SNP with only one type of allele (no other variant) was identified   
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5.3.1.2 Selection of MINCLE SNPs 
MINCLE is a 6-exon gene that is located on chromosome 12 with length of 7,7 kb (from 
8,533,305 to 8,540,963) (Figure 5.2). As with DECTIN1, the SNPs across MINCLE and 
30 kb upstream and 15 kb downstream of the gene were investigated. There were 95 
SNPs across the spanning region of MINCLE; however MINCLE was highly conserved 
with very few SNPs (n= 8) in the gene while most of SNPs were distributed in the 
upstream region (Figure 5.2A). Approximately one third of SNPs in the region were 
monomorphic or had MAF < 5% (Table 5.2). 62 SNPs with MAF > 5 % were examined 
and 10 tagging SNPs were identified (Table 5.2). Finally 12 SNPs across MINCLE 
region were selected for genotyping (Table 5.2 and Figure 5.2B). All SNPs were in the 
non-coding regions including either introns or intergenic upstream of gene. 
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Figure 5.2 Chromosomal location and polymorphisms across MINCLE region  
(A) MINCLE gene region and its 20 kb upstream and 10 kb downstream on chromosome 12. SNPs across the region from HCB population from 
International HapMap Project were presented as lines; the SNP line lengths are proportional to the minor allele frequency in the population. Figure 
was originated from http://gvs.gs.washington.edu build 147 based on human genome assembly GRCh38.p10. (B) Chromosomal map of candidate 
SNPs in MINCLE region for genotyping. Tagging SNPs and other potential SNPs in Table 5.2 were mapped. Boxes showed exonic regions. 
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Table 5.2 SNPs information on MINCLE region from CHB population 
   
Location with 
respect to gene 
Function 
Total SNPs 
(N= 96) 
Monomorphic 
(N= 26) 
Rare SNPs  
(MAF< 5 %) 
(N= 8) 
Common SNPs  
(≥ 5 %)  
(N= 62) 
Tagging SNPs  
(No. of tagged 
SNP) 
Other potential 
SNPs for 
genotyping 
Downstream Intergenic 7 6 - 1 - - 
3'-UTR 3'UTR 1 
 
- 1 - - 
Gene region Intronic 8 1 - 7 
rs10841846 (2) 
rs4562874 (2) 
rs10841856 (2) 
rs4620776 (7) 
rs4242896 
Upstream Intergenic 80 19 8 53 
rs4883167 (7) 
rs11046143 (2) 
rs7959223 (7) 
rs10841875 (12) 
rs10770855 (8) 
rs10770856 (8) 
rs10841871 
    
MAF: Minor allele frequencies  
  
  
3'-UTR: A variant of the 3' Untranslated  region     
5'-UTR: A variant of the 5' Untranslated  region 
 
 
Intergenic: A variant located in the intergenic region, between genes  
Intronic: A transcript variant occurring within an intron   
Monomorphic SNP: a SNP with only one type of allele (no other variant) was identified 
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5.3.1.3 Selection of MARCO SNPs 
MARCO is located on the chromosome 2 with length of 52,5 kb (from 118,942,166 to 
118,994,660) and has 17 exons (Figure 5.3). As with two of the above genes, I searched 
for the candidate SNPs across 20 kb upstream and 10 kb downstream of MARCO gene 
using the data from HCB population. There were 130 SNPs in this region, 78 of which 
were in the MARCO and concentrated in the region containing exons toward 5’ end of 
the gene (Figure 5.3A and Table 5.3). I also observed a number of variants in the 
upstream toward 3’ end of the gene. Out of 130 MARCO SNPs, 46 SNPs were 
monomorphic or had frequency < 5 %. Among 84 SNPs with MAF ≥ 5 %, 12 tagging 
SNPs were identified (Table 5.3). The rs6761637, a missense mutation in exon 10 was 
selected for genotyping. Finally, I had 14 MARCO SNPs for genotyping, all of which 
except rs6761637 were located in non-coding regions and their effect to the MARCO 
function has been unknown (Table 5.3 and Figure 5.3B).  
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Figure 5.3 Chromosomal location and polymorphisms across MARCO region  
(A) MARCO gene region and its 20 kb upstream and 10 kb downstream on chromosome 12. SNPs across the region from HCB population from 
International HapMap Project were presented as lines; the SNP line lengths are proportional to the minor allele frequency in the population. Figure 
was originated from http://gvs.gs.washington.edu build 147 based on human genome assembly GRCh38.p10. (B) Chromosomal map of candidate 
SNPs in MARCO region for genotyping. Tagging SNPs and other potential SNPs in Table 5.3 were mapped. Boxes showed exonic regions. 
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Table 5.3 SNPs information on MARCO region in CHB population 
   
Location with 
respect  to gene 
Function 
Total SNPs 
(N= 130) 
Monomorphic 
(N= 42 ) 
Rare SNPs  
(MAF< 5 %) 
(N= 4) 
Common SNPs  
(≥ 5 %)  
(N= 84) 
Tagging SNPs  
(No. of tagged SNP) 
Other potential 
SNPs for 
genotyping 
Upstream Intergenic 39 16 1 22 
rs1946890 (5) 
rs7573346 (11) 
rs3806496 (11) 
rs1318645 (5) 
  
Gene region 
 
 
Introgenic 
 
 
 
 
 
Missense 
F (TTC)--> S (TCC) 
 
 
 
 
78 
 
 
 
 
 
1 
 
 
 
 
20 
 
 
 
 
2 
 
 
 
 
 
1 
 
 
 
 
56 
 
rs4491733 (11) 
rs12998782 (10) 
rs17009726 (26) 
rs2011839 (2) 
rs1371562 (2) 
rs6751745 (4) 
rs17796260 (4) 
rs3765035 (2) 
 
 
 
rs2278589 
 
 
 
 
 
 
 
 
rs6761637 
Downstream Intergenic 12 6   6     
 
   MAF: Minor allele frequencies  
 3'-UTR: A variant of the 3' Untranslated region 
 
  
5'-UTR: A variant of the 5' Untranslated region 
Intergenic: A variant located in the intergenic region, between genes  
Monomorphic SNP: a SNP with only one type of allele (no other variant) was identified 
F: Phenylalanine, S: Serine 
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5.3.2 Association of SNPs in phagocytic genes and TB susceptibility 
I genotyped 10 SNPs in DECTIN-1, 12 SNPs in MINCLE and 14 SNPs in MARCO in 
TB cases and controls. SNPs were excluded if they had missing genotype calls> 5%, 
MAF< 10%, or P value for deviation from HWE of controls< 0.05 (see Section 2.10.3). 
After checking for quality, 1 SNP in DECTIN-1 (rs11053589) and 3 SNPs in MINCLE 
(rs4562874, rs10841871 and rs10841875) showed P value for HWE in control< 0.05; in 
MARCO, 1 SNP (rs1946890) was monomorphic and 1 SNP (rs2011839) had 30% 
missing data. Finally, 9 DECTIN-1 SNPs, 9 MINCLE SNPs and 12 MARCO SNPs, were 
analyzed for associations between SNPs and susceptibility to different TB clinical 
phenotypes (Table 5.4, 5.5, and 5.6).  
5.3.2.1 Association of DECTIN-1 SNPs and TB susceptibility 
 I first examined the association of DECTIN-1 SNPs and TB susceptibility using 
phenotypic and allelic models. By comparing the genotype frequencies of DECTIN-1 
SNPs in TB patients and controls, I found that none of the 9 SNPs associated with PTB 
(P> 0.05) while 2 of them (rs7959451 and rs7137840) were associated with TBM (P= 
0.027 and 0.044, respectively) (Table 5.4). However, the association did not remain 
significant after applying Bonferroni correction for multiple tests (rs7959451: 0.027 x 9 
SNPs = 0.243, rs7137840: 0.044 x 9 SNPs = 0.396). As with the genotypic model, when 
I compared the allele frequency of SNPs in TB patients and controls in allelic model, 
none of the 9 SNPs were associated with PTB (P> 0.05) while 3 SNPs including 
rs7959451, rs7137840 and rs11053613 were associated with TBM (P = 0.008, 0.012, 
and 0.018, respectively) (Table 5.4). The association did not remain significant after 
applying Bonferroni correction for multiple tests of 9 SNPs.  
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Table 5.4 Summary of genotyped SNPs in DECTIN-1 in Vietnamese population 
rs ID Cases (N)                  Controls (N) Genotypic Allelic 
Location PTB/TBM 11/12/22  11/12/22 HWE-P P P 
rs7959451 PTB 244/176/24 249/173/14 0.073 0.632 0.455 
UTR-3’ TBM 216/196/31     0.027 0.008 
rs12829123 PTB 314/119/11 308/123/8 0.282 0.752 0.978 
Intron 4 TBM 300/126/15     0.316 0.294 
rs11053608 PTB 314/119/13 307/122/8 0.298 0.542 0.788 
Intron 4 TBM 303/125/15     0.335 0.334 
rs7137840 PTB 104/240/102 376/59/3 0.682 0.653 0.402 
Intron 4 TBM 374/70/3     0.044 0.012 
rs11053613 PTB 373/70/3 376/61/3 0.761 0.745 0.484 
Intron 3 TBM 354/85/6     0.060 0.018 
rs11053623 PTB 234/179/33 227/173/35 0.800 0.937 0.828 
UTR-5’ TBM 213/184/48     0.257 0.110 
rs11053624 PTB 234/179/33 225/176/36 0.848 0.887 0.671 
900 bp upstream TBM 213/183/48     0.345 0.169 
rs7959064 PTB 268/156/23 267/147/24 0.526 0.905 0.867 
1.3 Kb upstream  TBM 258/163/25     0.629 0.422 
rs10845051 PTB 254/170/21 264/150/25 0.547 0.417 0.602 
8.5 Kb upstream TBM 249/172/22     0.347 0.426 
1: majority allele; 2: minority allele. 11, 12, and 22: genotypes from different allelic combination.  
HWE: Hardy Weinberg equilibrium; P: P value 
Genotypic is the comparison of genotype frequencies (11, 12, and 22) between cases and controls; Allelic is the comparison of allele frequencies 
(allele 1 and 2) between cases and controls 
Numbers in bold in Genotypic P and Allelic P columns represent P value < 0.05 
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5.3.2.2 Association of MINCLE SNPs and TB susceptibility 
I did not observe the association of any 9 SNPs in this gene with either TBM or PTB 
using the genetic model (Table 5.5). Whereas in the allelic model, I found 2 SNPs 
(rs10770855 and rs10770856) were associated with TBM but not PTB (TBM: P= 0.017, 
0.028 respectively) (Table 5.5). However, after applying Bonferroni correction, none of 
the 2 SNPs remained the significant association.  
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Table 5.5 Summary of genotyped SNPs in MINCLE in Vietnamese population 
rs ID Cases (N) Controls (N) Genotypic Allelic 
Location PTB/TBM 11/12/22 11/12/22 HWE-P P P 
rs10841846 PTB 119/227/98 129/219/87 0.733 0.574 0.296 
Intron 5 TBM 123/229/84     0.779 0.502 
rs4562874 PTB 143/219/84 147/222/71 0.400 0.569 0.385 
Intron 3 TBM 146/220/79     0.814 0.632 
rs10841856 PTB 143/219/84 197/196/45 0.299 0.452 0.312 
Intron 1 TBM 177/206/66     0.689 0.477 
rs4620776 PTB 168/216/61 162/218/57 0.219 0.646 0.997 
Intron 1 TBM 175/208/62     0.913 0.764 
rs4883167 PTB 181/208/53 176/213/49 0.195 0.875 0.994 
700 bp upstream TBM 179/201/60     0.477 0.667 
rs11046143 PTB 413/35/1 413/29/0 0.476 0.388 0.346 
1.4 Kb upstream TBM 412/36/0     0.397 0.397 
rs7959223 PTB 174/214/59 167/220/53 0.131 0.782 0.968 
4 Kb upstream TBM 180/205/57     0.561 0.670 
rs10770855 PTB 154/229/62 180/201/60 0.744 0.145 0.150 
11Kb upstream TBM 150/218/78     0.057 0.017 
rs10770856 PTB 170/228/48 197/196/45 0.714 0.109 0.093 
11.8 Kb upstream TBM 177/206/66   0.075 0.028 
1: majority allele; 2: minority allele. 11, 12, and 22: genotypes from different allelic combinations  
HWE: Hardy Weinberg equilibrium; P: P value 
Genotypic is the comparison of genotype frequencies (11, 12, and 22) between cases and controls; Allelic is the comparison of allele frequencies 
(allele 1 and 2) between cases and controls 
Numbers in bold in Genotypic P and Allelic P columns represent P value < 0.05 
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5.3.2.3 Association of MARCO SNPs and TB susceptibility 
For MARCO, none of the 12 SNPs were associated with TBM, while 3 of them were 
associated with PTB using the genotypic model (rs6748401, P= 0.039; rs2278589, P= 
0.004; rs6751745, P= 0.011) (Table 5.6). However, the allelic model did not show any 
association of the MARCO SNPs and TB (Table 5.6). In genotypic model, only 
rs2278589 remained significant after Bonferroni correction for multiple tests (0.004 x 
12 SNPs= 0.048). When I analyzed the linkage disequilibrium of the MARCO SNPs, I 
found that among these 3 associated SNPs, rs2278589 was in high LD (D'= 1, r
2
= 0.88) 
with rs6751745 but not with rs6748401 in our Vietnamese Kinh control population 
(Figure 5.4A, B). I further investigated the association of two SNPs in high LD 
mentioned above with PTB using additional genetic models including heterozygote, 
dominant and recessive. I found that the heterozygous advantage model displayed a 
significant association of rs2278589 and rs6751745 heterozygous genotypes with 
susceptibility to PTB (rs2278589; P= 0.001, OR= 1.6 and rs6751745; P= 0.009, OR= 
1.4; Table 5.7). Associations between these 2 SNPs with PTB in this model remained 
significant after Bonferroni correction (Table 5.7). 
Collectively, there was no association of DECTIN-1 and MINCLE SNPs with 
susceptibility to clinical TB phenotypes while the heterozygote genotypes of two SNPs 
in the MARCO gene were associated with PTB, but not with TBM. Therefore, I mainly 
focused on these MARCO SNPs for functional studies. 
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Table 5.6 Summary of genotyped SNPs in MARCO in Vietnamese population 
rs ID Cases (N) Controls (N) Genotypic Allelic 
Location PTB/TBM 11/12/22 11/12/22 HWE-P P P 
rs7573346 PTB 131/233/84 122/213/105 0.524 0.175 0.159 
4.9 Kb upstream TBM 127/216/101     0.913 0.679 
rs6748401 PTB 108/245/90 120/215/100 0.845 0.039 0.063 
1.5 Kb upstream TBM 115/223/109     0.788 0.495 
rs1318645 PTB 109/246/92 119/215/100 0.879 0.057 0.079 
3 bp upstream TBM 115/223/109     0.815 0.525 
rs4491733 PTB 104/240/102 114/228/93 0.290 0.593 0.342 
intron 1 TBM 120/222/101     0.782 0.909 
rs12998782 PTB 228/184/34 243/160/31 0.510 0.345 0.207 
intron 1 TBM 239/168/33     0.883 0.634 
rs17009726 PTB 331/110/8 340/94/6 0.863 0.456 0.211 
intron 1 TBM 342/99/5     0.911 0.100 
rs2278589 PTB 165/245/35 194/190/48 0.885 0.004 0.286 
intron 3 TBM 194/203/47     0.871 0.878 
rs1371562 PTB 289/141/15 284/138/15 0.724 0.998 0.996 
intron 6 TBM 286/140/15     0.998 0.978 
rs6761637 PTB 323/114/8 335/89/9 0.289 0.202 0.169 
exon 10 TBM 333/101/6     0.519 0.761 
rs6751745 PTB 194/225/27 210/181/43 0.663 0.011 0.807 
intron 13 TBM 223/178/39     0.752 0.451 
rs17796260 PTB 293/139/13 283/135/18 0.708 0.622 0.566 
intron 13 TBM 292/136/14     0.739 0.573 
rs3765035 PTB 145/251/49 152/220/60 0.164 0.210 0.949 
intron 15 TBM 183/199/60     0.149 0.155 
1: majority allele; 2: minority allele. 11, 12, and 22: genotypes from different allelic combinations  
HWE: Hardy Weinberg equilibrium; P: P value 
Genotypic is the comparison of genotype frequencies (11, 12, and 22) between cases and controls; Allelic is the comparison of allele frequencies 
(allele 1 and 2) between cases and controls. Numbers in bold in Genotypic P and Allelic P columns represent P value < 0.05 
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Figure 5.4 Linkage disequilibrium of MARCO polymorphisms in a Vietnamese cohort 
(A, B) Linkage disequilibrium values (r
2
 and D') between SNPs were generated by Haploview 4.2 using the genotype data from the control 
population (Vietnamese Kinh). Empty squares indicate complete linkage disequilibrium (r
2
 or D'=1). 
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Table 5.7 MARCO SNPs rs2278589 and rs6751745 are associated with PTB 
SNP  rs2278589 rs6751745 
Genotypes 11 (N, %) 12 (N, %) 22 (N, %) 11 (N, %) 12 (N, %) 22 (N, %) 
Control  194 (0.45) 190 (0.44) 48 (0.11) 210 (0.48) 181 (0.42) 43 (0.10) 
PTB  165 (0.37) 245 (0.55) 35 (0.08) 194 (0.43) 225 (0.50) 27 (0.06) 
Comparison models P P* OR (95%CI) P P* OR (95%CI) 
Dominant  0.101 0.202 1.5 (0.9-2.3) 0.035 0.070 1.7 (1.0-2.8) 
Recessive  0.018 0.036 0.7 (0.5-0.9) 0.146 0.292 0.8 (0.6-1.1) 
Heterozygous  0.001 0.002 1.6 (1.2-2.0) 0.009 0.018 1.4 (1.1-1.8) 
1: majority allele; 2: minority allele; 11, 12, and 22: genotypes from different allelic combinations 
Dominant is the comparison of (11+12) vs. 22 between cases and controls; Recessive is the comparison of 11 vs (12+22) between cases and 
controls; Heterozygous is the comparison of (11+22) vs. 12 between cases and controls 
P: P value 
P*: corrected P value, Bonferroni correction by 2 SNPs (P value x 2) 
OR (95%CI): odds ratio (95% confidence interval) 
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5.3.3 MARCO polymorphisms are associated with chest X-ray presentation 
To investigate whether MARCO polymorphisms influence clinical presentation or 
disease outcome, I examined the relationship between the two associated SNPs 
(rs2278589 and rs6751745), pre-treatment CXR abnormalities, and 8-month treatment 
outcomes. Patients enrolled in this study were sputum smear-positive for pulmonary TB 
before treatment. Pre-treatment CXR showed 427/429 (99.5%) were abnormal with 
evidence of nodules (139, 32.4%), infiltrates (407, 94.9%), consolidation (40, 9.3%), 
and cavities (139, 32.4%).  
SNPs rs2278589 and rs6751745 were associated with severity of CXR abnormality. 
SNP rs2278589 was associated with intermediate and severe CXR abnormality in the 
heterozygote model (P= 0.008 intermediate; P= 0.007 severe, OR= 1.6; Table 5.8). SNP 
rs6751745 was also associated with severe CXR abnormality in the heterozygote model 
(P= 0.007, OR= 1.6; Table 5.8). 
There was no association between rs2278589 and rs6751745 genotype and poor 
treatment outcome (29/429, 6%), which was defined by death, or failure to convert to 
sputum smear negativity, however this may be due to the lack of events in this dataset 
and consequent lack of statistical power.  
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Table 5.8 MARCO SNPs rs2278589 and rs6751745 are associated with level of CXR 
abnormality in PTB patients 
Abnormality level 
Genotype 
(N, %) Genotypic Heterozygous 
  GG AG AA P P OR (95%CI) 
rs2278589            
Controls 194 (0.45) 190 (0.44) 48 (0.11)      
   Mild 26 (0.38) 39 (0.57) 4 (0.06) 0.112 0.052 1.7 (1.0-2.7) 
   Intermediate 67 (0.37) 101 (0.56) 13 (0.07) 0.022 0.008 1.6 (1.1-2.3) 
   Severe 60 (0.35) 96 (0.56) 15 (0.09) 0.026 0.007 1.6 (1.1-2.3) 
rs6751745             
Controls 210 (0.48) 181 (0.42) 43 (0.10)       
   Mild 31 (0.44) 35 (0.50) 4 (0.06) 0.314 0.193 1.4 (0.8-2.3) 
   Intermediate 82 (0.45) 90 (0.50) 9 (0.05) 0.055 0.068 1.4 (1.0-2.0) 
   Severe 68 (0.40) 92 (0.54) 11 (0.06) 0.026 0.007 1.6 (1.1-2.3) 
CXR: Chest X-ray; P: P value; OR (95%CI): odds ratio (95% confidence interval) 
Genotypic is the comparison of genotype frequencies (genotype GG, AG and AA) 
between cases with Mild/Intermediate/Severe CXR and controls; Heterozygous is the 
comparison of (GG+AA) vs. AG between cases with Mild/Intermediate/Severe CXR 
and controls 
Mild: abnormal features (nodules, infiltrates, consolidation, cavities or miliary TB) on a 
chest radiograph were present in one lobe; Intermediate: abnormal features were present 
in one lung; Severe: abnormal features were present in both lungs 
Numbers in bold represent P value <0.05 
5.3.4 MARCO polymorphisms are associated with Beijing lineage 
Our previous studies have reported association between lineages of Mtb, particularly the 
modern East Asian/Beijing lineage, with TB clinical phenotypes
20,70
. Given a worldwide 
emergence of Mtb East Asian/Beijing strains
42
, I hypothesized that variation in the 
scavenger receptor gene MARCO might be preferentially associated with a specific 
lineage. Therefore, I next examined whether the rs2278589 and rs6751745 genotypes 
are associated with infection caused by a particular bacterial lineage and whether this 
relationship influences disease phenotype. 
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The genotypic frequencies of rs2278589 and rs6751745 in all PTB patients (N= 445) 
and in those patients where the lineage of the infecting Mtb isolate was determined (N= 
370), were compared with controls (Table 5.9). There was no significant association 
between the two SNPs and infection with either Indo-Oceanic or Euro-American 
lineage, or when combined as non-Beijing lineages (Table 5.9). However, I found a 
significant association between these SNPs and infection with East Asian/Beijing 
isolates in a genotypic comparison (rs2278589, P= 0.005; rs6751745, P= 0.033), and in 
a heterozygous model (rs2278589, P= 0.001, OR= 1.7; rs6751745, P= 0.012, OR= 1.5; 
Table 5.9).  
Table 5.9 MARCO SNPs rs2278589 and rs6751745 are associated with the Beijing 
strain 
Group 
Genotype 
(N, %) Genotypic Heterozygous 
  GG AG AA P P OR (95%CI) 
rs2278589             
Controls 194 (0.45) 190 (0.44) 48 (0.11)       
PTB 165 (0.37) 245 (0.55) 35 (0.08) 0.004 0.001 1.6 (1.2-2.0) 
   All isolates 135 (0.36) 205 (0.55) 30 (0.08) 0.005 0.001 1.6 (1.2-2.1) 
   Non-Beijing  61 (0.42) 77 (0.53) 8 (0.05) 0.060 0.066 1.4 (1.0-2.1) 
   East Asian/Beijing  74 (0.33) 128 (0.57) 22 (0.10) 0.005 0.001 1.7 (1.2-2.3) 
rs6751745             
Controls 210 (0.48) 181 (0.42) 43 (0.10)       
PTB 194 (0.43) 225 (0.50) 27 (0.06) 0.011 0.009 1.4 (1.1-1.9) 
   All isolates 161 (0.47) 187 (0.48) 23 (0.05) 0.021 0.014 1.4 (1.1-1.9) 
   Non-Beijing  68 (0.47) 70 (0.48) 8 (0.05) 0.174 0.188 1.3 (0.9-1.9) 
   East Asian/Beijing  93 (0.41) 117 (0.52) 15 (0.07) 0.033 0.012 1.5 (1.1-2.1) 
P: P value; OR (95%CI): odds ratio (95% confidence interval) 
Genotypic is the comparison of genotype frequencies (genotype GG, AG and AA) 
between cases stratified by Mtb lineage and controls; Heterozygous is the comparison of 
(GG+AA) vs. AG between cases stratified by Mtb lineage and controls 
Numbers in bold represent P value <0.05 
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5.3.5 Association of MARCO SNPs with macrophage phagocytosis, mRNA 
expression and cytokines in response to Mtb  
MARCO is a phagocytic receptor on macrophages which binds bacteria and facilitates 
phagocytosis to control and clear the pathogens
325,330,331
. Therefore, I examined whether 
MARCO SNPs are associated with susceptibility to TB and disease severity since these 
SNPs influence macrophage phagocytosis, gene expression, and cytokine profiles.  
I genotyped twelve MARCO tagging SNPs from 41 volunteers and performed 
phagocytosis assays (this data was a subset of LTB dataset in Chapter 4). 10 SNPs in 
MARCO that were not associated with PTB were also not associated with phagocytosis 
of any IgG, TDM or β-glucan beads except for rs4491433 (β-glucan beads, P= 0.02) 
(Figure 5.5). The genotypes of both rs2278589 and rs6751745, were associated with 
phagocytosis of either TDM or β-glucan beads, but were not associated with 
phagocytosis of IgG beads (Figure 5.6A, 5.6B). Since the heterozygote genotypes of 
these two SNPs displayed significant association with susceptibility to PTB, I wondered 
whether the heterozygotes could influence the phagocytosis. Our results showed that 
heterozygous genotypes of both SNPs were associated with reduced phagocytosis of 
TDM and β-glucan beads (rs2278589, P= 0.04 and 0.03; rs6751745, P= 0.01 and 0.007) 
(Figure 5.6A, 5.6B).  
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Figure 5.5 Phagocytic ability of macrophages from healthy subjects 
Macrophage phagocytosis of IgG, TDM and β-glucan beads was plotted by MARCO SNP genotype. Data is shown for 10 tagging SNPs in 41 
healthy subjects. Bars in plots represent median values. Comparisons across three groups of genotypes were performed by using one-way ANOVA. 
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Figure 5.6 Phagocytic ability of macrophages from healthy subjects  
Macrophage phagocytosis of beads was assessed according to MARCO SNP genotypes 
in healthy subjects; (A) rs2278589 (18 GG, 18 AG, 5 AA) and (B) rs6751745 (19 GG, 
18 AG, 4 AA). Bars in plots represent median values. Comparisons across three groups 
of genotypes were performed by using one-way ANOVA, or two groups by using 
Mann-Whitney U test. 
I also examined the association of MARCO SNPs rs2278589 and rs6751745 with 
mRNA expression or cytokines in PBMCs from 31 healthy subjects. MARCO mRNA 
P= 0.02 P= 0.12 
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levels were up-regulated approximately 2 fold in PBMCs stimulated with LPS or Mtb 
whole cell lysate compared with un-stimulated cells (Figure 5.7A). The genotypes of 
rs2278589 and rs6751745 were marginally associated with MARCO mRNA expression 
in cells stimulated with Mtb (Figure 5.7B) (P= 0.068 and 0.039 respectively). For the 
heterozygous model, the AG genotype of these two SNPs was not significantly 
associated with reduced levels of MARCO mRNA in PBMCs stimulated with Mtb. For 
cytokine production, PBMCs were activated and produced pro-inflammatory cytokines 
TNF-α and IL-1β in response to both TDM and Mtb lysate. The anti-inflammatory 
cytokine IL-10 was induced by Mtb lysate stimulation, but not TDM (Figure 5.7C). In 
TDM or Mtb lysate stimulated cells, there was no significant association of the two SNP 
genotypes with TNF-α, IL-1β and IL-10 levels (Figure 5.7D-E for rs2278589, and F-G 
for rs6751745).  
Collectively, these data showed that the AG genotype of rs2278589 and rs6751745 in 
MARCO was not associated with MARCO mRNA expression or cytokine concentrations 
in PBMCs, but it was associated with reduced phagocytosis activated via TDM and β-
glucan in macrophages. 
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Figure 5.7 MARCO polymorphisms and variation in mRNA expression or cytokine production from healthy subjects 
(A) mRNA was isolated from monocytes stimulated with Media, LPS at 100 ng/ml or Mtb whole cell lysate at 5µg/ml. MARCO mRNA expression 
was measured and normalizes to GAPDH. (B) Association of MARCO mRNA expression from cells stimulated with Mtb whole cell lysate was 
analysed with SNPs in MARCO: rs2278589 (4 AA, 12 AG, 15 GG), P= 0.068 and rs6751745 (3 AA, 13 AG, 15 GG), P= 0.039. (C) Cytokines were 
measured from monocytes stimulated with media alone, TDM at 100µg/ml or Mtb whole cell lysate at 25µg/ml. Cytokines from cells stimulated 
with TDM (D) or Mtb whole cell lysate (E) were analysed with SNP rs2278589 (4 AA, 12 AG, 15 GG). Cytokines from cells stimulated with TDM 
(F) or Mtb whole cell lysate (G) were analysed with SNP rs6751745 (3 AA, 13 AG, 15 GG).  Data were collected from duplicate samples. Bars in 
plots represent median values. Comparisons across three genotypes were performed by using one-way ANOVA. 
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5.4  Discussion  
I found, among three genes examined, that polymorphisms in MARCO (rs2278589 and 
rs6751745) were associated with increased susceptibility to pulmonary TB and severe 
chest radiography abnormality.  The SNP genotypes were also associated with a 
reduction of phagocytosis of beads coated with pathogen-derived ligands, TDM from 
Mtb. Our results suggest that these polymorphisms may regulate phagocytosis of Mtb, 
and impairment of phagocytic ability could increase susceptibility to, and severity of, 
pulmonary TB. The MARCO genotypes were preferentially associated with Beijing 
rather than Indo-Oceanic or Euro-American lineage, which implies that MARCO 
genotype may increase the susceptibility to tuberculosis particularly of the Beijing 
lineage. 
This is the first study investigating the association of DECTIN-1 polymorphisms in TB 
susceptibility, however I did not observe any association. Consistent with our findings 
in our Vietnamese population, a genetic study in South African coloured (SAC) 
population did not find an association between MINCLE SNPs with TB either
201
. 
Although DECTIN-1 and MINCLE may not be associated with TB susceptibility, its 
function in the human immune system cannot be discounted
306,315,316,321,332
. Since Mtb 
engages a wide range of host receptors to initiate the immune response
 36,87,120
, it is 
possible that the influence of DECTIN-1 and MINCLE SNPs on disease susceptibility 
could be compensated by other receptors. 
Scavenger receptors on human monocytes have been found to bind to β-glucan333, and 
MARCO on macrophages treated with CpG-containing oligodeoxynucleotides (CpG-
ODN), a ligand for TLR9) has been found to participate in the uptake of zymosan 
(which is derived from β-glucan)334. In line with these findings, I observed the 
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association of MARCO SNPs with phagocytosis of β-glucan beads similar to TDM 
beads, suggesting that β-glucan might be a ligand for MARCO. 
MARCO plays a key role in bacterial phagocytosis and clearance
325,330,335
. Recognition 
of TDM by MARCO, in conjunction with TLR2/CD4, activates transcriptional 
expression of immunity genes
336
 and cytokine production
294
. However, no studies have 
yet shown the influence of MARCO genetic variation on the antimicrobial activity of 
macrophages such as phagocytosis or immune response.  In this study, I found that 
MARCO SNPs rs2278589 and rs6751745 were not associated with gene expression and 
cytokine production in PBMCs but were associated with reduced phagocytosis of beads 
coated with pathogen-derived ligands, TDM or β-glucan in macrophages. I found that 
MARCO polymorphisms were not associated with cytokine production while in murine 
studies, macrophages from Marco-deficient mice were associated with a reduction of 
TNFα, IL-6 and IL-1β cytokine production. The difference in the study design could 
account for the differences seen in cytokine production between these two studies. I 
used human PBMCs, whereas in study of Bowdish et al.
294
 murine macrophages were 
used. In the macrophages from knockout mice, Marco was absent, potentially having a 
major impact. In our study, MARCO was still produced, albeit a variant of MARCO 
with an unknown and potentially smaller impact. Another reason for the difference may 
be the limited numbers of samples in our study once stratified by genotype. 
MARCO is involved in phagocytosis of bacteria, a step in pathogenesis which may be 
important in the development of pulmonary TB in the early phase of infection. The 
heterozygous genotypes of two MARCO SNPs were associated with reduced 
macrophage phagocytic function. The impairment of phagocytosis at the beginning of 
infection reduces the number of macrophages infected with Mtb, which then limits 
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microbial killing and antigen presentation to lymphocytes
275,293
. The consequence of 
this could be the inadequate induction of innate and adaptive immune responses against 
Mtb, potentially increasing the susceptibility to active disease. Deficient responses could 
also lead to increased microbial replication, which could manifest as severe 
abnormalities on CXR, as observed in TB patients carrying the heterozygous genotypes. 
Together, our data suggest that TB susceptibility and disease severity in patients with 
the MARCO AG genotype may be due to impairment of Mtb phagocytosis. 
Our results show that variations in human MARCO gene were associated with 
susceptibility to pulmonary TB in the Vietnamese Kinh population. The associated 
intronic SNPs rs6748401 and rs2278589 are part of a wide haplotype block, suggesting 
they are markers in high LD with the unknown causative SNP(s). Two MARCO SNPs 
(rs17009726 or rs4491733) were previously associated with TB susceptibility in the 
Han Chinese Beijing and Gambian populations
326,327
, however I did not observe any 
association with these SNPs in our TB population. Conversely, the associated SNPs 
(rs6748401 and rs2278589) described in this study were not associated in the Gambian 
population and were not genotyped in the Chinese population. The discrepancy in our 
results may be due to different population LD structure. The frequencies of the 
associated SNPs found in the three studies were very different based on the 1000 
Genomes Project (http://www.ncbi.nlm.nih.gov/projects/SNP; rs17009726 minor allele 
frequency in African 0.0008, Ad Mixed American 0.0014, European 0.0060, East Asian 
0.1210 and  South Asian 0.1483 super populations) and overall linkage (D' plots) across 
the MARCO SNPs in three populations are visually different (figure 5.5 and 
326,327
). LD 
in the Vietnamese Kinh population across this gene region contains larger haplotype 
blocks with more SNPs compared to both the Han Chinese (HCB) and Gambian 
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populations. The differing population structures in this gene region may account for the 
inability to replicate individual SNP associations, however the accumulated evidence 
across these populations suggests that MARCO variation contributes to pulmonary TB 
susceptibility.  
The remarkable emergence of Beijing lineage worldwide, including Vietnam, supports 
the hypothesis that the variation in the scavenger receptor MARCO, which binds 
Mycobacterium and promotes macrophage internalization, might support the emergence 
of the Beijing lineages. Our data shows associations of  both MARCO variants with Mtb 
lineage and TB susceptibility suggesting potential role of  host-pathogen co-evolution, 
as reported previously with TLR2, EREG, and NRAMP1
20,199,337
. Our associated SNPs 
may be markers of non-synonymous structural variants of MARCO that effects ability 
to bind ligands from Beijing lineage strains, reducing phagocytosis and increasing 
susceptibility to TB. Host-pathogen co-evolution in tuberculosis needs to be studied on 
a larger scale with respect to patients and genes, coupled with functional studies to 
determine the underlying mechanisms.  
In conclusion, out of the three phagocytic genes examined, MARCO is likely to play an 
important role in TB susceptibility. Our results suggest that MARCO polymorphisms 
may regulate phagocytosis of Mtb, influence pathogen clearance and thus increase 
susceptibility to and severity of pulmonary tuberculosis. The results also suggest that 
MARCO genotype and Beijing strains may interact to increase the risk of pulmonary 
tuberculosis. 
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VIRULENCE OF MTB CLINICAL STRAINS AND ITS 
ASSOCIATION TO BACTERIA GENOTYPE AND HOST IMMUNE 
RESPONSE 
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6.1 Introduction 
Together with host genetic and physiological factors, the virulence of Mtb strains is 
thought to contribute to TB susceptibility
338
. Understanding Mtb virulence and its 
determinants could help us to understand how the bacteria survive from host defense to 
cause disease, which is important in regard to efforts at TB control and improvement of 
TB treatment. 
There are different models and measurements to evaluate the virulence of Mtb. It can be 
assessed experimentally by the Mtb burden in the organs of infected animals such as 
mice or guinea pigs, or ability to cause the lung pathology or the death of the host. 
Many studies have shown that virulent Mtb strains are associated with the rapid growth 
in the lung, severe lung histopathology and the earlier death of infected animals
51,58,338
. 
Mtb virulence can also be gauged by intracellular growth in macrophage model in vitro, 
including murine or human macrophage cell lines or primary macrophages. In these 
models, the virulent Mtb strains are shown to grow more rapidly than avirulent or 
attenuated bacteria
260,290,339
. Mtb is obligate pathogen that requires human infection to 
replicate and spread, hence the ability to transmit is also considered as a measurement 
for Mtb virulence. The more transmissible a bacteria is, higher the virulence it is
66
. As 
an intracellular bacterium, Mtb also needs to escape from macrophages for new 
infection. Therefore, many studies have showed that host cell cytotoxicity is associated 
with the Mtb virulence
47,69,340
.  
Pro-inflammatory cytokine signaling is crucial for the host immune response against 
infection of intracellular pathogens such as Mtb
341
. Insufficient amount of these 
cytokine could increase the susceptibility to TB
14
. In consistency with this, virulent Mtb 
strains are demonstrated to reduce production of inflammatory cytokines and induce 
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production of anti-inflammatory cytokines in the host
51,53,61
. It could be that, by biasing 
the host immunity towards a non-protective response, the virulent Mtb strains are able to 
rapidly grow and lead to the disease development.  
Thanks to the development of new molecular biology techniques, Mtb has been known 
to have a wide range of genetic variation determined by deletion, repetition and 
polymorphisms on the genome
342
. Based on these variations, Mtb isolates were globally 
categorized into 7 main lineages, comprising East-Asian/Beijing, Indo-Oceanic, East 
African-Indian, Euro-American, M. africanum West African-1 and 2 and Ethipoian
38
. 
Some of these lineages are present worldwide while others are restricted to specific 
global regions. A number of studies have indicated that such genetic diversity 
influences the transmissibility and virulence of clinical Mtb isolates, host immune 
response and clinical picture they evoke
20,66,70,343
. However, to my knowledge, analysis 
of  the virulence of clinical isolates have mainly been restricted to a very few isolates. 
In this study, I evaluated the variation in virulence indicated by the host cell lysis of a 
large number of clinical Mtb isolates. I hypothesized that there was variation in the 
virulence among different clinical Mtb strains and the variation was associated with 
distinct host immune responses and lineage-specific strains. 
6.2 Study design 
159 clinical Mtb isolates were collected from PTB patients from district TB control 
units in HCMC, Vietnam between January 2015 and October 2016 (see Section 2.8.2). 
Among them, 84 patients participated in the study of antimicrobial function of 
macrophages in TB (Chapter 4). I established the infection of these isolates at MOI 1 in 
human macrophage cell lines (see Section 2.8.3). To assess Mtb virulence, host cell 
Chapter 6 
171 
lysis of infected macrophages was monitored daily under a light microscopy (see 
Section 2.8.6). The stability of Mtb virulence after in vitro serial passages or in primary 
hMDM was also examined. The cytokine expression in hMDM infected with Mtb 
clinical isolates was measured (see Section 2.9.3) to investigate the association of 
macrophage responses and Mtb virulence. I also studied whether Mtb growth rate or 
strain genetic factor determines the virulence phenotypes. In vitro growth rate of 
bacteria was measured as detailed in section 2.8.4. Mtb strains were genotyped by LSP 
to identify the global lineages as detailed in Section 2.12.  
6.3 Results 
6.3.1 Diversity in virulence of different Mtb clinical isolates 
To examine the variation in virulence of different Mtb strains, 159 clinical isolates and 
the lab strain H37Rv, as a reference, were used to infect the human macrophage-like 
cell line, PMA-treated THP-1, and the host cell lysis was observed during 6 days post 
infection (Figure 6.1). During the first two days of infection, infected macrophages were 
observed to be still adherent and intact as were the controls. However after 3 days, 
several isolates induced cell death more readily than others, with up to 50 % cells 
infected with these strains being lysed. From day 4 and afterwards, there was significant 
variation on the level of cell lysis of THP1 infected with different isolates, which ranged 
from 0 % to 100 %. Up to day 6 I still observed different patterns where macrophages 
infected with a number of isolates were lysed completely whereas macrophages infected 
with other isolates remained intact. These results suggested that different isolates could 
have specific interaction with macrophages, leading to different outcomes of cell lysis. 
As such, cell lysis could be used as a maker for bacterial virulence.  
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Regarding host cell lysis at day 6 post-infection, I grouped clinical isolates into three 
different phenotypes of virulence: high virulence when ≥ 90 % infected cells were 
lysed, low virulence when ≤ 5 % infected cells were lysed, and moderate virulence for 
the remainder. Among 159 clinical isolates examined, 36 isolates (22.6 %) had low 
virulence phenotype, 49 isolates (30.8 %) had high virulence phenotype and 74 isolates 
(46.6 %) had moderate phenotype. The lab strain H37Rv exhibited the moderate 
virulence in THP-1 model, which caused 50 % macrophage lysis. I evaluated the 
virulence phenotype of Mtb on day 6 because it provided sufficient time to observe 
macrophage-Mtb interaction clearly through host cell lysis, enabling us to distinguish 
the isolates with really low or high virulent phenotypes.  
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Figure 6.1 Heat map of THP-1 cell lysis induced by different Mtb clinical isolates 
over 6-day post-infection 
Color from green to red represents the proportion of THP-1 lysis, ranging from 0-5 % to 
90-100%. The strains that caused cell lysis up to 90-100 % at day 6 (in red) were 
clustered as a group of high virulence phenotype, while to 0-5 % as a group of low 
virulence (in green) and the remainder as a group of moderate virulence.   
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6.3.2 Consistency of virulence phenotype of clinical isolates during in vitro passages  
It has been observed that in vitro serial passages of microorganisms may produce 
important changes in their genetic and phenotypic characteristics
344
. In Mtb, multiple in 
vitro subcultures of the laboratory strain H37Rv can reduce its ability to synthesize the 
cell wall lipid phthiocerol dimycocerosate (PDIM), an important Mtb virulence factor. 
This loss is irreversible and related to genetic change, particularly the deletion of two 
operons, namely drr and pps
345
. Hence, I examined whether the variation in the virulent 
phenotype observed was genetically stable through in vitro serial passage. I was very 
interested in the two extreme phenotypes of low and high virulence. Hence, I randomly 
selected approximately 20% isolates representative each group of phenotypes that were 
8 strains with low, 14 strains with high and 7 strains including H37Rv with moderate 
virulence. These isolates were serially passaged 10 times within 3 months; bacteria from 
passage 1
st
, 3
rd
, 7
th
 and the last 10
th
 were used to infect THP-1 and cell lysis was daily 
monitored (Figure 6.2).  
Among 8 low virulence isolates, five isolates (62.5 %) showed consistently low 
virulence during passages, two isolates (isolates 6 and 8) (25 %) changed the phenotype 
from low to moderate at the passage 10
th
. One isolate (isolate 19) (12.5 %) showed 
moderate virulence at passage 1
st
 but remained low virulence from passage 3
rd
 and 
afterwards, indicating that these changes were possibly minor variation among 
experiments. For the group of high virulence, 9 out of 14 (64.3 %) isolates remained 
high virulence during passages. In 5 isolates (isolates 114, 115, 126, 145, and 157) I 
observed inconsistently minor variations in virulence from high to high medium, and at 
the passage 10
th
 all of these isolates exhibit high virulence, indicating that this could be 
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possibly experiment-to-experiment variation. No isolates with moderate virulence 
(including H37Rv) remained consistent phenotype across initial screening and different 
passages. Among them, three isolates (isolate 50, 75, and 108) maintained the same 
phenotype while other isolates were variable across four passages because they are at 
borderline of phenotype grouping. To conclude, I observed distinct virulent phenotypes 
among different clinical isolates during serial passages, the isolates with low and high 
virulence remain stable while the moderate virulent isolates were likely to be variable 
across experiments.  
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Figure 6.2 Heat map of THP-1 cell lysis induced by Mtb clinical isolates at day 6 
post-infection from different in vitro passages 
Color from green to red represents the percentage of THP-1 lysis, ranging from 0-5 % to 
90-100 %. The strains that caused cell lysis at day 6 up to 90-100 % were considered as 
high virulence phenotype (in red), 0-5 % as low virulence (in green) and the remainder 
as moderate virulence. The isolates whose phenotype was consistent thorough screening 
and passages are indicated in bold with a superscripted star. 
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6.3.3 Validation of virulence phenotype of Mtb clinical isolates in hMDM  
THP-1 cells treated with PMA differentiate into mature macrophages that have been 
indicated to behave similarly to primary hMDM in their bacterial growth control and 
immune response to Mtb infection
346,347
.  However, PMA treatment is also considered as 
a confounding variable due to the fact that it activates the cells and produce TNF-α 
production, which could produce some undesirable response. Given this point, it is 
important that the results obtained with THP-1 cell line should be validated by in vivo 
studies or in hMDM cells for the results to be conclusive
347
. Therefore, I examined 
whether the difference in virulence of clinical isolates observed in THP-1 could be re-
produced in hMDM. Twenty-nine isolates including H37Rv at passage 10
th
, which were 
examined for the stability of virulent phenotype during in vitro serial passages, were 
used to infect hMDM from three healthy volunteers, and the percentages of cell lysis 
were daily assessed. In comparison to THP-1 cells, the lysis of hMDM was slower. For 
cells infected with a group of highly virulent isolates, complete destruction of THP-1 
cells was observed at day 6 post-infection while that of hMDM was observed at day 12 
(Figure 6.3). Therefore, the virulence phenotype of clinical isolates in infected hMDM 
was classified based on the level of cell lysis on day 12. Those were grouped for low 
virulence when they had ≤ 5 % of infected cells lysed, for high virulence when ≥ 90% 
of infected cells lysed, and the remainder was moderate virulence. 
Six out of eight (75 %) low virulent isolates in THP-1 exhibited consistently low 
virulence in hMDM from three subjects while an isolate (isolate 19) (12.5 %) changed 
phenotype from low in THP-1 to moderate in hMDM. Isolate 6 with low virulence in 
THP-1 showed a variation from low to moderate virulence among hMDM from 3 
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subjects, which could be possibly resulted from response variation among subjects or 
experimental variation. Among 14 isolates with high virulence in THP-1, 11 isolates 
(78.6 %) showed consistently high virulence phenotype in hMDM from 3 subjects 
whereas 3 isolates (21.4 %) changed to moderate phenotype. In moderate phenotype in 
THP-1, isolate 50 and H37Rv (28.6 %) showed consistently low virulence while isolate 
108 (14 %) showed consistently high virulence in hMDM. Two isolates 67 and 75 (28.6 
%) remained moderate virulence in hMDM whereas other two isolates 94 and 100 (28.6 
%) had phenotypic variation among different subjects. Altogether, these results indicate 
that majority (≥ 75 %) of isolates having low or high virulence in THP-1 conserved 
their phenotypes in hMDM while less consistent between these two cell types was 
observed in isolates having moderate virulence. 
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Figure 6.3 Heat map of cell lysis at day 12 post-infection induced by Mtb clinical 
isolates in hMDM from 3 subjects 
Color from green to red represents the percentage of hMDM lysis, ranging from 0-5 % 
to 90-100 %. The strains that caused cell lysis at day 12 up to 90-100 % were 
considered as high virulence phenotype (in red), 0-5 % as low virulence phenotype (in 
green) and the remainder as moderate virulence phenotype. The isolates whose 
phenotype was consistent thorough screening in THP-1 cells and hMDM from different 
subjects were indicated in bold with a superscripted star. 
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6.3.4 Association of Mtb virulence phenotype and cytokine response  
Several studies have revealed that Mtb strains with high virulence phenotype, which is 
indicated by their rapid intracellular growth in macrophage or by high lethality of 
infected animals, are able to suppress the host pro-inflammatory cytokine 
responses
53,66,343
. Such reduced immune responses might contribute to more rapid 
disease progression and transmission of these Mtb strains
61,60
. I hypothesized that the 
different virulence phenotypes in our study were associated with distinct patterns of host 
cytokine response. To answer this hypothesis, I infected hMDM from three healthy 
volunteers with each of 29 Mtb isolates, which were examined for consistency in 
virulent phenotype in both THP-1 cells and hMDM, and analyzed for production of pro-
inflammatory cytokine. 
It was noted that in hMDM model, 8 isolates showed low virulence phenotype, 9 
showed moderate virulence and 12 showed high virulence phenotype. Table 6.1 showed 
cytokine expression from infected hMDM and highlighted two observations. First, I 
observed a variation in cytokine production from three groups of virulence phenotype 
(greyed rows). Second, there was also variation in cytokine production among three 
independent subjects in response to infection (greyed column). Since low or high 
virulent phenotype remained consistently through in vitro serial passages or in different 
experimental models, I was interested in examining the influence of these two distinct 
phenotypes on cytokine response against the infection. The results showed that hMDM 
from two out of three individuals infected with high virulence isolates produced 
significantly higher level of IL-1β than that infected with low virulence isolates (S1, 
P=0.002 and S2, P= 0.0002) (Figure 6.4A). A similar trend was observed in the third 
individual, but was not statistically difference (P= 0.11). In contrast to IL-1β, the release 
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of IL-6 and TNF-α by hMDM infected with high virulence isolates were clearly reduced 
compared to the low virulence isolates (Figure 6.4 B, C). These results were observed in 
2 out of 3 subjects (TNF-α, S2, P= 0.03 and S3, P= 0.003; IL-6, S2, P= 0.02 and S3, P= 
0.002). Analyses of cytokine production in all three subjects  showed a significantly 
high concentration of IL-1β but low concentrations of IL-6 and TNF-α in high virulence 
isolates (IL-1β, P= 0.0001; IL-6, P= 0.002; and TNF- α, P= 0.006). (Figure 6.4D). 
 
 
  
Chapter 6 
182 
Table 6.1 Cytokines response in hMDM infected with clinical isolates from different virulence phenotypes   
    Isolates/ Phenotypes 
Cytokine Subject
a
 All  (n = 29) Low (n= 8) Moderate (n = 9) High (n = 12) 
IL-1β  
(pg/ml) 
S1 23.7 (36.1-45.9) 19.4 (15.7-25.6) 30.0 (26.1-42.1) 48.7 (42.8-56.1) 
S2 36.6 (33.4-64.3) 31.7 (27.8-33.5) 36.5 (34.0-53.5) 67.2 (39.9-80.3) 
S3 17.3 (14.5-21.3) 15.8 (12.9-19.7) 16.2 (14.5-17.5) 20.7 (15.8-26.6) 
S1, S2, and S3 19.1 (31.3-45.5) 15.7 (21.2-33.2) 17.4 (28.5-17.4) 24.8 (42.9-64.0) 
IL-6 
(pg/ml) 
S1 110.6 (147-177.0) 206.3 (110.8-290.2) 133.0 (98.3-177.0) 147.7 (113.8-162.5) 
S2 207.8 (183.8-351.3) 599.7 (251.2-877.7) 220.8 (194.2-344.9) 182.3 (161.0-194.3) 
S3 349.8 (292.1-736.6) 882.7 (582.7-1093.6) 342.4 (292.1-736.6) 307.8 (230.2-358.3) 
S1, S2, and S3 163.0 (217.6-350.5) 249.9 (387.5-873.9) 176.7 (86.7-343.6) 148.7 (182.3-271.2) 
TNF-α 
(pg/ml) 
S1 83.6 (110.2-180.9) 148.1 (105.2-166.4) 117.8 (83.3-181.1) 107.2 (84.5-148.1) 
S2 251.6 (180.0-435.2) 489.9 (280.8-585.0) 251.6 (183.2-465.8) 208.6 (170.3-261.9) 
S3 212.0 (160.1-490.5) 537.7 (326.0-662.0) 233.8(189.1-435.5) 161.2 (139.2-192.2) 
S1, S2, and S3 133.8 (184.2-329.4) 160.5 (264.6-555.7) 142.7 (51.8-329.2) 109.7 (160.8-212.6) 
a
Cytokines were measured in infected hMDM collected from  different subjects 
Data were represented by median (interquartile range) 
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Figure 6.4 Cytokine response in hMDM infected with low or high virulent Mtb clinical isolates  
(A) IL-1β, (B) IL-6, and (C) TNF-α expression by hMDM infected with low virulence Mtb (n= 8) or high virulence Mtb (n= 12) from three 
independent subjects. Bars in plots represent median values. (D) Average cytokine responses by infected hMDM from three subjects. Bars represent 
the mean value of cytokines with standard deviation. Comparisons across two virulent phenotypes were performed using Mann-Whitney U test.   
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6.3.5 Association of in vitro growth rate and virulent phenotype of Mtb clinical 
isolates 
Several previous studies have suggested that rapid destruction of infected macrophages 
could result from effective intracellular replication
152,259,290
. Mtb growth in liquid broth 
is likely to have positive correlation with its intracellular growth
343
 whereas other 
studies have showed that the in vitro growth in media does not influence bacterial 
growth inside the macrophages
339
. Therefore, I examined whether the intrinsic growth 
of bacteria in liquid media, where there is without nutrient limitations and immune 
pressure, could influence bacterial virulence. The OD600 of Mtb culture has a strong 
correlation with the CFU (see Section 3.2.5), hence I cultured Mtb isolates in liquid 
7H9T broth and evaluated bacterial growth by OD measurement. 
The log2 of OD600 value of 159 isolates and H37Rv was plotted over the 20-day period; 
overall I observed an increased number of bacteria during 20 days of measurement. As I 
anticipated, there was a wide variation in the growth curve among clinical isolates, 
ranging within 4 units of log2. Growth curves of many clinical strains were above the 
curve of H37Rv from day 6 (Figure 6.5). To compare the growth among different 
isolates, I determined a growth rate that was expressed as the slope of the line plotted in 
Figure 6.5. Approximately 20 % of them had growth rate 1.5-2 times higher than 
H37Rv while 12 % had significantly lower growth rate than lab strain (Figure 6.6A). I 
then investigated whether these distinct growth rates determined virulence of clinical 
isolates. There was no difference in growth rate between isolates with low, high or 
moderate virulence (P= 0.36) (Figure 6.6B). The growth rates of 29 isolates 
representative of three groups of virulence at 1
st
, 3
rd
, 7
th
 passage were also examined 
(Figure 6.6C, D, E). As previously presented, the low and high phenotypes were 
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conserved during in vitro passages. However, no statistical difference was observed 
among growth rate of low, high and moderate virulent isolates (1
st
: P= 0.15, 3
nd
: P= 
0.47, and 7
th
: P= 0.14) (Figure 6.6 C-E). These results confirmed that in vitro growth 
rate of Mtb did not contribute to host cell lysis. They also imply that outcome of Mtb 
infection is more likely determined by the interaction between macrophage and 
pathogen. 
 
Figure 6.5 Growth curves of Mtb clinical isolates and H37Rv in 7H9T broth at the 
initial screening 
The growth of bacteria (n= 160) was monitored by measuring the OD at 600nm. The 
growth curve of H37Rv was indicated in black thick line. 
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Figure 6.6 Growth rate of Mtb clinical isolates in 7H9T broth 
The growth rate of H37Rv and 159 clinical isolates (A) or of isolates with low (n= 36), moderate (n= 75) and high (n= 49) (B) at the initial 
screening were plotted. The growth rate of isolates with low (N= 8), moderate (N= 6), and high (N= 14) at passage 1
st 
(C), 3
rd 
(D), 7
th
 (E) were 
plotted. P value was determined using Kruskal-Wallis test. All P-value >0.05. 
Chapter 6 
187 
6.3.6 Association of Mtb lineages and virulence phenotype of clinical isolates 
The Mtb genotype has been demonstrated to influence the intracellular growth or 
pathogenicity of bacteria. The East-Asian/Beijing strains have been associated with 
rapid intracellular growth in cellular model
48,343
, high mortality in infected animals
56
, as 
well as drug resistance
70
. Therefore, I hypothesized that the East Asian/Beijing lineage 
is associated with the virulent phenotype of clinical isolates. 
 
Figure 6.7 Proportion of Mtb lineages in 159 clinical isolates 
I genotyped 159 Mtb isolates by LPS typing. In line with previous reports
20,70
, three 
main Mtb lineages that are known in Vietnam were observed in our isolate collection. 
Indo-oceanic lineage, with RD239 deleted, represented 49/159 (31%) of isolates. East 
Asian/Beijing lineage, with RD105 deleted, represented 80/159 (50%) of isolates. Euro-
American, pks 7bp deletion, was the least popular with 11% of isolates (Figure 6.7). 
There was a small proportion (5%) of undefined isolates that failed to generate a 
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product on repeated PCR for the two RD regions despite generating for other PCR 
products. To investigate the association of virulence phenotype and East Asian/Beijing 
lineages versus other lineages, I combined Euro-American, Indo-Oceanic and unknown 
group as non-Beijing lineages. The frequencies of East Asian/Beijing isolates with low, 
moderate and high virulence were 13/82 (15.9 %), 36/82 (43.9 %) and 33/82 (40.2 %), 
respectively, while there were 23/77 (29.9 %), 48/77 (49.4 %) and 16/77 (20.8 %) 
isolates with low, moderate, and high virulence, respectively, in non-Beijing lineages. 
When I compared the frequencies of Mtb genotypes contributing to each virulence 
phenotype, I found an influence of East Asian/Beijing lineage on virulence phenotype 
of Mtb (P= 0.01) and more closely, this lineage was associated with high virulence 
phenotype compared to low virulence (P= 0.004, OR= 3.65, 95%CI= 1.48-9.02) or to 
moderate virulence (P= 0.04, OR= 2.18, 95%CI= 1.03-4.61) (Table 6.2).  
Table 6.2 East Asian/Beijing strain was associated with high virulence phenotype 
 Phenotypes   Low  
(n = 36) 
Moderate 
 (n= 74) 
High 
 (n= 49) 
Non-Beijing (n, %) 23 (29.9) 38 (49.4) 16 (20.8) 
East-Asia/Beijing (n, %) 13 (15.9) 36 (43.9) 33 (40.2) 
Low vs. Moderate vs. High (P) 0.01 
Low vs. Moderate               (P) 
                                    OR (95%CI) 
0.21 
1.68 (0.74-3.80) 
Moderate vs. High               (P) 
                                    OR (95%CI) 
0.04 
2.18 (1.03-4.61) 
Low vs. High                      (P) 
                                    OR (95%CI) 
0.004 
3.65 (1.48-9.02) 
P: P value, were determined by using Chi-square test 
OR (95%CI): odds ratio (95% confidence interval) 
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6.4 Discussion 
In this study, I accessed Mtb virulence in a large sample set of 159 isolates from 
pulmonary TB patients by examining host cell lysis in macrophage models. I observed a 
wide range in cell lysis and regarding its extent, these Mtb clinical isolates were 
classified as being of low, moderate and high virulence. The extreme phenotypes of 
being low or high virulence in infected THP-1 cells were highly conserved during in 
vitro serial passages or in different model such as hMDM. I also confirmed that the high 
virulent isolates were associated with low production of TNF-α and IL-6. In consistent 
with previous studies, I clearly demonstrated that the East-Asian/Beijing lineage was 
associated with the high virulence phenotype, which strongly indicates that the lineage-
specific genetics could be the factor determining the interaction of macrophage and 
Mtb. 
The lysis of THP-1 cells induced by different Mtb isolated varied widely, ranging from 
no or very less cells lysed to 100% cells lysed after 6 days of infection. Such an 
outcome mirrored the diversity in the bacterial virulence which spanned a spectrum 
from low to high. Comparison of isolates with extreme phenotypes such as low and high 
virulence could enable us to further understand the determinants as well as the 
biological mechanism for bacterial virulence, which may contribute to TB treatment and 
disease control. Therefore, to discriminate the distinct phenotypes, the isolates with low 
virulence phenotype were defined by no capacity to lyse cells or lysing cells up to 5 % 
while the high virulence induced the cell lysis ≥ 90 %.  
Our study indicated that the levels of cytokines released by infected hMDM were highly 
variable in response to different strains. Nevertheless, there was a correlation of 
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cytokines induced by Mtb clinical isolates and their virulence. I observed lower 
concentration of IL-6 and TNF-α and higher IL-1β level among isolates with high 
virulence than in isolates with low virulence. The results on IL-6 and TNF-α has been 
consistent with the findings in previous study that demonstrated the correlation of low 
level of these cytokines and high necrotic cell death in THP-1 cells infected with K-
strain, a high virulent and transmitted Mtb
47
. Such a low inflammatory response has 
been observed in strains that are considered to be highly virulent due to rapid growth of 
Mtb in macrophages
260,343
, or high ability to cause tissue damage
57
 and early death in 
infected mice
53
, or highly transmissible
66
. Suppression of the pro-inflammatory cytokine 
response is likely to be a mechanism for survival and transmission of highly virulent 
bacteria because by avoiding the host protective immune response, the high virulent 
bacteria can rapidly replicate, leading to cell disruption for bacterial release. In addition, 
the cell lysis is known to release variety of cellular components that could enhance the 
influx of immune cells from the host, including neutrophils, that aggravate pathology by 
collateral tissue damage contributing to lung necrosis
69
. Therefore, it would be 
important to further examine the correlation of Mtb virulence and lung lesions in the 
patients.  
In this study, I observed an increased IL-1β concentration in high virulence phenotypes 
whereas many previous studies have demonstrated the reduced level of IL-1β produced 
by either murine or human macrophages infected with highly virulent 
mycobacteria
51,68,348
. Previous studies also have shown the increase level of IL-1β in 
virulent Mtb compared to BCG
349
 or in East Asian/Beijing compared to H37Rv or Euro-
American
67
. It has been demonstrated that the increased production of IL-1β in 
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macrophages infected with Mtb is dependent on caspase-1, a protease to cleave pro IL- 
1β to active form rather than due to the alteration in IL-1β transcription or level of pro 
IL-1β 350. Caspase-1 is also known to induce the host cell lysis which is accompanied by 
the release of IL-1β351,352. Therefore, the increased production of IL-1β in high 
virulence isolates could be involved in their alternative mechanism of inducing cell lysis 
which is dependent on caspase-1. Further examination on the level of caspase-1 in 
macrophages infected with low and high virulence isolates could help to elucidate the 
mechanism of bacterial virulence. 
There are many studies indicating the lineage-specific virulence of Mtb strains. 
Different models of infection with East Asian/Beijing genotype have suggested that this 
genotype leads to a hypervirulent phenotype compared with other strains such as Euro-
American or East Africa-Indian
51,54
. The East Asian/Beijing also causes a great concern 
because of its high prevalence and its association with multi-drug resistance
70
. A recent 
study has revealed the Beijing lineage is associated with high level of transmissions in 
Ho Chi Minh city, Vietnam
353
. In this study, I observed an association of clinical East 
Asian/ Beijing isolates with rapid cell lysis in macrophage models, which 
accumulatively demonstrates the hypervirulent phenotype of East Asian/Beijing 
genotype. The host cell lysis probably serves as an exit strategy which may help to 
explain why this genotype is likely to rapidly progress to active TB disease and has high 
transmission. Even though the East Asian/Beijing genotype is predominantly associated 
with high virulence, I still observed a proportion of East Asian/Beijing isolates with low 
virulence, which is in line with previous observation of virulent variation within East 
Asian/Beijing strains
56,57,69
. 
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Recent studies have indicated that Mtb has ability to cause phagosome rupture 
accompanied with the translocation intro the cytosol, which results in the host cell 
death
251
. The strains that lack the ESX-1 secretion system, such as BCG or mutant Mtb, 
fail in inducing phagosome rupture and cell death, which is reversed when the ESX-1 is 
restored in these bacteria
251,252
. A recent study has reported a clinical isolate that has a 
defect in the ESX-1 secretion system due to the insertion mutation in eccCa1 gene, one 
of component genes related to EXS-1
354
. This isolates is unable to disrupt the 
phagosome lysosome in THP-1 cells and associated with a mild pathology in lung of 
infected mice. A comparison on 12 ESX-1–associated genes on genomes of 143 clinical 
isolates and H37Rv has revealed that 26 isolates (18%) show critical mutations that are 
likely to prevent or diminish ESX-1 secretion
354
. A study using TEM has found that 
different Mtb clinical isolates have variations in intracellular niche preference which 
could be phagosome or cytosol
253
. Therefore, the difference in ability to rupture 
phagosomes, which is influenced by the variation on ESX-1-associated genes, could 
explain for the low or high level of host cell lysis which is associated with low or high 
virulence of clinical isolates.  
In conclusion, there is a wide variation on the bacterial virulence among different 
clinical Mtb isolates, which is associated with cytokine response and bacterial lineages. 
More specifically, high virulence isolates predominantly belong to East Asian/Beijing 
genotype and are able to suppress the expression of inflammatory cytokines of IL-6 and 
TNF-α in infected macrophage. The molecular mechanisms which could potentially 
contribute to variation in virulence between strains are not fully understood. Future 
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comparative genomic studies could be essential to shed light on discovering the 
determinants of such phenotypic differences. 
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CONCLUSION AND FUTURE RESEARCH 
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TB in humans is very complex with a wide range of pathology and clinical 
manifestations. Approximately one third of human population is latently infected with 
Mtb, but only 10% of them develop active TB disease during their lifetime. The lung is 
the favorable place for Mtb to develop the disease, however the bacteria can 
hematogenously spread to other organs or tissues where it causes extra-pulmonary TB, 
of which TBM is the most severe form. There are differences in clinical complications 
among PTB patients or among TBM patients. Some PTB patients have bloody cough or 
very severe lung damage while some TBM patients have very severe disease and are at 
high risk of death. To successfully control TB, I need to understand the factors that 
influence the susceptibility to pulmonary or extra-pulmonary TB, the disease severity, 
and the treatment outcome. For that reason, for this thesis I studied how the variations in 
host cellular and genetic factors, and the diversity in the virulence of Mtb strains, 
influence TB susceptibility. 
The antimicrobial activities of macrophages are achieved due to phagosomal 
maturation. Bacteria are killed mainly by the extremely acidic and protease-enriched 
environment that is achieved within the lysosome by fusion with multiple intra-vesicles, 
such as from the early or late endosomal system, the secretory system (including 
secretory lysosomes), and even the endoplasmic reticulum. All these components and 
proteins can affect the function of phagosome, therefore it could be misleading if the 
antimicrobial activities of macrophages are accessed by the presence of protein-markers 
only
275
. Previous studies have developed bead-based assays to assess in real-time the 
alterations in the kinetics of phagosomal physiology that directly indicate their influence 
to intracellular growth of bacteria
271,273,275,291
. In Chapter 3, I adopted and modified the 
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reporter beads specific for phagocytosis, acidification and proteolysis. Our beads were 
coated with TDM, an immunogenic component of Mtb’s cell wall recognized by 
MARCO and MINCLE receptor and with β-glucan, a fungi’s cell wall component 
recognized by DECTIN-1 receptor. Hence, I could study the macrophage antimicrobial 
activity induced by pathways initiated by these receptors. The assays exploiting these 
reporter beads revealed the high ability in bead uptake of macrophage cell lines. I also 
observed the kinetics of acidification and proteolysis in macrophage cell lines that are 
similar to previous reports. Most importantly, our bead-based assays showed the 
consistent repetitive results in macrophage cell lines. They also revealed the 
heterogeneity in the phagosomal activities among different host that may help to explain 
the difference in TB susceptibility in host populations. The Mtb reporter strain 
expressing fluorescent protein generated in this study provided us a sensitive and rapid 
method to study the bacterial growth within the macrophages as well ability of 
macrophages to inhibit intracellular bacterial growth. The fluorescence intensity was 
correlative of bacterial viability and it allowed us to observe the difference in the 
outcome of macrophage-bacteria interaction when macrophage cell lines were infected 
with Mtb at different MOI. The bead-based assays could not only be exploited to study 
the macrophage antimicrobial activities in TB pathogenesis but also could be modified 
to study such macrophage function in the pathogenesis of other infectious diseases 
caused by intracellular pathogens. Likewise, the model of bacterial expressing 
fluorescent protein could be generated for other intracellular bacteria to study the 
pathogen-host cell interactions or to follow the course of infections in animal models.   
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In Chapter 4, I exploited the bead-based assays established in chapter 3 to study 
whether the macrophage antimicrobial activities are associated with TB susceptibility. 
The acidification and proteolysis of hMDM collected from individuals with LTB were 
lower than that from patients with active TB when the macrophages were incubated 
with beads coated with either IgG, TDM or β-glucan. In response to the infection of live 
Mtb reporter strains, the proteolysis activity of hMDM from both LTB and ATB groups 
were significantly decreased compared to the resting macrophages. Consequently, the 
intracellular bacterial loads were increased, resulting in the necrotic death of infected 
hMDM from both LTB and ATB groups after 4 day post infection and afterwards. Our 
results indicated that Mtb can modulate the antimicrobial activities of macrophages to 
benefit their survival. The observation of no difference in antimicrobial activities of 
macrophage between LTB and ATB or between PTB and TBM in response to Mtb 
infection suggests that macrophage activities alone do not count for the development of 
different TB clinical phenotypes. Lu et al. have showed the efficiency of antibodies 
from people with LTB in enhancing the killing ability of macrophages against Mtb
183
. It 
is also known that the T cells can either drive the macrophage towards M1 activation 
state that has enhanced antimicrobial functions or direct cytolysis of Mtb-infected 
macrophages, resulting the control of Mtb growth
181,355
. Thus there could be difference 
in the T cells response which results in the protection from TB in some people and TB 
progression in others. It would be essential to further examine whether the incorporation 
of T cells or antibody and macrophage from LTB and ATB could help to understand the 
immunological mechanism in TB protection or TB development, which may allow us to 
predict the susceptibility to TB so that individuals at risk could be efficiently treated for 
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TB elimination. Although the ligand-coated beads are limited in reflecting the 
complicated interaction between antimicrobial functions of macrophages and live Mtb, 
this model suggests for the differences in macrophage antimicrobial functions driven by 
distinct immunogenic ligands and their associated pathways in host. More specifically, 
TDM is likely to inhibit the macrophage antimicrobial function, which may benefit for 
Mtb survival and causing disease
247,309
. The results could further help for the 
development of new class of anti-Mtb compounds that target the bacterial proteins/lipids 
that modulate the host immune response. 
Host genetic variation has been reported to be an important factor for the susceptibility 
to TB
20,328,329
. In Chapter 5, I found that among variations of three receptor genes 
involved in macrophage phagocytosis, two SNPs rs2278589 and rs6751745 on MARCO 
genes were strongly associated with susceptibility  to PTB as well as susceptible to 
infection with Beijing strains during the development of PTB. Such associations were 
possibly resulted from the association of these two MARCO SNPs with the reduced 
macrophage phagocytosis at the beginning of infection. The impaired phagocytosis then 
could limit the macrophage killing activity and antigen presentation that may lead to the 
increased susceptibility to active TB. The deficient response could also result in 
increased bacterial replication, which could manifest as severe lung abnormality. The 
two MARCO SNPs do not influence the MARCO transcription or change the protein 
sequence hence they could be the markers of functional variants that affect ability to 
bind bacterial ligands, reducing phagocytosis and increasing the disease susceptibility. 
Further study on sequencing MARCO gene would help to identify such causative 
mutations, which can allow us to understand the molecular mechanism of phagocytosis 
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impairment which could help in TB prevention and treatment. The MARCO SNPs 
rs2278589 and rs6751745 were found to be associated with the severe lung damage 
which may prolong the treatment time hence a further examination on the association of 
MARCO SNPs and time to smear conversion could help for host-directed therapy. 
In chapter 6, I studied the virulence of Mtb in a large number of isolates from PTB 
patients by examining the cell lysis of infected macrophages. I observed a spectrum of 
host cytotoxicity which could allow Mtb strains to be grouped as low, high and 
moderate phenotypes of virulence. I demonstrated that high virulent Mtb strains are 
associated with severe host cytotoxicity and reduced inflammatory cytokines while the 
low virulent strains fail to promote the host cell death and induce strong immune 
response. These results are consistent with previous studies of Mtb virulence reflected 
by rapid intracellular growth or high mortality of infected animals. It is likely that the 
reduced inflammatory response facilitates Mtb to multiply and lyse macrophages, so 
that Mtb could escape, infect other new cells and establish new infection. The difference 
in the virulence of Mtb strains was determined by their genetic background, of which 
Beijing genotype was strongly associated with high virulence while non-Beijing 
genotype was predominantly being low virulent. However, I still observed a proportion 
of Beijing isolates also being low virulent and a proportion of non-Beijing isolates being 
high virulent. The variation in the ESX-1 region of Mtb genome is thought to be related 
to distinct ability in inducing phagosome rupture
251,252
, which thereby may lead to 
different extent of cell death. Hence, it would be important to study the phagosome 
rupture of Mtb strains with low and high virulence in order to understand the underlying 
cellular mechanism of such different phenotypes. With the emerge of next generation 
Chapter 7 
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sequencing technologies coupled with advances in bioinformatics analysis in a genome 
era nowadays, whole genome sequencing (WGS) of bacteria would provide an 
invaluable tool in diagnosis and understanding insight bacterial pathogens, including 
their evolution, pathogenesis, and the design of related therapeutic interventions
356–358
. 
Therefore, the comparison of WGS of low and high virulent isolates of Beijing and non-
Beijing isolates would allow us to identify the specific genetic determinants for Mtb 
virulence. 
In conclusion, the findings from this thesis contribute to the current understanding of the 
influence of host and bacterial factors to the TB susceptibility and clinical 
manifestations of TB infection. They also provide foundation for further studies on 
improving TB prevention and treatment of TB.  
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APPENDIX 
Supplementary figure 4.1 Macrophage activities in PTB and TBM individuals 
Monocyte-derived macrophages from subjects with LTB, PTB, and TBM at day 7 were 
treated with reporter beads coated with either IgG, TDM or β-glucan. (A) Phagocytosis 
of macrophages from LTB (n= 39), PTB (n= 42) and TBM (n= 42), (B) Acidification 
Activity index at 60 min in macrophage from LTB (n= 43), PTB (n= 54) and TBM (n= 
60) and (C) Proteolysis Activity index at 210 min upon beat treatment in macrophage 
from LTB (n= 42), PTB (n= 52) and TBM (n= 59). Bars in the plots represent median 
values. To compare activity of macrophages from PTB and TBM individuals, P-value 
was determined using Mann-Whitney U test.  
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Supplementary figure 4.2 Proteolysis activity and killing ability of macrophages 
from PTB and TBM individuals during Mtb infection 
Macrophages derived from cryopreserved monocytes from subjects with LTB, PTB and 
TBM at day 5 were infected with reporter Mtb at MOI 1 or left uninfected. (A) 
Proteolytic Activity index of infected macrophages from LTB (n= 32), PTB (n= 48), 
and TBM (n= 44) individuals at 210 min. At day 2 post infection, macrophages were 
treated with reporter beads coated with IgG to measure proteolytic activity. (B, C) The 
bacteria intracellular growth during 5 days of infection was assessed by the mCherry 
intensity readout (B) and the viability of infected macrophages (C) from LTB (n= 26), 
PTB (n= 52) and TBM (n= 53). L indicates LTB, P indicates PTB, M indicates TBM. 
Bars in the plot represent median values. To compare activity of macrophages from 
PTB and TBM individuals, P-value was determined using Mann-Whitney U test. 
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Supplementary figure 4.3 Correlation between phagocytosis and acidification or 
proteolysis activities in macrophages treated with beads coated with either IgG, 
TDM or β-glucan (G-I). Macrophages were from LTB and ATB combined. r: 
correlation coefficient 
 
 
